WO2023054952A1 - Solventless quantum dot composition, method for producing same, and cured film, color filter, and display device comprising same - Google Patents
Solventless quantum dot composition, method for producing same, and cured film, color filter, and display device comprising same Download PDFInfo
- Publication number
- WO2023054952A1 WO2023054952A1 PCT/KR2022/013950 KR2022013950W WO2023054952A1 WO 2023054952 A1 WO2023054952 A1 WO 2023054952A1 KR 2022013950 W KR2022013950 W KR 2022013950W WO 2023054952 A1 WO2023054952 A1 WO 2023054952A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- quantum dot
- solvent
- group
- ligand
- dot composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/50—Sympathetic, colour changing or similar inks
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/02—Printing inks
- C09D11/03—Printing inks characterised by features other than the chemical nature of the binder
- C09D11/037—Printing inks characterised by features other than the chemical nature of the binder characterised by the pigment
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/02—Printing inks
- C09D11/10—Printing inks based on artificial resins
- C09D11/101—Inks specially adapted for printing processes involving curing by wave energy or particle radiation, e.g. with UV-curing following the printing
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/02—Printing inks
- C09D11/10—Printing inks based on artificial resins
- C09D11/106—Printing inks based on artificial resins containing macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C09D11/107—Printing inks based on artificial resins containing macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds from unsaturated acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/30—Inkjet printing inks
- C09D11/32—Inkjet printing inks characterised by colouring agents
- C09D11/322—Pigment inks
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
- C09K11/025—Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/0883—Arsenides; Nitrides; Phosphides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/54—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing zinc or cadmium
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/60—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing iron, cobalt or nickel
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/70—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing phosphorus
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/88—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing selenium, tellurium or unspecified chalcogen elements
- C09K11/881—Chalcogenides
- C09K11/883—Chalcogenides with zinc or cadmium
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B5/00—Optical elements other than lenses
- G02B5/20—Filters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
Definitions
- the present invention relates to a solvent-free quantum dot composition, a method for preparing the same, and a cured film including the same, a color filter, and a display device.
- the solvent-free quantum dot composition according to the present invention includes quantum dots surface-modified with two or more ligands, has low viscosity and excellent optical properties, and can be prepared by directly substituting ligands in a corresponding solution after synthesizing quantum dots (QDs). process is simplified.
- Quantum dot is a so-called semiconductor nanocrystals, which can generate various colors by generating light of different wavelengths for each particle size without changing the type of material, and is said to have higher color purity and light stability than conventional light emitting materials. Due to its advantages, it is attracting attention as a next-generation light emitting device.
- quantum dots which have become a new trend in the display field, can be applied to various displays and electronic devices in addition to TVs and LEDs.
- Quantum dots represented by CdSe, InP, etc.
- CdSe, InP, etc. are rapidly developing in terms of luminous efficiency (Quantum Yield), and synthesis methods with luminous efficiency close to 100% have been introduced.
- TVs using quantum dot sheets are currently being commercialized.
- quantum dots are included in the color filter layer of the existing LED TV (pigments and dyes are excluded), and a self-emitting version of the quantum dot TV is being developed instead of filtering in the color filter layer.
- the core of the development of such a quantum dot TV is focused on how much light efficiency of the quantum dots can be maintained in the process of configuring the pixels and the manufacturing process.
- a color filter applied to a conventional display is generally formed through a patterning process in which a desired pattern is formed through an exposure process in which a photomask is applied using a photosensitive resist composition, and then the unexposed portion is dissolved and removed through a development process.
- the viscosity of the quantum dot composition used in the inkjet method is required to be 100 cps or less, preferably 50 cps or less, a solvent is included to realize low viscosity.
- the quantum dot composition includes a solvent, there is a limit in increasing the thickness or increasing the film thickness after curing, and there is a concern about environmental pollution due to the use of an organic solvent.
- Hansol Chemical Co., Ltd. has applied for a solvent-free quantum dot composition, a manufacturing method thereof, and a cured film including the same, a color filter, and a display device (No. 10-2021-0011711).
- the problem to be solved by the present invention is to use the solution in which the quantum dots are synthesized as it is in the ligand substitution process without a separation and purification process such as centrifugation, thereby simplifying the process, reducing the cost accordingly, and providing excellent light efficiency and lower viscosity. It is to provide a solvent-free quantum dot composition and a manufacturing method thereof.
- Another problem to be solved in the present invention is to provide a cured film containing the solvent-free quantum dot composition, a color filter and a display device.
- M is a divalent to tetravalent metal
- R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms
- n is an integer from 2 to 4.
- step (d) obtaining surface-modified quantum dots from the product of step (c);
- the primary ligand has a molecular weight of 100 g / mol to 500 g / mol, and provides a method for producing a solvent-free quantum dot composition, characterized in that it comprises an ethylene glycol structure in 1 to 5 repeating units.
- At least one of R 1 to R 3 in Formula 1 repeatedly includes an ethylene glycol structure
- the number of repeating units of the total ethylene glycol structure included in R 1 to R 3 is 2 to 15,
- It provides a method for producing a solvent-free quantum dot composition, characterized in that an organic group of C1 to C15 is bonded to the terminal of the ethylene glycol structure.
- the tertiary ligand provides a method for preparing a solvent-free quantum dot composition represented by Formula 2 below.
- L is a single bond or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkylene group and a substituted or unsubstituted C1 to C20 alkenylene group;
- R is hydrogen or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkyl group and a substituted or unsubstituted C1 to C20 alkenyl group.
- the mixing ratio of the quantum dots and all ligands is 1:1 to 1:20 by weight, providing a method for producing a solvent-free quantum dot composition.
- the molar ratio of the primary ligand and the secondary ligand added to the solution is 1:1 to 1:20, providing a method for producing a solvent-free quantum dot composition.
- the molar ratio of the primary ligand, secondary ligand and tertiary ligand added to the solution is 1: 1 to 20: 1 to 30, providing a method for producing a solvent-free quantum dot composition.
- the primary ligand is from the group consisting of methoxy triethylene glycol thioglycolate and 2-(2-methoxyethoxy)acetic acid Provides a method for producing one or more selected, solvent-free quantum dot compositions.
- the secondary ligand is zinc-(3-methoxybutyl 3-mercaptopropionate) 2 (Zn-(3-methoxybutyl 3-mercaptopropionate) 2 ), zinc-(3-methoxybutyl thioglycolic acid) 2 (Zn-(3-methoxybutyl thioglycolate) 2 ), zinc-(2-ethylhexyl thioglycolate) 2 (Zn-(2-ethylhexyl thioglycolate) 2 ), zinc-(butyl mercaptopropionic acid) 2 (Zn-( butyl mercaptopropionate) 2 ), zinc-(isopropyl mercaptopropionate) 2 (Zn-(isopropyl mercaptopropionate) 2 ), zinc-(bis-(butoxy triethylene glycol) mercapto succinic acid) 2 (Zn-(Bis-( butoxy triethylene glycol)
- the tertiary ligand is 2-carboxyethyl acrylate, mono-2-(acryloyloxy)ethyl succinate, mono-2-( methacryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl maleate, 2-[2 -(2-methoxyethoxy)ethoxy]acetic acid (2-[2-(2-methoxyethoxy)ethoxy]acetic acid) and 2-(2-methoxyethoxy)acetic acid acid) provides a method for producing a solvent-free quantum dot composition, which is at least one selected from the group consisting of
- the solution contains fatty acids, fatty acid derivatives, by-products of the quantum dot synthesis reaction, dioctyl octadecenamide, trioctylphosphine and its oxides, n-octadecene, tri Octylamine, metal acetate, metal oleate, tris(trimethylsilyl)phosphine, selenium (Se), sulfur (S), selenium-trioctylphosphine, sulfur-trioctylphos It provides a method for producing a solvent-free quantum dot composition comprising at least one selected from the group consisting of pin, chloride salt and metal chloride.
- the photopolymerizable monomer is 1,6-hexanediol diacrylate, and a method for preparing a solvent-free quantum dot composition is provided.
- the quantum dots may include a primary ligand including an ethylene glycol structure
- a secondary ligand represented by Formula 1 below: Provides a solvent-free quantum dot composition that is surface-modified with.
- M is a divalent to tetravalent metal
- R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms
- n is an integer from 2 to 4.
- the surface-modified quantum dot provides a solvent-free quantum dot composition that is surface-modified with a tertiary ligand having 3 to 40 carbon atoms including a carboxyl group.
- the surface modification of the quantum dots provides a solvent-free quantum dot composition, characterized in that made in a solution in which the quantum dots are synthesized.
- the primary ligand has a molecular weight of 100 g/mol to 500 g/mol, and provides a solvent-free quantum dot composition comprising an ethylene glycol structure in 1 to 5 repeating units.
- At least one of R 1 to R 3 in Formula 1 repeatedly includes an ethylene glycol structure
- the number of repeating units of the total ethylene glycol structure included in R 1 to R 3 is 2 to 15,
- It provides a solvent-free quantum dot composition characterized in that an organic group of C1 to C15 is bonded to the terminal of the ethylene glycol structure.
- the tertiary ligand provides a solvent-free quantum dot composition represented by Formula 2 below.
- L is a single bond or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkylene group and a substituted or unsubstituted C1 to C20 alkenylene group;
- R is hydrogen or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkyl group and a substituted or unsubstituted C1 to C20 alkenyl group.
- the primary ligand is from the group consisting of methoxy triethylene glycol thioglycolate and 2-(2-methoxyethoxy)acetic acid Provides one or more selected, solvent-free quantum dot compositions.
- the secondary ligand is zinc-(3-methoxybutyl 3-mercaptopropionate) 2 (Zn-(3-methoxybutyl 3-mercaptopropionate) 2 ), zinc-(3-methoxybutyl thioglycolic acid) 2 (Zn-(3-methoxybutyl thioglycolate) 2 ), zinc-(2-ethylhexyl thioglycolate) 2 (Zn-(2-ethylhexyl thioglycolate) 2 ), zinc-(butyl mercaptopropionic acid) 2 (Zn-( butyl mercaptopropionate) 2 ), zinc-(isopropyl mercaptopropionate) 2 (Zn-(isopropyl mercaptopropionate) 2 ), zinc-(bis-(butoxy triethylene glycol) mercapto succinic acid) 2 (Zn-(Bis-( butoxy triethylene glycol)
- the tertiary ligand is 2-carboxyethyl acrylate, mono-2-(acryloyloxy)ethyl succinate, mono-2-( methacryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl maleate, 2-[2 -(2-methoxyethoxy)ethoxy]acetic acid (2-[2-(2-methoxyethoxy)ethoxy]acetic acid) and 2-(2-methoxyethoxy)acetic acid acid) to provide a solvent-free quantum dot composition that is at least one selected from the group consisting of.
- M is Mg, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, Sr, Mo, Pd, Cd, In or Sn, solvent-free
- a quantum dot composition is provided.
- the M is Zn, providing a solvent-free quantum dot composition.
- the molar ratio of the primary ligand to the secondary ligand is 1:1 to 1:20, providing a solvent-free quantum dot composition.
- the molar ratio of the primary ligand, secondary ligand and tertiary ligand is 1: 1 to 20: 1 to 30, providing a solvent-free quantum dot composition.
- the composition ratio of the quantum dots and the ligand is 1:1 to 1:20 by weight, providing a solvent-free quantum dot composition.
- the photopolymerizable monomer is a (meth)acrylate-based monomer, providing a solvent-free quantum dot composition.
- the photopolymerizable monomer is 1,6-hexandiol diacrylate, providing a solvent-free quantum dot composition.
- a solvent-free quantum dot composition having a viscosity of 30 cps or less is provided.
- a solvent-free quantum dot composition used for inkjet printing is provided.
- a cured film prepared using the solvent-free quantum dot composition is provided.
- a cured film having an absolute quantum efficiency of 30% or more is provided.
- a color filter including the solvent-free quantum dot composition is provided.
- a display device including the color filter is provided.
- quantum dot composition and its manufacturing method have advantages that enable this, and thus process simplification and cost reduction are achieved.
- the solvent-free quantum dot composition according to the present invention may exhibit excellent miscibility between quantum dots and monomers without including a solvent.
- the solvent-free quantum dot composition according to the present invention since the solvent-free quantum dot composition according to the present invention has excellent optical properties and low viscosity, it can be used for inkjet printing.
- (meth)acrylate represents acrylate and methacrylate
- (meth)acryl represents acryl and methacryl
- (meth)acryloyl represents acryloyl. and methacryloyl.
- monomers in the present invention are distinguished from oligomers and polymers and refer to compounds having a weight average molecular weight of 1,000 or less.
- photopolymerizable monomer refers to a functional group involved in polymerization, such as a (meth)acrylate group.
- organic group means a C1 to C30 straight chain or branched chain alkyl group, a C2 to C30 straight chain or branched chain alkenyl group, or a C2 to C30 straight chain or branched chain alkynyl group.
- alkyl group, alkenyl group, and alkynyl group may be substituted or unsubstituted, respectively.
- alkyl means a monovalent substituent derived from a straight or branched chain saturated hydrocarbon having 1 to 40 carbon atoms. Examples thereof include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl, and the like.
- alkenyl means a monovalent substituent derived from a straight-chain or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond. Examples thereof include, but are not limited to, vinyl, allyl, isopropenyl, and 2-butenyl.
- the quantum dot composition according to an embodiment of the present invention is a solvent-free quantum dot composition, and specifically, even if it does not contain a solvent, it has low viscosity and excellent optical properties, so it can be applied to inkjet printing.
- a solvent-free quantum dot composition comprising quantum dots and a photopolymerizable monomer, wherein the quantum dots are surface-modified with a primary ligand containing an ethylene glycol structure and a secondary ligand represented by Formula 1 below provides
- quantum dots and photopolymerizable monomers, and the quantum dots are surface-modified with a primary ligand having an ethylene glycol structure, a secondary ligand represented by Formula 1 below, and a tertiary ligand having 3 to 40 carbon atoms including a carboxyl group.
- a phosphorus, solvent-free quantum dot composition is provided.
- M is a divalent to tetravalent metal
- R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms
- n is an integer from 2 to 4.
- the surface modification of the quantum dots may be performed in a solution in which the quantum dots are synthesized.
- Quantum Dot is a nano-sized semiconductor material, and may have different energy band gaps depending on its size and composition, and thus emit light of various emission wavelengths.
- quantum dots have a homogeneous monolayer structure; a multilayer structure such as a core-shell type, a gradient structure, and the like; or a mixture thereof.
- each layer may contain components different from each other, such as (semi)metal oxides.
- the quantum dot may be freely selected from a group II-VI compound, a group III-V compound, a group IV-VI compound, a group IV element, a group IV compound, and combinations thereof.
- the core and the shell may be freely composed of the components exemplified below, respectively.
- the II-VI compound is a binary element compound selected from the group consisting of CdO, CdS, CdSe, CdTe, ZnO, ZnS, ZnSe, ZnTe, HgS, HgSe, HgTe, MgSe, MgS, and mixtures thereof;
- the group III-V compound is a binary element compound selected from the group consisting of GaN, GaP, GaAs, GaSb, AlN, AlP, AlAs, AlSb, InN, InP, InAs, InSb, and mixtures thereof;
- it may be selected from the group consisting of quaternary compounds selected from the group consisting of GaAlNP, GaAlNAs, GaAlNSb, GaAlPAs, GaAlPSb, GaInNP, GaInNAs, GaInNSb, GaInPAs, GaInPSb, InAlNP, InAlNAs, InAlNSb, InAlPAs, InAlPSb, and mixtures thereof.
- the group IV-VI compound is a binary compound selected from the group consisting of SnS, SnSe, SnTe, PbS, PbSe, PbTe, and mixtures thereof; a ternary compound selected from the group consisting of SnSeS, SnSeTe, SnSTe, PbSeS, PbSeTe, PbSTe, SnPbS, SnPbSe, SnPbTe, and mixtures thereof; And it may be selected from the group consisting of quaternary compounds selected from the group consisting of SnPbSSe, SnPbSeTe, SnPbSTe, and mixtures thereof.
- the group IV element may be selected from the group consisting of Si, Ge, and mixtures thereof.
- the group IV compound may be a binary element compound selected from the group consisting of SiC, SiGe, and mixtures thereof.
- the above-mentioned two-element compound, three-element compound, or quaternary element compound may be present in the particle at a uniform concentration, or may be present in the same particle in a state in which the concentration distribution is partially different.
- one quantum dot may have a core/shell structure surrounding another quantum dot.
- the interface between the core and the shell may have a concentration gradient in which the concentration of elements present in the shell decreases toward the center.
- the shape of the quantum dot is not particularly limited as long as it is a shape commonly used in the art.
- spherical, rod-shaped, pyramidal, disc-shaped, multi-arm, or cubic nanoparticles, nanotubes, nanowires, nanofibers, nanoplatelet particles etc. can be used.
- the size of the quantum dots is not particularly limited and may be appropriately adjusted within a common range known in the art.
- the average particle diameter (D50) of the quantum dots may be about 2 to 10 nm.
- the particle diameter of the quantum dots is controlled to be in the range of about 2 to 10 nm, light of a desired color can be emitted.
- the particle diameter of the quantum dot core/shell containing InP is about 5 to 6 nm, light having a wavelength of about 520 to 550 nm can be emitted, while the particle diameter of the quantum dot core/shell containing InP is about In the case of 7 to 8 nm, light of about 620 to 640 wavelengths can be emitted.
- a non-cadmium (Cd) group III-V QD eg, InP, InGaP, InZnP, GaN, GaAs, GaP
- Cd non-cadmium
- the quantum dots may have a full width of half maximum (FWHM) of an emission wavelength spectrum of about 40 nm or less, and color purity or color reproducibility may be improved within this range.
- FWHM full width of half maximum
- the quantum dots since light emitted through the quantum dots is emitted in all directions, a wide viewing angle may be improved.
- the content of the quantum dot may be 1 to 60% by weight, preferably 20 to 50% by weight based on the total weight of the solvent-free quantum dot composition.
- the ligand serves to modify the surface of the quantum dots.
- Quantum dots have a barrier to dispersal to photopolymerizable monomers due to their hydrophobic surface properties, and the miscibility of quantum dots to photopolymerizable monomers can be improved by modifying the surface of quantum dots with appropriate ligands.
- the ligand may include a primary ligand including an ethylene glycol structure and a secondary ligand represented by Chemical Formula 1 below.
- the ligand may include a primary ligand having an ethylene glycol structure, a secondary ligand represented by Chemical Formula 1 below, and a tertiary ligand having 3 to 40 carbon atoms including a carboxyl group.
- the primary ligand is introduced into the solution in which the quantum dot is synthesized and first modifies the surface of the hydrophobic quantum dot so that the surface of the quantum dot has a slight polarity. Facilitates substitution of secondary ligands.
- M is a divalent to tetravalent metal
- R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms
- n is an integer of 2 to 4.
- the solvents used in the production of quantum dots are hydrophobic (for example, solvents such as 1-Octadecene, n-octadecene, and trioctyl amine are used), and various synthetic residues are present in the solution in which the quantum dots are synthesized.
- fatty acids such as oleic acid, fatty acid derivatives such as octyl oleate, other by-products such as dioctyl octadecenamide, trioctylphosphine and its oxides, solvents such as n-octadecene or trioctyl amine, metal acetate, metal oleate, tris(trimethylsilyl)phosphide Since pin, Se, S, Se-trioctylphosphine, S-trioctylphosphine, chloride salt, metal chloride, etc.) are mixed, most of the metal-thiol ligands are included immediately without separation and purification of quantum dots.
- the primary ligand preferably has a molecular weight of 100 g / mol to 500 g / mol, more preferably has a molecular weight of 100 g / mol to 500 g / mol and comprises an ethylene glycol structure with 1 to 5 repeating units.
- MTEGT methoxy triethylene glycol thioglycolate
- MEAA 2-(2-Methoxyethoxy)acetic acid
- the secondary ligand may be a metal-thiol-based compound formed by reacting a metal salt with a thiol-based compound.
- M is a divalent to tetravalent metal.
- M is a group 2 to 14 metal, Mg, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, Sr, Y, Zr, It may be Nb, Mo, Tc, Ru, Rh, Pd, Cd, In or Sn, preferably Zn.
- n is determined according to the valence of M and is an integer of 2 to 4.
- At least one of R 1 to R 3 repeatedly includes an ethylene glycol structure, and the total number of repeating units of the ethylene glycol structure included in R 1 to R 3 is 2 to 15, , It may be characterized in that an organic group of C1 to C15 is bonded to the terminal of the ethylene glycol structure.
- R 1 to R 3 in Formula 1 may be an organic group having 3 to 20 carbon atoms.
- the thiol group in the secondary ligand has excellent affinity with the surface of the quantum dots, the dispersibility of the quantum dots in the photopolymerizable monomer can be improved.
- the secondary ligand includes not only a thiol group, but also an ester, ether, carbonyl, carboxyl group, alkoxy group, cycloalkyl group, or hydroxy group, thereby maximizing the dispersibility of the surface-modified quantum dot to a polar monomer having hydrophobicity.
- a quantum dot composition including such quantum dots may have advantageous characteristics (eg, low viscosity) for a display process.
- a thiol-based compound having 3 or less carbon atoms surface modification of quantum dots is possible, but due to the high polarity of surface-modified quantum dots, dispersion in common solvents and monomers may be difficult.
- the secondary ligand is specifically Zn-(3-methoxybutyl 3-mercaptopropionate) 2 , Zn-(3-methoxybutyl thioglycolate) 2 , Zn-(2-ethylhexyl thioglycolate) 2 , Zn-(butyl mercaptopropionate) 2, Zn-( isopropyl mercaptopropionate) 2, Zn-(Bis-(butoxy triethylene glycol)mercapto succinate) 2 and Zn-(poly(ethylene glycol)methyl ether-thioglycolate) 2 may be at least one selected from the group consisting of.
- the tertiary ligand may have 3 to 40 carbon atoms and include a carboxyl group. Also, according to an embodiment of the present invention, the tertiary ligand may not include a thiol group.
- the tertiary ligand may be represented by Formula 2 below.
- L is a single bond or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkylene group and a substituted or unsubstituted C1 to C20 alkenylene group;
- R is hydrogen or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkyl group and a substituted or unsubstituted C1 to C20 alkenyl group.
- a in the tertiary ligand may include an ester (-COO-), an ether (-O-), or a combination thereof.
- A may be a C2 to C15 alkylene group or alkenylene group, preferably a C2 to C10 alkylene group or alkenylene group.
- the tertiary ligand is specifically 2-carboxyethyl acrylate, mono-2-(acryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl maleate, 2-[2-(2- It may be at least one selected from the group consisting of methoxyethoxy)ethoxy]acetic acid and 2-(2-methoxyethoxy)acetic acid.
- quantum dot compositions containing only thiol-based ligands are not suitable for use in inkjet compositions because they generate harmful odors (gases) or deteriorate storage stability due to increased viscosity.
- the quantum dot composition according to the present invention exhibited low viscosity and excellent storage stability (degree of change in QE value before and after heat treatment) by using a secondary ligand containing a thiol-based ligand and a tertiary ligand not containing a thiol group together.
- ether -O-
- the viscosity and optical properties of the ink composition may be excellent compared to cases where the ethylene glycol structure is not included. This seems to be because the dispersibility of QDs in the composition is further improved because ethylene glycol has strong hydrophilicity due to its structural characteristics.
- the molar ratio of the primary ligand and the secondary ligand is 1: 1 to 20, preferably 1: 1 to 10 molar ratio, more preferably 1: 1 to 5 molar ratio, but Not limited to this.
- the molar ratio of the primary ligand, secondary ligand and tertiary ligand is 1: 1 to 20: 1 to 30, preferably 1: 1 to 10: 1 to 15 molar ratio, More preferably, it may be 1: 1 to 5: 1 to 8, but is not limited thereto.
- the mixing ratio of the quantum dots and the ligand may be 1: 1 to 20 weight ratio, preferably 1: 1 to 10 weight ratio, more preferably 1: 5 to 10.
- the ligand means the sum of a primary ligand and a secondary ligand or a sum of a primary ligand, a secondary ligand and a tertiary ligand.
- the photopolymerizable monomer serves to express the structure and physical properties of the matrix by controlling the total crosslinking density of the formulation in which the quantum dots (QDs) are dispersed, that is, the polymer matrix.
- QDs quantum dots
- the photopolymerizable monomer may include a (meth)acrylate-based monomer. Any monomer that can be used can be used without particular limitation as long as it is a monomer commonly used in the art.
- the (meth)acrylate-based monomer may include at least one of a (meth)acrylic group, a vinyl group, and an allyl group.
- a (meth)acrylic group e.g., 1,6-hexanediol diacrylate, 1,6-cyclohexanediol diacrylate, 2,2-dimethyl-1 ,3-propanediol diacrylate (2,2-dimethyl-1,3-propanediol diacylate), diethylene glycol diacrylate, dipropylene glycol diacrylate, 1, 3-butylene glycol dimethacrylate, trimethylolpropane trimethacrylate, isobornyl acrylate, isobornyl methacrylate , tetrahydrofuryl acrylate, acryloyl morpholine, 2-phenoxyethyl acrylate, tripropylene glycol diacrylate, trimethylolpropane Trimethylolpropane triacrylate,
- 1,6-hexanediol diacrylate as a photopolymerizable monomer is preferable to achieve the viscosity characteristics of the solvent-free quantum dot composition.
- the content of the (meth)acrylamide-based monomer may be 35 to 80% by weight, preferably 45 to 70% by weight based on the total weight of the solvent-free quantum dot composition.
- the photoinitiator is a component that is excited by a light source such as ultraviolet (UV) and serves to initiate photopolymerization
- a light source such as ultraviolet (UV) and serves to initiate photopolymerization
- a conventional photopolymerization photoinitiator in the art may be used without limitation.
- an acetophenone-based compound, a benzophenone-based compound, a thioxanthone-based compound, a benzoin-based compound, a triazine-based compound, an oxime-based compound, and the like may be used.
- Non-limiting examples of usable photoinitiators include Ethyl (2,4,6-trimethylbenzoyl) phenylphosphinate, Irgacure 184, Irgacure 369, Irgacure 651, Irgacure 819, Irgacure 907, Benzionalkylether, Benzophenone ), Benzyl dimethyl katal, Hydroxycyclohexyl phenyl acetone, Chloroacetophenone, 1,1-Dichloro acetophenone, Diethoxyacetophenone (Diethoxy acetophenone), Hydroxy Acetophenone, 2-Chloro thioxanthone, 2-ETAQ (2-EthylAnthraquinone), 1-hydroxy-cyclohexyl-phenyl-ketone (1- Hydroxy- cyclohexyl-phenyl-ketone), 2-hydroxy-2-methyl-1-phenyl-1-propanone (2-Hydr
- the amount of the photoinitiator may be appropriately adjusted within a range known in the art. For example, it may be 0.01 to 10% by weight, preferably 0.1 to 5% by weight based on the total weight of the solvent-free quantum dot composition. When the content of the photoinitiator falls within the aforementioned range, photopolymerization may be sufficiently performed without deterioration of physical properties of the matrix.
- the diffusion agent reflects light not absorbed by the light conversion material, and allows the light conversion material to absorb the reflected light again. That is, the diffusion agent may increase light conversion efficiency by increasing the amount of light absorbed by the light conversion material.
- the dispersing agent may be in a solid form such as a powder or may be a dispersion in which the dispersing agent is dispersed.
- Non-limiting examples of usable diffusing agents include barium sulfate (BaSO 4 ), calcium carbonate (CaCO 3 ), titanium dioxide (TiO 2 ), zirconia (ZrO 2 ), or a combination thereof.
- the average particle diameter or shape of the diffusing agent is not particularly limited, and may be appropriately selected from configurations known in the art.
- the average particle diameter (D50) may be 150 nm to 250 nm, specifically 180 nm to 230 nm. When the average particle diameter of the diffusing agent is within the above range, a superior light diffusing effect may be obtained and light conversion efficiency may be increased.
- the content of the diffusing agent may be appropriately adjusted within a range known in the art. For example, it may be 0.01 to 10% by weight, preferably 0.1 to 5% by weight based on the total weight of the solvent-free quantum dot composition.
- the content of the diffusion agent falls within the above-mentioned range, the effect of improving light conversion efficiency may be exhibited without deterioration of physical properties of the matrix.
- the polymerization inhibitor reacts with radicals to form radicals or compounds of low reactivity that cannot cause polymerization, and can control the rate of photopolymerization.
- the polymerization inhibitor materials known in the art may be used without limitation.
- quinone-based compounds such as phenol or aniline-based compounds, and aromatic nitro and nitroso compounds
- HQ hydroquinone
- THQ methylhydroquinone
- MEHQ hydroquinone monomethyl ether
- EEHQ hydroquinone monoethyl ether
- 1,4-benzoquinone (BQ) 2,5-diphenylbenzo quinone
- DVBQ 2,5-diphenylbenzo quinone
- MBQ methyl-1,4-benzoquinone
- PBQ phenyl-1,4-benzoquinone
- BHT 2,6-diphenyl-4-octadecyloxyphenol
- catechol phenocyazine, bis( ⁇ -methylbenzyl)phenocyazine, 3,7-dioctylphenocyazine,
- the content of the polymerization inhibitor may be appropriately adjusted within a range known in the art. For example, it may be 0.01 to 2% by weight, preferably 0.05 to 1% by weight based on the total weight of the solvent-free quantum dot composition.
- a stabilizer may be added to improve stability and dispersibility of the quantum dots.
- the stabilizer may stabilize the quantum dots by substituting the shell surface of the quantum dots to improve dispersion stability of the quantum dots in a solvent.
- any stabilizer that can be used in the art can be used without limitation as long as it can improve the stability and dispersibility of quantum dots, and for example, a thiol-based stabilizer can be used.
- the thiol-based stabilizer may improve the dispersibility of the quantum dots with respect to the photopolymerizable monomer.
- the thiol group of the thiol-based stabilizer reacts with the acryl group of the photopolymerizable monomer to form a covalent bond, thereby improving heat resistance of the quantum dot composition.
- the thiol-based stabilizer may have 7 or more carbon atoms, and may have 2 to 10, for example, 2 to 6 thiol groups (-SH) at the terminal depending on its structure, but is not particularly limited thereto.
- usable thiol-based stabilizers include pentaerythritol tetrakis (3-mercaptopropionate), trimethylolpropane tris (3-mercaptopropionate) ( trimethylolpropane tris(3-mercaptopropionate), pentaerythritol tetrakis(mercaptoacetate), trimethylolpropane tris(2-mercaptoacetate), glycol di -3-mercaptopropionate (Glycol di-3-mercaptopropionate), or mixtures thereof.
- the quantum dot composition of the present invention may use additives known in the art without limitation within a range that does not impair the effects of the present invention. At this time, the content of the additive may be appropriately adjusted within a range known in the art.
- Examples of usable additives include silane-based compounds, siloxane-based compounds, antioxidants, polymerization inhibitors, lubricants, surface conditioners, surfactants, adhesion promoters, antifoaming agents, slip agents, solvents, wetting agents, light stabilizers, stain inhibitors, softeners, There are thickeners, polymers, and the like. These may be used alone or in combination of two or more.
- the silane-based compound serves to impart adhesiveness to the matrix, and the siloxane-based compound serves to impart wettability.
- Components known in the art may be used as the silane-based compound and the siloxane-based compound without limitation.
- Antioxidants suppress discoloration due to heat or light irradiation and discoloration due to various oxidizing gases such as ozone, active oxygen, NOx, and SOx (X is an integer), and in the present invention, by adding antioxidants, matrix coloration is prevented. It is possible to reduce the decrease in film thickness due to decomposition.
- examples of usable antioxidants include hydrazides, hindered amine-based antioxidants, nitrogen-containing heterocyclic mercapto-based compounds, thioether-based antioxidants, hindered phenol-based antioxidants, ascorbic acids, zinc sulfate, and thiocyanic acid. Salts, thiourea derivatives, sugars, nitrites, sulfites, thiosulfates, hydroxylamine derivatives, and the like.
- a leveling agent may be included for the purpose of further increasing the adhesive strength in the composition by leveling the quantum dot composition so that the quantum dot composition can be coated flatly and smoothly.
- the leveling agent may include acrylic, silicone, or the like alone or in combination of two or more.
- polyether-modified polydimethylsiloxane may be included, and a (meth)acryloyl group may be added to the polyether chain.
- a surfactant may be included for mixing and coating uniformity of the quantum dot composition.
- the surfactant conventional cationic, anionic, and nonionic surfactants known in the art may be used, and for example, one or more of fluorine-based surfactants, silicone-based surfactants, and fluorosilicone-based surfactants may be used.
- the light stabilizer is an ultraviolet absorber and has an effect of increasing the weatherability of the matrix.
- the softening agent is for relieving cracks in the dried polymer matrix, and can improve impact resistance and bending resistance by mitigating cracks in the cured matrix.
- the solvent-free quantum dot composition according to the present invention includes quantum dots surface-modified with two or more ligands and a photopolymerizable monomer having excellent compatibility with the ligand-substituted quantum dots.
- the above-described solvent-free quantum dot composition according to the present invention has excellent optical properties such as light absorption rate and light change rate, and can realize low viscosity.
- the viscosity at room temperature (25° C.) may be 30 cps or less, preferably 28 cps or less, and more preferably 25 cps or less.
- the solvent-free quantum dot composition not only has excellent workability and processability, but also has excellent storage stability at high temperatures.
- the solvent-free quantum dot composition according to the present invention can be implemented with low viscosity, it can be used for inkjet printing.
- a method for producing a solvent-free quantum dot composition includes the steps of (a) synthesizing quantum dots, (b) without separating the quantum dots from the solution in which the quantum dots are synthesized, and containing an ethylene glycol structure Primary surface modification of the quantum dots with a primary ligand, (c) secondary surface modification of the primary surface-modified quantum dots with a secondary ligand represented by Formula 1 below, (d) result of step (c) It may include separating and obtaining surface-modified quantum dots, and (e) dispersing the obtained surface-modified quantum dots in a photopolymerizable monomer.
- M is a divalent to tetravalent metal
- R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms
- n is an integer from 2 to 4.
- step (c) the modification of the quantum dots with the secondary ligand is preferably performed after the modification of the quantum dots with the primary ligand.
- the quantum dots, the primary ligand, the secondary ligand, the tertiary ligand, and the photopolymerizable monomer are as described above.
- a method for manufacturing quantum dots conventionally known methods (eg, a high-temperature injection method, a microfluidic reactor method, a method using microwave irradiation, etc.) may be used.
- a high-temperature injection method, a microfluidic reactor method, a method using microwave irradiation, etc.) may be used.
- the composition of the ligand and its modification method in the state of the quantum dot production solution are characteristic, not the manufacturing method of the quantum dot, this will be described in detail.
- step (b) while the temperature of the solution in which the quantum dots were synthesized was lowered and maintained at about 80 ° C, a solution in which a primary ligand was diluted in cyclohexylacetate at 20 wt% was added and stirred for about 5 hours to perform primary modification. It may be a step to In the step (c), a solution in which the secondary ligand is diluted to 20wt% in cyclohexylacetate is added and stirred for about 90 minutes in a state where the temperature is lowered to about 30 ° C., thereby secondaryly modifying the surface of the quantum dots. .
- step (c) a step of modifying the surface of the quantum dots by adding a tertiary ligand and reacting for 30 minutes to 3 hours in a state where the temperature is lowered to about 30° C. by cooling again may be included.
- the surface modification step of the quantum dots can be divided into two or three steps to modify the surface of the quantum dots to prevent the formation of an adduct due to a reaction between a primary ligand, a secondary ligand, and a tertiary ligand.
- a reaction between a primary ligand, a secondary ligand, and a tertiary ligand By first reacting with the hydrophobic quantum dots to weaken the hydrophobicity, the reaction with the secondary ligand and the tertiary ligand proceeds even in the overall hydrophobic quantum dot synthesis solution, so that the surface of the quantum dots is modified, and then the dispersibility in the photopolymerizable monomer is improved. .
- an adduct may be formed due to a thiol-ene reaction between the thiol group of the secondary ligand and the acrylate of the tertiary ligand. .
- These adducts can improve the viscosity of the quantum dot composition when the surface-modified quantum dots are dispersed in the photopolymerizable monomer.
- the step of modifying the surface of the quantum dots is the step of simultaneously adding the secondary ligand and the tertiary ligand to the primary surface-modified quantum dots and reacting at 25 ° C to 100 ° C for 30 minutes to 3 hours to modify the surface of the quantum dots.
- the surface-modified quantum dots may be obtained through centrifugation.
- the solvent-free quantum dot composition may be prepared by dispersing the obtained surface-modified quantum dots in a polymerizable monomer.
- the present invention may provide a cured film comprising the above-described solvent-free quantum dot composition.
- the cured film according to the present invention has excellent light properties, and specifically, the light absorption rate may be 75% or more, preferably 78% or more.
- the cured film may have a light conversion rate of 25% or more, specifically 29% or more.
- the absolute quantum efficiency may be 30% or more.
- the present invention provides a color filter comprising the above-described solvent-free quantum dot composition.
- a color filter is an optical component in the form of a thin film that extracts three colors of red, green, and blue in pixel units from white light emitted from a rear light source to realize color in a liquid crystal display.
- Such a color filter may be manufactured by methods such as a dyeing method, a pigment dispersion method, a printing method, and an electrodeposition method.
- a color filter including a quantum dot composition may be prepared by an ink jet method. Since the inkjet method uses materials only for desired pixels, unnecessary waste of materials can be prevented.
- the present invention provides a display device comprising the quantum dot composition described above.
- the display device includes a liquid crystal display (LCD), an electroluminescence display (EL), a plasma display (PDP), a field emission display (FED), an organic light emitting diode (OLED), and the like, but is not limited thereto.
- Zinc acetate and oleic acid are dissolved in trioctylamine (TOA) in a 300 mL reactor and subjected to vacuum treatment at about 120° C. for about 10 minutes to obtain a zinc precursor. After replacing the inside of the flask with nitrogen (N 2 ), the temperature is raised to about 280° C., and the temperature is maintained for a predetermined time.
- TOA trioctylamine
- the prepared InZnP core and the prepared Se/TOP are added at a predetermined ratio and heated to a high temperature of about 300° C. or more to react to form a ZnSe-containing layer.
- InZnP/ZnSe/ZnS (core/shell/shell) quantum dots are made.
- a solution containing the quantum dots dispersed in a hydrophobic TOA solvent and impurities such as reaction residues (oleic acid, TOP, etc.) is obtained.
- MTEGT methoxy triethylene glycol thioglycolate
- BTEGMS Bis-(butoxy triethylene glycol)mercaptosuccinate
- Zn-(BTEGMS) 2 is obtained as the secondary ligand 2-1 by reacting ZnCl 2 and BTEGMS at a molar ratio of about 1:3.
- PEG550-T PEG 550-thioglycolate
- Zn-(PEG550-T) 2 is obtained as a secondary ligand 2-2 by reacting ZnCl 2 and PEG550-T at a molar ratio of about 1:3.
- zinc chloride (ZnCl 2 ) and a compound represented by Formula A-1 are put into cyclohexyl acetate at a molar ratio of about 1:3 and then dissolved by thermal stirring at about 60°C. Thereafter, HCl was removed in a vacuum for about 2 hours to prepare a secondary ligand 2-3.
- Secondary ligand 2-4 was prepared in the same manner as in Preparation Example 2-3, except that the compound represented by Formula A-2 was used instead of the compound represented by Formula A-1 in Preparation Example 2-3. .
- Secondary ligand 2-5 was prepared in the same manner as in Preparation Example 2-3, except that the compound represented by Formula A-3 was used instead of the compound represented by Formula A-1 in Preparation Example 2-3. .
- Secondary ligand 2-6 was prepared in the same manner as in Preparation Example 2-3, except that the compound represented by Formula A-4 was used instead of the compound represented by Formula A-1 in Preparation Example 2-3. .
- Secondary ligand 2-7 was prepared in the same manner as in Preparation Example 2-3, except that the compound represented by Formula A-5 was used instead of the compound represented by Formula A-1 in Preparation Example 2-3. .
- a tertiary ligand 3-2 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-2 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
- Tertiary ligand 3-3 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-3 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
- a tertiary ligand 3-4 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-4 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
- a tertiary ligand 3-5 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-5 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
- a tertiary ligand 3-6 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-6 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
- InZnP/ZnSe/ZnS quantum dots are synthesized according to the synthesis example of the QD. It does not go through the process of separating and purifying the quantum dots from the solution in which the quantum dots are synthesized.
- Quantum dot powder is obtained by centrifuging the surface-modified quantum dot-containing solution with hexane and acetone.
- QD dispersion 1 was prepared by dispersing the quantum dot powder in 1,6-hexandiol diacrylate at 50wt%.
- a TiO 2 dispersion was prepared by dispersing about 50wt% of TiO 2 powder in 1,6-hexandiol diacrylate as a dispersing agent and ensuring that the 90% particle diameter (D90) in the particle size distribution did not exceed 300 nm.
- QD Ink (Composition 1) was prepared by mixing 80 g of QD dispersion 1, 8 g of TiO 2 dispersion, 1 g of TPO-L, and 11 g of 1,6-hexandiol diacrylate.
- Example 2 As in Example 1, the surface of the quantum dots is modified twice.
- QD dispersion 2 was prepared in the same manner as in Example 1.
- QD Ink (Composition 2) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 2 instead of QD Dispersion 1.
- Example 1 was performed except that Zn-(PEG550-T) 2 (secondary ligand 2-2) was used instead of Zn-(BTEGMS) 2 .
- QD dispersion 3 was prepared in the same manner as in Example 1.
- QD Ink (Composition 3) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 3 instead of QD Dispersion 1.
- Example 2 was performed except that Zn-(PEG550-T) 2 (secondary ligand 2-2) was used instead of Zn-(BTEGMS) 2 .
- QD dispersion 4 was prepared in the same manner as in Example 1.
- QD Ink (Composition 4) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 4 instead of QD Dispersion 1.
- Example 3 The same procedure as in Example 3 was performed except that 1.56 g of a solution in which Zn-(PEG550-T) 2 (secondary ligand 2-2) was diluted to 20wt% in cyclohexylacetate was used.
- QD dispersion 5 was prepared in the same manner as in Example 1.
- QD Ink (Composition 5) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 5 instead of QD Dispersion 1.
- Example 4 The same procedure as in Example 4 was performed except that 1.56 g of a solution in which Zn-(PEG550-T) 2 (secondary ligand 2-2) was diluted to 20wt% in cyclohexylacetate was used.
- QD dispersion 6 was prepared in the same manner as in Example 1.
- QD Ink (Composition 6) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 6 instead of QD Dispersion 1.
- QD comparative dispersion 1 was prepared in the same manner as in Example 1.
- Quantum dots were modified in the same manner as in Comparative Example 1, except that MTEGT was used instead of MEAA.
- QD Ink (Comparative Composition 2) was prepared in the same manner as in Example 1, but by mixing QD Comparative Dispersion 2 instead of QD Dispersion 1.
- Quantum dots are prepared in the same manner as in Example 1, but the solution containing the synthesized quantum dots is cooled to room temperature and centrifuged with ethanol and acetone to obtain quantum dot powder.
- QD comparative dispersion 3 was prepared in the same manner as in Example 1.
- QD Ink (Comparative Composition 3) was prepared in the same manner as in Example 1, but by mixing QD Comparative Dispersion 3 instead of QD Dispersion 1.
- QD comparative dispersion 4 was prepared in the same manner as in Example 1.
- QD Ink (Comparative Composition 4) was prepared in the same manner as in Example 1, but by mixing QD Comparative Dispersion 4 instead of QD Dispersion 1.
- QD dispersions 1 to 6 and QD comparative dispersions 1 to 4 obtained in Examples 1 to 6 and Comparative Examples 1 to 4 were examined for QD precipitation to confirm dispersibility, and the absolute quantum efficiency of the QD dispersions QE (Otsuka, QE-2000 ), wavelength and full width at half maximum were measured. The results are shown in Table 2 below.
- QD comparative dispersions 1 and 2 When comparing QD comparative dispersions 1 and 2 using only one ligand, only QD comparative dispersion 2 was dispersible, which means that MTEGT (QD comparative dispersion 2) has more repeated ethylene glycol structures than MEAA (QD comparative dispersion 1). It is believed that the QD surface was modified to be more hydrophilic, thereby improving the dispersibility.
- ligand substitution is possible immediately after QD synthesis, and QD dispersibility and QE do not decrease accordingly. There was no significant difference in performance or there was a better aspect.
- the QD Ink composition/comparative composition prepared in Examples 1 to 6 and Comparative Examples 2 to 4 was applied on a glass substrate to a thickness of 10 ⁇ m by a spin coating method (spin coater, Mikasa, Opticoat MS-A150) and irradiated with 395 nm UV. and exposed to light at 4000 mJ (83° C., 4 seconds) to prepare a cured film.
- a 2 cm x 2 cm single-film specimen was loaded into an integrating sphere equipment (QE-2100, otsuka electronics), the initial light absorption was measured and the QE was measured (Otsuka, QE-2000). Thereafter, QE was measured after heat treatment (Post-Bake) at 180 ° C. for 30 minutes under a nitrogen atmosphere. The results are shown in Table 3 below.
- compositions 1 to 6 using two or more ligands have a smaller difference in QE values before and after heat treatment than Comparative Composition 2 using only one ligand, and thus have excellent stability (reliability) against an external heat source, and QD composition It was confirmed that the QD performance can be well maintained in the subsequent heat treatment process required for product production using .
- metal-bonded secondary ligands Zn-(BTEGMS) 2 , Zn-(PEG550-T) 2
- MTEGT non-metal-bonded primary ligands
- compositions 2, 4, and 6 When comparing compositions 1, 3, and 5 using two ligands and compositions 2, 4, and 6 using three ligands, respectively, compositions 2, 4, and 6 have lower viscosities, and the difference in QE values before and after heat treatment is higher. It was confirmed that less When a tertiary ligand is added, this property induces detachment of the primary or secondary ligand that is simply physically attached without binding to the QD surface, resulting in aggregation between ligands or between ligands and 1,6-hexandiol diacrylate. ) appears to be prevented.
- Compositions 3 and 4 using the secondary ligand 2-2 have slightly higher viscosities than those of Compositions 1 and 2, at 25 cps or more, and a larger difference in QD values before and after heat treatment. This seems to be because the molecular weight of Zn-(PEG550-T) 2 as the secondary ligand 2-2 is relatively high, and the molar equivalent of the secondary ligand 2-2 bound to the QD surface is relatively small compared to Compositions 1 and 2.
- compositions 5 and 6 had the same ligand composition as compositions 3 and 4, but the secondary ligand 2-2 was added twice to modify the QD.
- Compositions 5 and 6 were confirmed to have lower viscosity and improved light absorption when compared to compositions 3 and 4, respectively, and the degree of retention of the QE value before and after heat treatment was greatly improved.
- Compositions 5 and 6 which was subjected to tertiary modification with a tertiary ligand, exhibited better viscosity and optical properties. Therefore, those skilled in the art will be able to adjust the addition amount of the secondary ligand and whether or not to add the tertiary ligand in consideration of the necessary viscosity and the reliability of the QE value.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Luminescent Compositions (AREA)
- Optical Filters (AREA)
- Electroluminescent Light Sources (AREA)
- Devices For Indicating Variable Information By Combining Individual Elements (AREA)
Abstract
Description
본 발명은 무용매형 양자점 조성물, 그 제조방법 및 이를 포함하는 경화막, 컬러필터 및 디스플레이 장치에 관한 것이다. 구체적으로 본 발명에 따른 무용매형 양자점 조성물은 2종 이상의 리간드로 표면 개질된 양자점을 포함하며 점도가 낮고 광특성이 우수할 뿐만 아니라 양자점(QD) 합성 후 해당 용액에서 바로 리간드 치환하여 제조할 수 있어 공정이 간소화된다.The present invention relates to a solvent-free quantum dot composition, a method for preparing the same, and a cured film including the same, a color filter, and a display device. Specifically, the solvent-free quantum dot composition according to the present invention includes quantum dots surface-modified with two or more ligands, has low viscosity and excellent optical properties, and can be prepared by directly substituting ligands in a corresponding solution after synthesizing quantum dots (QDs). process is simplified.
양자점(Quantum dot, QD)은 일명 반도체 나노 결정(semiconductor nanocrystals)으로, 물질 종류의 변화 없이 입자 크기별로 다른 파장의 빛이 발생하여 다양한 색을 낼 수 있고, 기존 발광체보다 색 순도, 광 안정성이 높다는 장점이 있어 차세대 발광 소자로 주목받고 있다. Quantum dot (QD) is a so-called semiconductor nanocrystals, which can generate various colors by generating light of different wavelengths for each particle size without changing the type of material, and is said to have higher color purity and light stability than conventional light emitting materials. Due to its advantages, it is attracting attention as a next-generation light emitting device.
특히, 디스플레이 분야에 새로운 트렌드로 자리잡은 양자점은 TV, LED 외에 다양한 디스플레이, 전자 소자 등에 적용이 가능하다. CdSe, InP 등으로 대표되는 양자점은 발광효율(Quantum Yield)면에서 빠르게 발전하여, 발광 효율이 100%에 가까운 합성법들이 소개되고 있다. 이를 토대로 현재 양자점 시트를 적용한 TV가 상 용화 되고 있다. 다음 단계로 양자점을 기존 LED TV의 컬러필터층에 포함(안료, 염 료 배제)하여 컬러필터층에서 필터링 방식이 아닌 자체 발광 버전으로의 양자점 TV 가 개발되고 있다. 이러한 양자점 TV 개발의 핵심은 양자점이 화소를 구성하는 공정 및 제조공정에서 양자점의 광효율을 얼마나 유지시킬 수 있는가에 초점이 맞춰지고 있다. In particular, quantum dots, which have become a new trend in the display field, can be applied to various displays and electronic devices in addition to TVs and LEDs. Quantum dots, represented by CdSe, InP, etc., are rapidly developing in terms of luminous efficiency (Quantum Yield), and synthesis methods with luminous efficiency close to 100% have been introduced. Based on this, TVs using quantum dot sheets are currently being commercialized. As a next step, quantum dots are included in the color filter layer of the existing LED TV (pigments and dyes are excluded), and a self-emitting version of the quantum dot TV is being developed instead of filtering in the color filter layer. The core of the development of such a quantum dot TV is focused on how much light efficiency of the quantum dots can be maintained in the process of configuring the pixels and the manufacturing process.
한편, 컬러필터용 소재는 높은 감도, 기판에 대한 부착력, 내화학성, 내열성 등이 요구된다. 종래 디스플레이에 적용하는 컬러필터는 일반적으로 광감성 레지스트 조성물을 사용하여 포토마스크를 적용한 노광공정을 통해 원하는 패턴을 형성하고, 이어서 현상 공정을 통해 비노광부를 용해시켜 제거하는 패터닝 공정을 통해 형성되었다.On the other hand, materials for color filters require high sensitivity, adhesion to a substrate, chemical resistance, heat resistance, and the like. A color filter applied to a conventional display is generally formed through a patterning process in which a desired pattern is formed through an exposure process in which a photomask is applied using a photosensitive resist composition, and then the unexposed portion is dissolved and removed through a development process.
최근 화소에 사용되는 재료의 고급화 및 이로 인한 비용 상승을 해소하고자, 기존과 같이 스핀코팅이나 슬릿코팅을 하여 패터닝을 진행하는 것보다 원하는 부분에만 재료를 사용하여 재료의 사용을 최대한 절감하는 방법이 관심을 받고 있다. 가장 대표적인 방법으로 잉크젯법을 들 수 있는데, 잉크젯법은 원하는 화소에만 재료를 사용하기 때문에 불필요한 재료의 낭비를 방지할 수 있다. Recently, in order to solve the high quality of materials used in pixels and the resulting cost increase, a method of reducing the use of materials as much as possible by using materials only for the desired area is of interest, rather than performing patterning by spin coating or slit coating as in the past. is receiving The most representative method is the inkjet method. Since the inkjet method uses materials only for desired pixels, unnecessary waste of materials can be prevented.
그러나, 잉크젯법에 사용되는 양자점 조성물은 점도가 100cps 이하, 바람직하게는 50 cps 이하일 것이 요구되므로, 저점도의 구현을 위해 용매를 포함하였다. 이와 같이 양자점 조성물이 용매를 포함함으로써, 경화 후 두께의 편차가 심해지거나 막 두께를 두껍게 하는데 한계가 있었으며, 유기용매의 사용으로 환경오염의 우려가 있었다. However, since the viscosity of the quantum dot composition used in the inkjet method is required to be 100 cps or less, preferably 50 cps or less, a solvent is included to realize low viscosity. In this way, since the quantum dot composition includes a solvent, there is a limit in increasing the thickness or increasing the film thickness after curing, and there is a concern about environmental pollution due to the use of an organic solvent.
이에, 본 출원인인 (주)한솔케미칼은 무용매형 양자점 조성물, 그 제조방법, 및 이를 포함하는 경화막, 컬러필터 및 디스플레이 장치를 출원하였다(제10-2021-0011711호). 이는 용매를 포함하지 않으면서 점도가 낮게 나타나고, 광특성이 우수한 양자점 조성물 및 그 제조방법 발명이었다.Accordingly, the present applicant, Hansol Chemical Co., Ltd. has applied for a solvent-free quantum dot composition, a manufacturing method thereof, and a cured film including the same, a color filter, and a display device (No. 10-2021-0011711). This was a quantum dot composition that does not contain a solvent, has a low viscosity and has excellent optical properties, and a method for manufacturing the same.
상기의 선출원발명은 그 제조과정에서 양자점 표면에서의 리간드 치환을 위해 다른 종래의 방법과 동일하게, 분리 정제된 양자점 파우더를 사용해야했다. 합성된 양자점을 분리 정제하기 위해 최소 2회 이상의 원심분리 공정이 필요하여 공정이 다소 복잡하고 그에 따른 비용이 추가되는 문제점을 발견하였다.The above-described prior filed invention had to use separated and purified quantum dot powder in the same way as other conventional methods for ligand substitution on the surface of quantum dots during the manufacturing process. In order to separate and purify the synthesized quantum dots, it was found that at least two centrifugation processes were required, which made the process somewhat complicated and added cost accordingly.
이에, 본 발명이 해결하고자 하는 과제는 양자점이 합성된 용액을 원심분리 등의 분리 정제 공정없이 그대로 리간드 치환공정에 사용하여, 공정을 간소화하고 그에 따른 비용을 절감하며, 우수한 광효율 및 보다 낮은 점도를 가지는 무용매형 양자점 조성물 및 그 제조방법을 제공하는 것이다. Therefore, the problem to be solved by the present invention is to use the solution in which the quantum dots are synthesized as it is in the ligand substitution process without a separation and purification process such as centrifugation, thereby simplifying the process, reducing the cost accordingly, and providing excellent light efficiency and lower viscosity. It is to provide a solvent-free quantum dot composition and a manufacturing method thereof.
본 발명에서 해결하고자 하는 다른 과제는 상기 무용매형 양자점 조성물을 포함하는 경화막, 컬러필터 및 디스플레이 장치를 제공하는 것이다.Another problem to be solved in the present invention is to provide a cured film containing the solvent-free quantum dot composition, a color filter and a display device.
상술한 과제를 해결하기 위한 본 발명의 일 측면에 따르면, According to one aspect of the present invention for solving the above problems,
(a) 양자점을 합성하는 단계;(a) synthesizing quantum dots;
(b) 상기 양자점의 합성이 일어난 용액으로부터 상기 양자점을 분리하지 않고, 에틸렌 글리콜(ethylene glycol) 구조를 포함하는 1차 리간드로 상기 양자점을 1차 표면 개질하는 단계;(b) first surface-modifying the quantum dots with a primary ligand having an ethylene glycol structure without separating the quantum dots from the solution in which the quantum dots were synthesized;
(c) 상기 1차 표면 개질된 양자점을 하기 화학식 1로 나타나는 2차 리간드로 2차 표면 개질하는 단계;(c) secondarily surface-modifying the first surface-modified quantum dots with a second ligand represented by Chemical Formula 1 below;
[화학식 1][Formula 1]
(상기 화학식 1에서, (In Formula 1 above,
M은 2 내지 4가의 금속이고,M is a divalent to tetravalent metal;
R1 내지 R3은 독립적으로 수소 또는 탄소수 3 내지 70의 유기기이고, R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms;
n은 2 내지 4의 정수이다.) n is an integer from 2 to 4.)
(d) 상기 (c)단계의 생성물로부터 표면 개질된 양자점을 수득하는 단계; 및(d) obtaining surface-modified quantum dots from the product of step (c); and
(e) 상기 수득된 표면 개질된 양자점을 광중합성 모노머에 분산시키는 단계:를 포함하는 무용매형 양자점 조성물의 제조방법을 제공한다.(e) dispersing the surface-modified quantum dots obtained above in a photopolymerizable monomer;
바람직하게는, 상기 (c)단계 이후에, Preferably, after step (c),
(f) 카르복실기를 포함하는 탄소수 3 내지 40의 3차 리간드를 첨가하여 상기 개질된 양자점을 3차 표면 개질하는 단계:를 포함하는 무용매형 양자점 조성물의 제조방법을 제공한다.(f) tertiary surface modification of the modified quantum dots by adding a tertiary ligand having 3 to 40 carbon atoms including a carboxyl group;
바람직하게는, 상기 1차 리간드는 그 분자량이 100g/mol 내지 500g/mol이고, 에틸렌 글리콜 구조를 1 내지 5개의 반복단위로 포함하는 것을 특징으로 하는 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the primary ligand has a molecular weight of 100 g / mol to 500 g / mol, and provides a method for producing a solvent-free quantum dot composition, characterized in that it comprises an ethylene glycol structure in 1 to 5 repeating units.
바람직하게는, 상기 화학식 1에서 R1 내지 R3 중 하나 이상은 에틸렌 글리콜 구조를 반복적으로 포함하되,Preferably, at least one of R 1 to R 3 in Formula 1 repeatedly includes an ethylene glycol structure,
상기 R1 내지 R3에 포함된 총 에틸렌 글리콜 구조의 반복단위의 수는 2 내지 15이고, The number of repeating units of the total ethylene glycol structure included in R 1 to R 3 is 2 to 15,
상기 에틸렌 글리콜 구조의 말단에 C1 내지 C15의 유기기가 결합된 것을 특징으로 하는 무용매형 양자점 조성물의 제조방법을 제공한다.It provides a method for producing a solvent-free quantum dot composition, characterized in that an organic group of C1 to C15 is bonded to the terminal of the ethylene glycol structure.
바람직하게는, 상기 3차 리간드는 하기 화학식 2으로 표시되는 것인, 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the tertiary ligand provides a method for preparing a solvent-free quantum dot composition represented by Formula 2 below.
[화학식 2][Formula 2]
(상기 화학식 2에서,(In Formula 2 above,
L은 단일결합이거나, 또는 치환 또는 비치환된 C1 내지 C20의 알킬렌기 및 치환 또는 비치환된 C1 내지 C20의 알케닐렌으로 이루어진 군에서 선택되고,L is a single bond or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkylene group and a substituted or unsubstituted C1 to C20 alkenylene group;
A는 단일결합이거나, 또는 에스테르(-C(=O)O-), 에테르(-O-), 카르보닐(- C(=O)-), 설포닐(-SO2-), 설파이드(-S-) 및 설폭사이드(-SO-)로 이루어진 군에서 선택되는 작용기를 하나 이상 포함하는 C1 내지 C20의 알킬렌기 또는 알케닐렌기이고,A is a single bond, or ester (-C(=O)O-), ether (-O-), carbonyl (-C(=O)-), sulfonyl (-SO 2 -), sulfide (- A C1 to C20 alkylene or alkenylene group containing at least one functional group selected from the group consisting of S-) and sulfoxide (-SO-),
R은 수소이거나, 또는 치환 또는 비치환된 C1 내지 C20의 알킬기 및 치환 또는 비치환된 C1 내지 C20의 알케닐기로 이루어진 군에서 선택된다.)R is hydrogen or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkyl group and a substituted or unsubstituted C1 to C20 alkenyl group.)
바람직하게는, 상기 양자점과 전체 리간드의 혼합비율은 1:1 내지 1:20 중량비인, 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the mixing ratio of the quantum dots and all ligands is 1:1 to 1:20 by weight, providing a method for producing a solvent-free quantum dot composition.
바람직하게는, 상기 용액에 첨가되는 상기 1차 리간드와 2차 리간드의 몰비는 1:1 내지 1:20 인, 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the molar ratio of the primary ligand and the secondary ligand added to the solution is 1:1 to 1:20, providing a method for producing a solvent-free quantum dot composition.
바람직하게는, 상기 용액에 첨가되는 상기 1차 리간드, 2차 리간드 및 3차 리간드의 몰비는 1 : 1~20 : 1~30 인, 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the molar ratio of the primary ligand, secondary ligand and tertiary ligand added to the solution is 1: 1 to 20: 1 to 30, providing a method for producing a solvent-free quantum dot composition.
바람직하게는, 상기 1차 리간드는 메톡시 트리에틸렌 글리콜 티오글리콜산(Methoxy triethylene glycol thioglycolate) 및 2-(2-메톡시에톡시)아세트산(2-(2-Methoxyethoxy)acetic acid)으로 이루어진 군에서 선택된 하나 이상인, 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the primary ligand is from the group consisting of methoxy triethylene glycol thioglycolate and 2-(2-methoxyethoxy)acetic acid Provides a method for producing one or more selected, solvent-free quantum dot compositions.
바람직하게는, 상기 2차 리간드는 아연-(3-메톡시부틸 3-머캅토프로피온산)2(Zn-(3-methoxybutyl 3-mercaptopropionate)2), 아연-(3-메톡시부틸 티오글리콜산)2(Zn-(3-methoxybutyl thioglycolate)2), 아연-(2-에틸헥실 티오글리콜산)2(Zn-(2-ethylhexyl thioglycolate)2), 아연-(부틸 머캅토프로피온산)2(Zn-(butyl mercaptopropionate)2), 아연-(이소프로필 머캅토프로피온산)2(Zn-(isopropyl mercaptopropionate)2), 아연-(비스-(부톡시 트리에틸렌 글리콜) 머캅토 숙신산)2(Zn-(Bis-(butoxy triethylene glycol)mercapto succinate)2) 및 아연-(폴리(에틸렌 글리콜)메틸 에테르-티오글리콜산)2(Zn-(poly(ethylene glycol)methyl ether-thioglycolate)2)로 이루어진 군에서 선택된 하나 이상인, 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the secondary ligand is zinc-(3-methoxybutyl 3-mercaptopropionate) 2 (Zn-(3-methoxybutyl 3-mercaptopropionate) 2 ), zinc-(3-methoxybutyl thioglycolic acid) 2 (Zn-(3-methoxybutyl thioglycolate) 2 ), zinc-(2-ethylhexyl thioglycolate) 2 (Zn-(2-ethylhexyl thioglycolate) 2 ), zinc-(butyl mercaptopropionic acid) 2 (Zn-( butyl mercaptopropionate) 2 ), zinc-(isopropyl mercaptopropionate) 2 (Zn-(isopropyl mercaptopropionate) 2 ), zinc-(bis-(butoxy triethylene glycol) mercapto succinic acid) 2 (Zn-(Bis-( butoxy triethylene glycol)mercapto succinate) 2 ) and zinc-(poly(ethylene glycol)methyl ether-thioglycolic acid) 2 (Zn-(poly(ethylene glycol)methyl ether-thioglycolate) 2 ) At least one selected from the group consisting of, It provides a method for preparing a solvent-free quantum dot composition.
바람직하게는, 상기 3차 리간드는 2-카복시에틸 아크릴산(2-carboxyethyl acrylate), 모노-2-(아크릴로일옥시)에틸 숙신산(mono-2-(acryloyloxy)ethyl succinate), 모노-2-(메타크릴로일옥시)에틸 숙신산(mono-2-(methacryloyloxy)ethyl succinate), 모노-2-(메타크릴로일옥시)에틸 말레산(mono-2-(methacryloyloxy)ethyl maleate), 2-[2-(2-메톡시에톡시)에톡시]아세트산(2-[2-(2-methoxyethoxy)ethoxy]acetic acid) 및 2-(2-메톡시에톡시)아세트산(2-(2-methoxyethoxy)acetic acid)으로 이루어진 군에서 선택된 하나 이상인, 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the tertiary ligand is 2-carboxyethyl acrylate, mono-2-(acryloyloxy)ethyl succinate, mono-2-( methacryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl maleate, 2-[2 -(2-methoxyethoxy)ethoxy]acetic acid (2-[2-(2-methoxyethoxy)ethoxy]acetic acid) and 2-(2-methoxyethoxy)acetic acid acid) provides a method for producing a solvent-free quantum dot composition, which is at least one selected from the group consisting of
바람직하게는, 상기 용액은 지방산, 지방산 유도체, 양자점 합성 반응의 부산물, 디옥틸 옥타데센아마이드(dioctyl octadecenamide), 트리옥틸포스핀(trioctylphosphine) 및 그 산화물, n-옥타데센(n-octadecene), 트리옥틸아민(Trioctylamine), 금속 아세트산(metal acetate), 금속 올레산(metal oleate), 트리스(트리메틸실릴)포스핀, 셀레늄(Se), 황(S), 셀레늄-트리옥틸포스핀, 황-트리옥틸포스핀, 염소염(chloride salt) 및 염화금속(metal chloride)으로 이루어진 군에서 선택된 하나 이상을 포함하는 것을 특징으로 하는, 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the solution contains fatty acids, fatty acid derivatives, by-products of the quantum dot synthesis reaction, dioctyl octadecenamide, trioctylphosphine and its oxides, n-octadecene, tri Octylamine, metal acetate, metal oleate, tris(trimethylsilyl)phosphine, selenium (Se), sulfur (S), selenium-trioctylphosphine, sulfur-trioctylphos It provides a method for producing a solvent-free quantum dot composition comprising at least one selected from the group consisting of pin, chloride salt and metal chloride.
바람직하게는, 상기 광중합성 모노머는 1,6-헥산디올 디아크릴산(1,6-hexandiol diacrylate)인, 무용매형 양자점 조성물의 제조방법을 제공한다.Preferably, the photopolymerizable monomer is 1,6-hexanediol diacrylate, and a method for preparing a solvent-free quantum dot composition is provided.
본 발명의 다른 측면에서, In another aspect of the invention,
양자점 및 광중합성 모노머를 포함하고,Including quantum dots and photopolymerizable monomers,
상기 양자점은 에틸렌 글리콜 구조를 포함하는 1차 리간드; 및 The quantum dots may include a primary ligand including an ethylene glycol structure; and
하기 화학식 1로 나타나는 2차 리간드:로 표면 개질된 것인, 무용매형 양자점 조성물을 제공한다.A secondary ligand represented by Formula 1 below: Provides a solvent-free quantum dot composition that is surface-modified with.
[화학식 1][Formula 1]
(상기 화학식 1에서, (In Formula 1 above,
M은 2 내지 4가의 금속이고,M is a divalent to tetravalent metal;
R1 내지 R3은 독립적으로 수소 또는 탄소수 3 내지 70의 유기기이고, R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms;
n은 2 내지 4의 정수이다.) n is an integer from 2 to 4.)
바람직하게는, 상기 표면 개질된 양자점은 카르복실기를 포함하는 탄소수 3 내지 40의 3차 리간드로 표면 개질된 것인, 무용매형 양자점 조성물을 제공한다.Preferably, the surface-modified quantum dot provides a solvent-free quantum dot composition that is surface-modified with a tertiary ligand having 3 to 40 carbon atoms including a carboxyl group.
바람직하게는, 상기 양자점의 표면 개질은 양자점의 합성이 일어난 용액에서 이루어지는 것을 특징으로 하는, 무용매형 양자점 조성물을 제공한다.Preferably, the surface modification of the quantum dots provides a solvent-free quantum dot composition, characterized in that made in a solution in which the quantum dots are synthesized.
바람직하게는, 상기 1차 리간드는 분자량이 100g/mol 내지 500g/mol이고, 에틸렌 글리콜 구조를 1 내지 5개의 반복단위로 포함하는 것을 특징으로 하는 무용매형 양자점 조성물을 제공한다.Preferably, the primary ligand has a molecular weight of 100 g/mol to 500 g/mol, and provides a solvent-free quantum dot composition comprising an ethylene glycol structure in 1 to 5 repeating units.
바람직하게는, 상기 화학식 1에서 R1 내지 R3 중 하나 이상은 에틸렌 글리콜 구조를 반복적으로 포함하되,Preferably, at least one of R 1 to R 3 in Formula 1 repeatedly includes an ethylene glycol structure,
상기 R1 내지 R3에 포함된 총 에틸렌 글리콜 구조의 반복단위의 수는 2 내지 15이고, The number of repeating units of the total ethylene glycol structure included in R 1 to R 3 is 2 to 15,
상기 에틸렌 글리콜 구조의 말단에 C1 내지 C15의 유기기가 결합된 것을 특징으로 하는 무용매형 양자점 조성물을 제공한다.It provides a solvent-free quantum dot composition characterized in that an organic group of C1 to C15 is bonded to the terminal of the ethylene glycol structure.
바람직하게는, 상기 3차 리간드는 하기 화학식 2로 표시되는, 무용매형 양자점 조성물을 제공한다.Preferably, the tertiary ligand provides a solvent-free quantum dot composition represented by Formula 2 below.
[화학식 2][Formula 2]
(상기 화학식 2에서,(In Formula 2 above,
L은 단일결합이거나, 또는 치환 또는 비치환된 C1 내지 C20의 알킬렌기 및 치환 또는 비치환된 C1 내지 C20의 알케닐렌으로 이루어진 군에서 선택되고,L is a single bond or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkylene group and a substituted or unsubstituted C1 to C20 alkenylene group;
A는 단일결합이거나, 또는 에스테르(-C(=O)O-), 에테르(-O-), 카르보닐(-C(=O)-), 설포닐(-SO2-), 설파이드(-S-) 및 설폭사이드(-SO-)로 이루어진 군에서 선택되는 작용기를 하나 이상 포함하는 C1 내지 C20의 알킬렌기 또는 알케닐렌기이고,A is a single bond, or ester (-C(=O)O-), ether (-O-), carbonyl (-C(=O)-), sulfonyl (-SO 2 -), sulfide (- A C1 to C20 alkylene or alkenylene group containing at least one functional group selected from the group consisting of S-) and sulfoxide (-SO-),
R은 수소이거나, 또는 치환 또는 비치환된 C1 내지 C20의 알킬기 및 치환 또는 비치환된 C1 내지 C20의 알케닐기로 이루어진 군에서 선택된다.)R is hydrogen or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkyl group and a substituted or unsubstituted C1 to C20 alkenyl group.)
바람직하게는, 상기 1차 리간드는 메톡시 트리에틸렌 글리콜 티오글리콜산(Methoxy triethylene glycol thioglycolate) 및 2-(2-메톡시에톡시)아세트산(2-(2-Methoxyethoxy)acetic acid)으로 이루어진 군에서 선택된 하나 이상인, 무용매형 양자점 조성물을 제공한다.Preferably, the primary ligand is from the group consisting of methoxy triethylene glycol thioglycolate and 2-(2-methoxyethoxy)acetic acid Provides one or more selected, solvent-free quantum dot compositions.
바람직하게는, 상기 2차 리간드는 아연-(3-메톡시부틸 3-머캅토프로피온산)2(Zn-(3-methoxybutyl 3-mercaptopropionate)2), 아연-(3-메톡시부틸 티오글리콜산)2(Zn-(3-methoxybutyl thioglycolate)2), 아연-(2-에틸헥실 티오글리콜산)2(Zn-(2-ethylhexyl thioglycolate)2), 아연-(부틸 머캅토프로피온산)2(Zn-(butyl mercaptopropionate)2), 아연-(이소프로필 머캅토프로피온산)2(Zn-(isopropyl mercaptopropionate)2), 아연-(비스-(부톡시 트리에틸렌 글리콜) 머캅토 숙신산)2(Zn-(Bis-(butoxy triethylene glycol)mercapto succinate)2) 및 아연-(폴리(에틸렌 글리콜)메틸 에테르-티오글리콜산)2(Zn-(poly(ethylene glycol)methyl ether-thioglycolate)2)로 이루어진 군에서 선택된 하나 이상인, 무용매형 양자점 조성물을 제공한다.Preferably, the secondary ligand is zinc-(3-methoxybutyl 3-mercaptopropionate) 2 (Zn-(3-methoxybutyl 3-mercaptopropionate) 2 ), zinc-(3-methoxybutyl thioglycolic acid) 2 (Zn-(3-methoxybutyl thioglycolate) 2 ), zinc-(2-ethylhexyl thioglycolate) 2 (Zn-(2-ethylhexyl thioglycolate) 2 ), zinc-(butyl mercaptopropionic acid) 2 (Zn-( butyl mercaptopropionate) 2 ), zinc-(isopropyl mercaptopropionate) 2 (Zn-(isopropyl mercaptopropionate) 2 ), zinc-(bis-(butoxy triethylene glycol) mercapto succinic acid) 2 (Zn-(Bis-( butoxy triethylene glycol)mercapto succinate) 2 ) and zinc-(poly(ethylene glycol)methyl ether-thioglycolic acid) 2 (Zn-(poly(ethylene glycol)methyl ether-thioglycolate) 2 ) At least one selected from the group consisting of, A solvent-free quantum dot composition is provided.
바람직하게는, 상기 3차 리간드는 2-카복시에틸 아크릴산(2-carboxyethyl acrylate), 모노-2-(아크릴로일옥시)에틸 숙신산(mono-2-(acryloyloxy)ethyl succinate), 모노-2-(메타크릴로일옥시)에틸 숙신산(mono-2-(methacryloyloxy)ethyl succinate), 모노-2-(메타크릴로일옥시)에틸 말레산(mono-2-(methacryloyloxy)ethyl maleate), 2-[2-(2-메톡시에톡시)에톡시]아세트산(2-[2-(2-methoxyethoxy)ethoxy]acetic acid) 및 2-(2-메톡시에톡시)아세트산(2-(2-methoxyethoxy)acetic acid)으로 이루어진 군에서 선택된 하나 이상인, 무용매형 양자점 조성물을 제공한다.Preferably, the tertiary ligand is 2-carboxyethyl acrylate, mono-2-(acryloyloxy)ethyl succinate, mono-2-( methacryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl maleate, 2-[2 -(2-methoxyethoxy)ethoxy]acetic acid (2-[2-(2-methoxyethoxy)ethoxy]acetic acid) and 2-(2-methoxyethoxy)acetic acid acid) to provide a solvent-free quantum dot composition that is at least one selected from the group consisting of.
바람직하게는, 상기 M은 Mg, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, Sr, Mo, Pd, Cd, In 또는 Sn 인, 무용매형 양자점 조성물을 제공한다.Preferably, M is Mg, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, Sr, Mo, Pd, Cd, In or Sn, solvent-free A quantum dot composition is provided.
바람직하게는, 상기 M은 Zn인, 무용매형 양자점 조성물을 제공한다.Preferably, the M is Zn, providing a solvent-free quantum dot composition.
바람직하게는, 상기 1차 리간드와 2차 리간드의 몰비는 1:1 내지 1:20인, 무용매형 양자점 조성물을 제공한다.Preferably, the molar ratio of the primary ligand to the secondary ligand is 1:1 to 1:20, providing a solvent-free quantum dot composition.
바람직하게는, 상기 1차 리간드, 2차 리간드 및 3차 리간드의 몰비는 1 : 1~20 : 1~30인, 무용매형 양자점 조성물을 제공한다.Preferably, the molar ratio of the primary ligand, secondary ligand and tertiary ligand is 1: 1 to 20: 1 to 30, providing a solvent-free quantum dot composition.
바람직하게는, 상기 양자점과 리간드의 조성비는 1:1 내지 1:20 중량비인, 무용매형 양자점 조성물을 제공한다.Preferably, the composition ratio of the quantum dots and the ligand is 1:1 to 1:20 by weight, providing a solvent-free quantum dot composition.
바람직하게는, 상기 광중합성 모노머는 (메타)아크릴레이트계 모노머인, 무용매형 양자점 조성물을 제공한다.Preferably, the photopolymerizable monomer is a (meth)acrylate-based monomer, providing a solvent-free quantum dot composition.
바람직하게는, 상기 광중합성 모노머는 1,6-헥산디올 디아크릴산(1,6-hexandiol diacrylate)인, 무용매형 양자점 조성물을 제공한다.Preferably, the photopolymerizable monomer is 1,6-hexandiol diacrylate, providing a solvent-free quantum dot composition.
바람직하게는, 점도가 30cps 이하인, 무용매형 양자점 조성물을 제공한다.Preferably, a solvent-free quantum dot composition having a viscosity of 30 cps or less is provided.
바람직하게는, 잉크젯 프린트용으로 사용되는, 무용매형 양자점 조성물을 제공한다.Preferably, a solvent-free quantum dot composition used for inkjet printing is provided.
바람직하게는, 상기 무용매형 양자점 조성물을 이용하여 제조된 경화막을 제공한다.Preferably, a cured film prepared using the solvent-free quantum dot composition is provided.
바람직하게는, 상기 무용매형 양자점 조성물을 10±0.5㎛ 두께로 코팅하였을 때 절대양자효율이 30% 이상인 경화막을 제공한다.Preferably, when the solvent-free quantum dot composition is coated to a thickness of 10 ± 0.5 μm, a cured film having an absolute quantum efficiency of 30% or more is provided.
바람직하게는, 상기 무용매형 양자점 조성물을 포함하는, 컬러필터를 제공한다.Preferably, a color filter including the solvent-free quantum dot composition is provided.
바람직하게는 상기 컬러필터를 포함하는, 디스플레이 장치를 제공한다.Preferably, a display device including the color filter is provided.
종래에는 양자점 합성 이후에 추가적인 공정을 통해 양자점을 분리 정제하지 않고 양자점 합성을 위한 용매 및 그 잔류물이 존재하는 상태에서 바로 리간드를 투입하여 양자점의 표면을 개질하기 어려웠으나, 본 발명에 따른 무용매형 양자점 조성물 및 그 제조방법은 이를 가능하게 하는 이점이 있으며, 그에 따라 공정간소화 및 비용절감이 이루어진다. In the past, it was difficult to modify the surface of quantum dots by directly injecting a ligand in the presence of a solvent for quantum dot synthesis and its residue without separating and purifying the quantum dots through an additional process after quantum dot synthesis, but the solvent-free type according to the present invention The quantum dot composition and its manufacturing method have advantages that enable this, and thus process simplification and cost reduction are achieved.
본 발명에 따른 무용매형 양자점 조성물은 용매를 포함하지 않고도 양자점과 모노머간 혼화성이 우수하게 나타날 수 있다. 또한, 본 발명에 따른 무용매형 양자 점 조성물은 광특성이 우수하며, 점도가 낮게 나타나므로 잉크젯 프린트용으로 사용될 수 있다. The solvent-free quantum dot composition according to the present invention may exhibit excellent miscibility between quantum dots and monomers without including a solvent. In addition, since the solvent-free quantum dot composition according to the present invention has excellent optical properties and low viscosity, it can be used for inkjet printing.
이하, 본 발명에 대하여 설명한다.Hereinafter, the present invention will be described.
본 명세서에서 사용되는 모든 용어(기술 및 과학적 용어를 포함)는, 다른 정의가 없다면, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 공통적으로 이해될 수 있는 의미로 사용될 수 있을 것이다. 또 일반적으로 사용되는 사전에 정의되어 있는 용어들은 명백하게 특별히 정의되어 있지 않은 한 이상적으로 또는 과도하게 해석되지 않는다.All terms (including technical and scientific terms) used in this specification, unless otherwise defined, may be used in a meaning commonly understood by those of ordinary skill in the art to which the present invention belongs. In addition, terms defined in commonly used dictionaries are not interpreted ideally or excessively unless explicitly specifically defined.
또한 본 명세서 전체에서, 어떤 부분이 어떤 구성요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한, 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있는 것을 의미한다. In addition, throughout this specification, when a certain component is said to "include", it means that it may further include other components, not excluding other components, unless otherwise stated.
또한, 본 명세서 중에 있어서, "(메타)아크릴레이트"는 아크릴레이트 및 메타크릴레이트를 나타내고, "(메타)아크릴"은 아크릴 및 메타크릴을 나타내며, "(메타)아크릴로일"은 아크릴로일 및 메타크릴로일을 의미한다.In addition, in this specification, “(meth)acrylate” represents acrylate and methacrylate, “(meth)acryl” represents acryl and methacryl, and “(meth)acryloyl” represents acryloyl. and methacryloyl.
또한, 본 명세서 중에 있어서, "단량체" 와 "모노머"는 동일한 의미이다. 본 발명에 있어서의 단량체는 올리고머 및 폴리머와 구별되고, 중량 평균 분자량이 1,000 이하인 화합물을 말한다. 본 명세서 중에 있어서, "광중합성 모노머"는 중합반응에 관여하는 관능기, 예컨대 (메타)아크릴레이트기를 말한다.In addition, in this specification, "monomer" and "monomer" have the same meaning. Monomers in the present invention are distinguished from oligomers and polymers and refer to compounds having a weight average molecular weight of 1,000 or less. In this specification, "photopolymerizable monomer" refers to a functional group involved in polymerization, such as a (meth)acrylate group.
본 명세서 중에 있어서, "치환"은 화합물이나 작용기 중의 수소가 C1 내지 C30의 알킬기, C2 내지 C30의 알케닐기, C2 내지 C30의 알키닐기, C1 내지 C30의 알콕시기, C1 내지 C30의 헤테로알킬기, C3 내지 C30의 헤테로알킬아릴기, C3 내지 C30의 사이클로알킬기, C3 내지 C15의 사이클로알케닐기, C6 내지 C30의 사이클로 알키닐기, C2 내지 C30의 헤테로사이클로알킬기, 할로겐(-F, -Cl, -Br 또는 -I), 히드록시기(-OH), 니트로기(-NO2), 시아노기(-CN), 에스테르기(-C(=O)OR), 여기서 R 은 C1 내지 C10 알킬기 또는 알케닐기임), 에테르기(-O-R, 여기서 R은 C1 내지 C10 알킬기 또는 알케닐기임), 카르보닐 (-C(=O)-R, 여기서 R은 C1 내지 C10 알킬기 또 는 알케닐기임), 카르복실기(-COOH) 및 이들의 조합에서 선택된 치환기로 치환된 것을 의미한다.In this specification, "substitution" means that hydrogen in a compound or functional group is a C1 to C30 alkyl group, a C2 to C30 alkenyl group, a C2 to C30 alkynyl group, a C1 to C30 alkoxy group, a C1 to C30 heteroalkyl group, a C3 to C30 heteroalkylaryl group, C3 to C30 cycloalkyl group, C3 to C15 cycloalkenyl group, C6 to C30 cycloalkynyl group, C2 to C30 heterocycloalkyl group, halogen (-F, -Cl, -Br or -I), a hydroxyl group (-OH), a nitro group (-NO 2 ), a cyano group (-CN), an ester group (-C(=O)OR), where R is a C1 to C10 alkyl group or an alkenyl group), Ether group (-OR, where R is a C1 to C10 alkyl or alkenyl group), carbonyl (-C(=O)-R, where R is a C1 to C10 alkyl or alkenyl group), carboxyl group (-COOH) And means substituted with a substituent selected from combinations thereof.
본 명세서 중에 있어서, "유기기"는 C1 내지 C30의 직쇄 또는 분지쇄 알킬기, C2 내지 C30의 직쇄 또는 분지쇄 알케닐기, C2 내지 C30의 직쇄 또는 분지쇄 알키닐기를 의미한다. 또한 상기 알킬기, 알케닐기, 알키닐기는 각각 치환 또는 비치환된 것일 수 있다.In this specification, "organic group" means a C1 to C30 straight chain or branched chain alkyl group, a C2 to C30 straight chain or branched chain alkenyl group, or a C2 to C30 straight chain or branched chain alkynyl group. In addition, the alkyl group, alkenyl group, and alkynyl group may be substituted or unsubstituted, respectively.
본 명세서 중에 있어서, "알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있으나, 이에 한정되지는 않는다.In this specification, “alkyl” means a monovalent substituent derived from a straight or branched chain saturated hydrocarbon having 1 to 40 carbon atoms. Examples thereof include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl, and the like.
본 명세서 중에 있어서, "알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In this specification, "alkenyl" means a monovalent substituent derived from a straight-chain or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond. Examples thereof include, but are not limited to, vinyl, allyl, isopropenyl, and 2-butenyl.
<무용매형 양자점 조성물><Solvent-free quantum dot composition>
본 발명의 일 실시예에 따른 양자점 조성물은 무용매형 양자점 조성물로서, 구체적으로 용매를 포함하지 않더라도 낮은 점도를 가지고 광특성이 우수하여 잉크젯 프린트에 적용 가능하다.The quantum dot composition according to an embodiment of the present invention is a solvent-free quantum dot composition, and specifically, even if it does not contain a solvent, it has low viscosity and excellent optical properties, so it can be applied to inkjet printing.
구체예를 들면, 양자점 및 광중합성 모노머를 포함하고, 상기 양자점은 에틸렌글리콜(ethylene glycol) 구조를 포함하는 1차 리간드 및 하기 화학식 1로 나타나는 2차 리간드로 표면 개질된 것인, 무용매형 양자점 조성물을 제공한다.For example, a solvent-free quantum dot composition comprising quantum dots and a photopolymerizable monomer, wherein the quantum dots are surface-modified with a primary ligand containing an ethylene glycol structure and a secondary ligand represented by Formula 1 below provides
또한, 양자점 및 광중합성 모노머를 포함하고, 상기 양자점은 ethylene glycol 구조를 포함하는 1차 리간드, 하기 화학식 1로 나타나는 2차 리간드 및 카르복실기를 포함하는 탄소수 3 내지 40의 3차 리간드로 표면 개질된 것인, 무용매형 양자점 조성물을 제공한다. In addition, it includes quantum dots and photopolymerizable monomers, and the quantum dots are surface-modified with a primary ligand having an ethylene glycol structure, a secondary ligand represented by Formula 1 below, and a tertiary ligand having 3 to 40 carbon atoms including a carboxyl group. A phosphorus, solvent-free quantum dot composition is provided.
[화학식 1][Formula 1]
(상기 화학식 1에서, (In Formula 1 above,
M은 2 내지 4가의 금속이고,M is a divalent to tetravalent metal;
R1 내지 R3은 독립적으로 수소 또는 탄소수 3 내지 70의 유기기이고, R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms;
n은 2 내지 4의 정수이다.) n is an integer from 2 to 4.)
또한, 상기 무용매형 양자점 조성물들에서 상기 양자점의 표면 개질은 양자점의 합성이 일어난 용액에서 이루어지는 것을 특징으로 할 수 있다.In addition, in the solvent-free quantum dot compositions, the surface modification of the quantum dots may be performed in a solution in which the quantum dots are synthesized.
이하, 상기 양자점 조성물의 조성을 구체적으로 살펴보면 다음과 같다.Hereinafter, a detailed composition of the quantum dot composition is as follows.
양자점quantum dot
양자점(Quantum Dot, QD)은 나노 크기의 반도체 물질로, 크기 및 조성에 따라 상이한 에너지 밴드갭을 가질 수 있고, 이에 따라 다양한 발광 파장의 광을 방출할 수 있다.Quantum Dot (QD) is a nano-sized semiconductor material, and may have different energy band gaps depending on its size and composition, and thus emit light of various emission wavelengths.
이러한 양자점은 균질한(homogeneous) 단일층 구조; 코어-쉘(core-shell) 형태, 그래디언트(gradient) 구조 등과 같은 다중층 구조; 또는 이들의 혼합 구조일 수 있다. 쉘이 복수층일 경우, 각 층은 서로 상이한 성분, 예컨대 (준)금속산화물을 함유할 수 있다.These quantum dots have a homogeneous monolayer structure; a multilayer structure such as a core-shell type, a gradient structure, and the like; or a mixture thereof. When the shell has multiple layers, each layer may contain components different from each other, such as (semi)metal oxides.
양자점(QD)은 II-VI족 화합물, III-V족 화합물, IV-VI족 화합물, IV족 원소, IV족 화합물 및 이들의 조합에서 자유롭게 선택될 수 있다. 양자점이 코어-쉘 형태일 경우, 코어와 쉘은 각각 하기 예시된 성분에서 자유롭게 구성될 수 있다. The quantum dot (QD) may be freely selected from a group II-VI compound, a group III-V compound, a group IV-VI compound, a group IV element, a group IV compound, and combinations thereof. When the quantum dot is in the core-shell form, the core and the shell may be freely composed of the components exemplified below, respectively.
일례로, II-VI족 화합물은 CdO, CdS, CdSe, CdTe, ZnO, ZnS, ZnSe, ZnTe, HgS, HgSe, HgTe, MgSe, MgS 및 이들의 혼합물로 이루어진 군에서 선택되는 이원소 화합물; CdSeS, CdSeTe, CdSTe, ZnSeS, ZnSeTe, ZnSTe, HgSeS, HgSeTe, HgSTe, CdZnS, CdZnSe, CdZnTe, CdHgS, CdHgSe, CdHgTe, HgZnS, HgZnSe, HgZnTe, MgZnSe, MgZnS 및 이들의 혼합물로 이루어진 군에서 선택되는 삼원소 화합물; 및 CdZnSeS, CdZnSeTe, CdZnSTe, CdHgSeS, CdHgSeTe, CdHgSTe, HgZnSeS, HgZnSeTe, HgZnSTe 및 이들의 혼합물로 이루어진 군에서 선택되는 사원소 화합물로 이루어진 군에서 선택될 수 있다. In one example, the II-VI compound is a binary element compound selected from the group consisting of CdO, CdS, CdSe, CdTe, ZnO, ZnS, ZnSe, ZnTe, HgS, HgSe, HgTe, MgSe, MgS, and mixtures thereof; A ternary selected from the group consisting of CdSeS, CdSeTe, CdSTe, ZnSeS, ZnSeTe, ZnSTe, HgSeS, HgSeTe, HgSTe, CdZnS, CdZnSe, CdZnTe, CdHgS, CdHgSe, CdHgTe, HgZnS, HgZnSe, HgZnTe, MgZnSe, MgZnS and mixtures thereof bovine compounds; and CdZnSeS, CdZnSeTe, CdZnSTe, CdHgSeS, CdHgSeTe, CdHgSTe, HgZnSeS, HgZnSeTe, HgZnSTe, and quaternary compounds selected from the group consisting of mixtures thereof.
다른 일례로, III-V족 화합물은 GaN, GaP, GaAs, GaSb, AlN, AlP, AlAs, AlSb, InN, InP, InAs, InSb 및 이들의 혼합물로 이루어진 군에서 선택되는 이원소 화합물; GaNP, GaNAs, GaNSb, GaPAs, GaPSb, AlNP, AlNAs, AlNSb, AlPAs, AlPSb, InNP, InNAs, InNSb, InPAs, InPSb 및 이들의 혼합물로 이루어진 군에서 선택되는 삼원소 화합물; 및 GaAlNP, GaAlNAs, GaAlNSb, GaAlPAs, GaAlPSb, GaInNP, GaInNAs, GaInNSb, GaInPAs, GaInPSb, InAlNP, InAlNAs, InAlNSb, InAlPAs, InAlPSb 및 이들의 혼합물로 이루어진 군에서 선택되는 사원소 화합물로 이루어진 군에서 선택될 수 있다. In another example, the group III-V compound is a binary element compound selected from the group consisting of GaN, GaP, GaAs, GaSb, AlN, AlP, AlAs, AlSb, InN, InP, InAs, InSb, and mixtures thereof; A ternary compound selected from the group consisting of GaNP, GaNAs, GaNSb, GaPAs, GaPSb, AlNP, AlNAs, AlNSb, AlPAs, AlPSb, InNP, InNAs, InNSb, InPAs, InPSb, and mixtures thereof; And it may be selected from the group consisting of quaternary compounds selected from the group consisting of GaAlNP, GaAlNAs, GaAlNSb, GaAlPAs, GaAlPSb, GaInNP, GaInNAs, GaInNSb, GaInPAs, GaInPSb, InAlNP, InAlNAs, InAlNSb, InAlPAs, InAlPSb, and mixtures thereof. there is.
다른 일례로, IV-VI족 화합물은 SnS, SnSe, SnTe, PbS, PbSe, PbTe 및 이들의 혼합물로 이루어진 군에서 선택되는 이원소 화합물; SnSeS, SnSeTe, SnSTe, PbSeS, PbSeTe, PbSTe, SnPbS, SnPbSe, SnPbTe 및 이들의 혼합물로 이루어진 군에 서 선택되는 삼원소 화합물; 및 SnPbSSe, SnPbSeTe, SnPbSTe 및 이들의 혼합물로 이루어진 군에서 선택되는 사원소 화합물로 이루어진 군에서 선택될 수 있다. In another example, the group IV-VI compound is a binary compound selected from the group consisting of SnS, SnSe, SnTe, PbS, PbSe, PbTe, and mixtures thereof; a ternary compound selected from the group consisting of SnSeS, SnSeTe, SnSTe, PbSeS, PbSeTe, PbSTe, SnPbS, SnPbSe, SnPbTe, and mixtures thereof; And it may be selected from the group consisting of quaternary compounds selected from the group consisting of SnPbSSe, SnPbSeTe, SnPbSTe, and mixtures thereof.
다른 일례로, IV족 원소로는 Si, Ge 및 이들의 혼합물로 이루어진 군에서 선택될 수 있다. IV족 화합물로는 SiC, SiGe 및 이들의 혼합물로 이루어진 군에서 선택되는 이원소 화합물일 수 있다. In another example, the group IV element may be selected from the group consisting of Si, Ge, and mixtures thereof. The group IV compound may be a binary element compound selected from the group consisting of SiC, SiGe, and mixtures thereof.
전술한 이원소 화합물, 삼원소 화합물 또는 사원소 화합물은 균일한 농도로 입자 내에 존재하거나, 농도 분포가 부분적으로 다른 상태로 나누어져 동일 입자내에 존재하는 것일 수 있다. 또한 하나의 양자점이 다른 양자점을 둘러싸는 코어/쉘 구조를 가질 수도 있다. 코어와 쉘의 계면은 쉘에 존재하는 원소의 농도가 중심으로 갈수록 낮아지는 농도 구배(gradient)를 가질 수 있다. The above-mentioned two-element compound, three-element compound, or quaternary element compound may be present in the particle at a uniform concentration, or may be present in the same particle in a state in which the concentration distribution is partially different. Also, one quantum dot may have a core/shell structure surrounding another quantum dot. The interface between the core and the shell may have a concentration gradient in which the concentration of elements present in the shell decreases toward the center.
양자점의 형태는 당 분야에서 일반적으로 사용되는 형태라면 특별히 제한되지 않는다. 일례로, 구형, 막대(rod)형, 피라미드형, 디스크(disc)형, 다중 가지형(multi-arm), 또는 입방체(cubic)의 나노 입자, 나노 튜브, 나노와이어, 나노 섬유, 나노 판상 입자 등의 형태의 것을 사용할 수 있다.The shape of the quantum dot is not particularly limited as long as it is a shape commonly used in the art. For example, spherical, rod-shaped, pyramidal, disc-shaped, multi-arm, or cubic nanoparticles, nanotubes, nanowires, nanofibers, nanoplatelet particles etc. can be used.
또한, 양자점의 크기는 특별히 제한되지 않으며, 당 분야에 공지된 통상의 범위 내에서 적절히 조절할 수 있다. 일례로, 양자점의 평균 입경(D50)은 약 2 내지 10 nm 일 수 있다. 이와 같이 양자점의 입경이 대략 약 2 내지 10 nm 범위로 제어될 경우, 원하는 색상의 광을 방출할 수 있다. 예를 들어, InP를 함유하는 양자점 코어/쉘의 입경이 약 5 내지 6 nm일 경우, 약 520 내지 550 ㎚ 파장의 광을 방출할 수 있고, 한편 InP를 함유하는 양자점 코어/쉘의 입경이 약 7 내지 8 nm일 경우, 약 620 내지 640 파장의 광을 방출할 수 있다. 예를 들면, 청색-발광 QD(Quantum dot)로서는 비(非)-카드뮴(Cd)계 Ⅲ-V족 QD(예로서, InP, InGaP, InZnP, GaN, GaAs, GaP)을 사용할 수 있다.In addition, the size of the quantum dots is not particularly limited and may be appropriately adjusted within a common range known in the art. For example, the average particle diameter (D50) of the quantum dots may be about 2 to 10 nm. In this way, when the particle diameter of the quantum dots is controlled to be in the range of about 2 to 10 nm, light of a desired color can be emitted. For example, when the particle diameter of the quantum dot core/shell containing InP is about 5 to 6 nm, light having a wavelength of about 520 to 550 nm can be emitted, while the particle diameter of the quantum dot core/shell containing InP is about In the case of 7 to 8 nm, light of about 620 to 640 wavelengths can be emitted. For example, as the blue-emitting QD (Quantum dot), a non-cadmium (Cd) group III-V QD (eg, InP, InGaP, InZnP, GaN, GaAs, GaP) can be used.
또한 상기 양자점은 약 40 nm 이하의 발광 파장 스펙트럼의 반치폭(full width of half maximum, FWHM)을 가질 수 있으며, 이 범위에서 색 순도나 색 재현성을 향상시킬 수 있다. 또한, 이러한 양자점을 통해 발광되는 광은 전 방향으로 방출되는 바, 광 시야각이 향상될 수 있다. In addition, the quantum dots may have a full width of half maximum (FWHM) of an emission wavelength spectrum of about 40 nm or less, and color purity or color reproducibility may be improved within this range. In addition, since light emitted through the quantum dots is emitted in all directions, a wide viewing angle may be improved.
본 발명의 일 실시예에 따르면, 상기 양자점의 함량은 상기 무용매형 양자점 조성물의 총 중량을 기준으로 1 내지 60중량%, 바람직하게는 20 내지 50중량% 일 수 있다.According to one embodiment of the present invention, the content of the quantum dot may be 1 to 60% by weight, preferably 20 to 50% by weight based on the total weight of the solvent-free quantum dot composition.
리간드ligand
본 발명에 따른 무용매형 양자점 조성물에서, 리간드는 양자점의 표면을 개질하는 역할을 한다. 양자점은 소수성을 가지는 표면 특성으로 인해 광중합성 모노머에 대한 분산에 장벽이 존재하는데, 적절한 리간드로 양자점의 표면을 개질시켜 광중합성 모노머에 대한 양자점의 혼화성을 향상시킬 수 있다. In the solvent-free quantum dot composition according to the present invention, the ligand serves to modify the surface of the quantum dots. Quantum dots have a barrier to dispersal to photopolymerizable monomers due to their hydrophobic surface properties, and the miscibility of quantum dots to photopolymerizable monomers can be improved by modifying the surface of quantum dots with appropriate ligands.
본 발명의 일 실시예에 따르면, 상기 리간드는 에틸렌 글리콜(ethylene glycol) 구조를 포함하는 1차 리간드 및 하기 화학식 1로 나타나는 2차 리간드를 포함할 수 있다.According to one embodiment of the present invention, the ligand may include a primary ligand including an ethylene glycol structure and a secondary ligand represented by Chemical Formula 1 below.
본 발명의 일 실시예에 따르면, 상기 리간드는 ethylene glycol 구조를 포함하는 1차 리간드, 하기 화학식 1로 나타나는 2차 리간드 및 카르복실기를 포함하는 탄소수 3 내지 40의 3차 리간드를 포함할 수 있다. According to one embodiment of the present invention, the ligand may include a primary ligand having an ethylene glycol structure, a secondary ligand represented by Chemical Formula 1 below, and a tertiary ligand having 3 to 40 carbon atoms including a carboxyl group.
상기 1차 리간드는 양자점의 합성이 일어난 용액 중에 투입되어 소수성인 양자점의 표면을 가장 먼저 개질하여 양자점 표면이 약간의 극성을 갖게 하며, 일반적으로 소수성인 양자점 합성 용액내에서 이후의 2차 리간드와 3차 리간드의 치환을 용이하게 한다.The primary ligand is introduced into the solution in which the quantum dot is synthesized and first modifies the surface of the hydrophobic quantum dot so that the surface of the quantum dot has a slight polarity. Facilitates substitution of secondary ligands.
[화학식 1][Formula 1]
상기 화학식 1에서, M은 2 내지 4가의 금속이고, R1 내지 R3은 독립적으로 수소 또는 탄소수 3 내지 70의 유기기이고, n은 2 내지 4의 정수이다.In Formula 1, M is a divalent to tetravalent metal, and R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms, and n is an integer of 2 to 4.
일반적으로 양자점을 제조할 때 사용하는 용매는 소수성을 띠기도 하고(예를 들면, 1-Octadecene, n-octadecene, Trioctyl amine 등과 같은 용매를 사용), 양자점의 합성이 일어난 용액 내에는 여러가지 합성 잔류물(예를 들면, Oleic acid 등 지방산, octyl oleate 등 지방산 유도체, dioctyl octadecenamide 등 그 외 부산물, trioctylphosphine 및 그 산화물, n-octadecene 또는 Trioctyl amine과 같은 용매, metal acetate, metal oleate, 트리스(트리메틸실릴)포스핀, Se, S, Se-트리옥틸포스핀, S-트리옥틸포스핀, chloride salt, metal chloride 등)이 혼재하고 있기 때문에, 양자점을 분리 정제하지 않은 상태에서 바로 금속-티올계 리간드를 포함한 대부분의 리간드로 양자점 표면을 개질하는 것이 곤란하였다. 그런데 본 발명의 한 실시예는 양자점이 합성된 용액내에서 ethylene glycol 구조를 포함하는 1차 리간드로 양자점을 개질하고 나면, 잔류 불순물이 존재하는 양자점이 합성된 후의 용액에서도 금속-티올계 리간드를 포함한 다른 리간드의 개질이 용이하게 가능하다. In general, the solvents used in the production of quantum dots are hydrophobic (for example, solvents such as 1-Octadecene, n-octadecene, and trioctyl amine are used), and various synthetic residues are present in the solution in which the quantum dots are synthesized. (For example, fatty acids such as oleic acid, fatty acid derivatives such as octyl oleate, other by-products such as dioctyl octadecenamide, trioctylphosphine and its oxides, solvents such as n-octadecene or trioctyl amine, metal acetate, metal oleate, tris(trimethylsilyl)phosphide Since pin, Se, S, Se-trioctylphosphine, S-trioctylphosphine, chloride salt, metal chloride, etc.) are mixed, most of the metal-thiol ligands are included immediately without separation and purification of quantum dots. It was difficult to modify the surface of the quantum dots with the ligands of . However, in one embodiment of the present invention, after modifying the quantum dots with a primary ligand containing an ethylene glycol structure in the solution in which the quantum dots are synthesized, even in the solution after the synthesis of the quantum dots in which residual impurities exist, a metal-thiol ligand containing Modification of other ligands is readily possible.
상기 1차 리간드는 바람직하게는 분자량이 100g/mol 내지 500g/mol이고, 더욱 바람직하게는 분자량이 100g/mol 내지 500g/mol이면서 ethylene glycol 구조를 1 내지 5개의 반복단위로 포함하는 것을 특징으로 할 수 있다. 구체적으로 Methoxy triethylene glycol thioglycolate(이하, MTEGT) 및 2-(2-Methoxyethoxy)acetic acid(이하, MEAA)로 이루어진 군에서 선택된 하나 이상을 사용할 수 있으며 바람직하게는 MTEGT를 사용할 수 있다. 1차 리간드의 분자량이 지나치게 클 경우에는 1차 표면 개질에 불리할 수 있다. The primary ligand preferably has a molecular weight of 100 g / mol to 500 g / mol, more preferably has a molecular weight of 100 g / mol to 500 g / mol and comprises an ethylene glycol structure with 1 to 5 repeating units. can Specifically, at least one selected from the group consisting of methoxy triethylene glycol thioglycolate (hereinafter referred to as MTEGT) and 2-(2-Methoxyethoxy)acetic acid (hereinafter referred to as MEAA) may be used, and preferably MTEGT may be used. If the molecular weight of the primary ligand is too large, it may be disadvantageous to primary surface modification.
상기 2차 리간드는 금속 염과 티올계 화합물을 반응시켜 형성되는 금속-티올계 화합물일 수 있다. The secondary ligand may be a metal-thiol-based compound formed by reacting a metal salt with a thiol-based compound.
상기 2차 리간드에서 M은 2 내지 4가의 금속이다. 예를 들면, 상기 M은 2족 내지 14족의 금속으로서, Mg, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, Sr, Y, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Cd, In 또는 Sn일 수 있으며, 바람직하게는 Zn을 사용할 수 있다. 상기 화학식 1에서 n은 M의 가수에 따라 결정되고, 2 내지 4의 정수이다. In the secondary ligand, M is a divalent to tetravalent metal. For example, M is a group 2 to 14 metal, Mg, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, Sr, Y, Zr, It may be Nb, Mo, Tc, Ru, Rh, Pd, Cd, In or Sn, preferably Zn. In Formula 1, n is determined according to the valence of M and is an integer of 2 to 4.
상기 2차 리간드를 나타내는 화학식 1에서 R1 내지 R3 중 하나 이상은 ethylene glycol 구조를 반복적으로 포함하되, 상기 R1 내지 R3에 포함된 ethylene glycol 구조의 총 반복단위의 수는 2 내지 15이고, 상기 ethylene glycol 구조의 말단에 C1 내지 C15의 유기기가 결합된 것을 특징으로 할 수 있다. In Formula 1 representing the secondary ligand, at least one of R 1 to R 3 repeatedly includes an ethylene glycol structure, and the total number of repeating units of the ethylene glycol structure included in R 1 to R 3 is 2 to 15, , It may be characterized in that an organic group of C1 to C15 is bonded to the terminal of the ethylene glycol structure.
또한, 상기 화학식 1에서 R1 내지 R3 중 하나 이상은 탄소수 3 내지 20의 유기기일 수 있다. 예를 들면, 에스테르(-C(=O)O-), 에테르(-O-), 카르보닐(-C(=O)-), 카르복실기(-C(=O)-OH), 설포닐(-SO2-), 설파이드(-S-) 및 설폭사이드(-SO-), 알콕시기(CnH2n+1O-), 히드록시기(-OH)로 이루어진 군에서 선택되는 작용기를 하나 이상 포함하는 탄소수 3 내지 20의 알킬렌기 또는 알케닐렌기일 수 있다. 구체적으로, 상기 R1은 에스테르(-C(=O)O-) 작용기를 포함하는 탄소수 4 내지 15의 유기기이고, R2 및 R3은 수소로 이루어질 수 있다.In addition, at least one of R 1 to R 3 in Formula 1 may be an organic group having 3 to 20 carbon atoms. For example, ester (-C(=O)O-), ether (-O-), carbonyl (-C(=O)-), carboxyl group (-C(=O)-OH), sulfonyl ( -SO 2 -), sulfide (-S-) and sulfoxide (-SO-), alkoxy group (C n H 2n+1 O-), hydroxy group (-OH) containing at least one functional group selected from the group consisting of may be an alkylene group or an alkenylene group having 3 to 20 carbon atoms. Specifically, R 1 is an organic group having 4 to 15 carbon atoms including an ester (-C(=O)O-) functional group, and R 2 and R 3 may be formed of hydrogen.
상기 2차 리간드에서 티올기(Thiol group)는 양자점 표면과의 친화성(affinity)이 우수하므로 양자점의 광중합성 모노머에 대한 분산성을 향상시킬 수 있다. 또한 상기 2차 리간드는 티올기 뿐만 아니라, 에스테르, 에테르, 카르보닐, 카르복실기, 알콕시기, 사이클로알킬기 또는 히드록시기를 포함함으로써 표면 개질된 양자점의, 소수성을 가지는 극성 모노머에 대한 분산성이 극대화될 수 있다. 또한 이러한 양자점을 포함하는 양자점 조성물은 디스플레이 공정에 유리한 특성(예를 들면, 저점도)을 가질 수 있다. 한편, 탄소수가 3 이하인 티올계 화합물을 사용하는 경우 양자점의 표면 개질은 가능하나, 표면 개질된 양자점의 높은 극성으로 인하여 일반적인 용매 및 모노머에 대한 분산이 어려운 문제가 발생할 수 있다.Since the thiol group in the secondary ligand has excellent affinity with the surface of the quantum dots, the dispersibility of the quantum dots in the photopolymerizable monomer can be improved. In addition, the secondary ligand includes not only a thiol group, but also an ester, ether, carbonyl, carboxyl group, alkoxy group, cycloalkyl group, or hydroxy group, thereby maximizing the dispersibility of the surface-modified quantum dot to a polar monomer having hydrophobicity. . In addition, a quantum dot composition including such quantum dots may have advantageous characteristics (eg, low viscosity) for a display process. On the other hand, when using a thiol-based compound having 3 or less carbon atoms, surface modification of quantum dots is possible, but due to the high polarity of surface-modified quantum dots, dispersion in common solvents and monomers may be difficult.
상기 2차 리간드는 구체적으로 Zn-(3-methoxybutyl 3-mercaptopropionate)2, Zn-(3-methoxybutyl thioglycolate)2, Zn-(2-ethylhexyl thioglycolate)2, Zn-(butyl mercaptopropionate)2, Zn-(isopropyl mercaptopropionate)2, Zn-(Bis-(butoxy triethylene glycol)mercapto succinate)2 및 Zn-(poly(ethylene glycol)methyl ether-thioglycolate)2로 이루어진 군에서 선택된 하나 이상일 수 있다.The secondary ligand is specifically Zn-(3-methoxybutyl 3-mercaptopropionate) 2 , Zn-(3-methoxybutyl thioglycolate) 2 , Zn-(2-ethylhexyl thioglycolate) 2 , Zn-(butyl mercaptopropionate) 2, Zn-( isopropyl mercaptopropionate) 2, Zn-(Bis-(butoxy triethylene glycol)mercapto succinate) 2 and Zn-(poly(ethylene glycol)methyl ether-thioglycolate) 2 may be at least one selected from the group consisting of.
상기 3차 리간드는 탄소수가 3 내지 40이고, 카르복실기를 포함할 수 있다. 또한, 본 발명의 일 실시예에 따르면 상기 3차 리간드는 티올기를 포함하지 않을 수 있다. The tertiary ligand may have 3 to 40 carbon atoms and include a carboxyl group. Also, according to an embodiment of the present invention, the tertiary ligand may not include a thiol group.
본 발명의 일 실시예에 따르면, 상기 3차 리간드는 하기 화학식 2로 표시될 수 있다. According to one embodiment of the present invention, the tertiary ligand may be represented by Formula 2 below.
[화학식 2][Formula 2]
상기 화학식 2에서,In Formula 2,
L은 단일결합이거나, 또는 치환 또는 비치환된 C1 내지 C20의 알킬렌기 및 치환 또는 비치환된 C1 내지 C20의 알케닐렌으로 이루어진 군에서 선택되고,L is a single bond or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkylene group and a substituted or unsubstituted C1 to C20 alkenylene group;
A는 단일결합이거나, 또는 에스테르(-C(=O)O-), 에테르(-O-), 카르보닐(- C(=O)-), 설포닐(-SO2-), 설파이드(-S-) 및 설폭사이드(-SO-)로 이루어진 군에서 선택되는 작용기를 하나 이상 포함하는 C1 내지 C20의 알킬렌기 또는 알케닐렌기이고,A is a single bond, or ester (-C(=O)O-), ether (-O-), carbonyl (-C(=O)-), sulfonyl (-SO 2 -), sulfide (- A C1 to C20 alkylene or alkenylene group containing at least one functional group selected from the group consisting of S-) and sulfoxide (-SO-),
R은 수소이거나, 또는 치환 또는 비치환된 C1 내지 C20의 알킬기 및 치환 또는 비치환된 C1 내지 C20의 알케닐기로 이루어진 군에서 선택된다.R is hydrogen or is selected from the group consisting of a substituted or unsubstituted C1 to C20 alkyl group and a substituted or unsubstituted C1 to C20 alkenyl group.
바람직하게는, 상기 3차 리간드에서 A는 에스테르(-COO-), 에테르(-O-), 또는 이들의 조합을 포함할 수 있다. 또한, 상기 A는 C2 내지 C15의 알킬렌기 또는 알케닐렌기, 바람직하게는 C2 내지 C10의 알킬렌기 또는 알케닐렌기 일 수 있다.Preferably, A in the tertiary ligand may include an ester (-COO-), an ether (-O-), or a combination thereof. In addition, A may be a C2 to C15 alkylene group or alkenylene group, preferably a C2 to C10 alkylene group or alkenylene group.
상기 3차 리간드는 구체적으로 2-carboxyethyl acrylate, mono-2-(acryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl maleate, 2-[2-(2-methoxyethoxy)ethoxy]acetic acid, 2-(2-methoxyethoxy)acetic acid로 이루어진 군에서 선택된 하나 이상일 수 있다.The tertiary ligand is specifically 2-carboxyethyl acrylate, mono-2-(acryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl succinate, mono-2-(methacryloyloxy)ethyl maleate, 2-[2-(2- It may be at least one selected from the group consisting of methoxyethoxy)ethoxy]acetic acid and 2-(2-methoxyethoxy)acetic acid.
일반적으로 티올계 리간드는 양자점 표면과의 반응성이 높은 것으로 알려져 있다. 그러나, 티올계 리간드만을 포함하는 양자점 조성물은 유해한 냄새(기체)가 발생하거나, 또는 점도가 상승되어 저장 안정성이 저하되는 문제가 발생하여 잉크젯용 조성물에 사용하기에 적합하지 않았다. 본 발명에 따른 양자점 조성물은 티올계 리간드를 포함하는 2차 리간드와 티올기를 포함하지 않는 3차 리간드를 함께 사용함으로써 저점도 및 우수한 저장 안정성(열처리 전후 QE 값의 변화 정도)을 나타내었다. 또한, 상기 3차 리간드는 에스테르(-C(=O)O-), 에테르(-O-), 카르보닐(-C(=O)-), 카르복실기(-C(=O)-OH) 등의 작용기를 포함함으로써 광중합성 모노머에 대한 분산성이 우수하게 나타난다. 한편, 3차 리간드의 탄소수가 16개 이상인 경우, 양자점의 표면 개질이 이루어지지 않거나, 일반적인 용매 및 모노머에 대한 분산성이 저해되는 문제점이 발생할 수 있다. In general, thiol-based ligands are known to have high reactivity with the surface of quantum dots. However, quantum dot compositions containing only thiol-based ligands are not suitable for use in inkjet compositions because they generate harmful odors (gases) or deteriorate storage stability due to increased viscosity. The quantum dot composition according to the present invention exhibited low viscosity and excellent storage stability (degree of change in QE value before and after heat treatment) by using a secondary ligand containing a thiol-based ligand and a tertiary ligand not containing a thiol group together. In addition, the tertiary ligands are ester (-C(=O)O-), ether (-O-), carbonyl (-C(=O)-), carboxyl group (-C(=O)-OH), etc. By including the functional group of the excellent dispersibility to the photopolymerizable monomer. On the other hand, when the number of carbon atoms of the tertiary ligand is 16 or more, the surface of the quantum dot may not be modified or dispersibility in common solvents and monomers may be impaired.
상기 1차 리간드 및 2차 리간드 모두 ethylene glycol 구조를 반복적으로 포함한 경우, 그렇지 않은 경우에 비하여 잉크 조성물의 점도 및 광특성이 우수할 수 있다. 이는 ethylene glycol의 구조적 특징상 친수성이 강하기 때문에 조성물 내에서 QD의 분산성이 보다 향상되기 때문인 것으로 보인다.When both the primary ligand and the secondary ligand repeatedly include an ethylene glycol structure, the viscosity and optical properties of the ink composition may be excellent compared to cases where the ethylene glycol structure is not included. This seems to be because the dispersibility of QDs in the composition is further improved because ethylene glycol has strong hydrophilicity due to its structural characteristics.
본 발명의 일 실시예에 따르면 상기 1차 리간드와 2차 리간드의 몰비는 1 : 1~20, 바람직하게는 1 : 1~10 몰비이고, 더욱 바람직하게는 1 : 1~5 몰비일 수 있으나, 이에 제한되지 않는다.According to one embodiment of the present invention, the molar ratio of the primary ligand and the secondary ligand is 1: 1 to 20, preferably 1: 1 to 10 molar ratio, more preferably 1: 1 to 5 molar ratio, but Not limited to this.
또한, 본 발명의 일 실시예에 따르면 상기 1차 리간드, 2차 리간드와 3차 리간드의 몰비는 1 : 1~20 : 1~30, 바람직하게는 1 : 1~10 : 1~15 몰비이고, 더욱 바람직하게는 1 : 1~5 : 1~8일 수 있으나, 이에 제한되지 않는다.In addition, according to one embodiment of the present invention, the molar ratio of the primary ligand, secondary ligand and tertiary ligand is 1: 1 to 20: 1 to 30, preferably 1: 1 to 10: 1 to 15 molar ratio, More preferably, it may be 1: 1 to 5: 1 to 8, but is not limited thereto.
또한, 본 발명의 일 실시예에 따르면 상기 양자점과 리간드의 혼합비율은 1: 1~20 중량비, 바람직하게는 1: 1~10 중량비, 더욱 바람직하게는 1: 5~10일 수 있다. 여기서 상기 리간드는 1차 리간드와 2차 리간드의 합 또는 1차 리간드, 2차 리간드와 3차 리간드를 합을 의미한다.In addition, according to one embodiment of the present invention, the mixing ratio of the quantum dots and the ligand may be 1: 1 to 20 weight ratio, preferably 1: 1 to 10 weight ratio, more preferably 1: 5 to 10. Here, the ligand means the sum of a primary ligand and a secondary ligand or a sum of a primary ligand, a secondary ligand and a tertiary ligand.
광중합성 모노머photopolymerizable monomer
본 발명에 따른 양자점 조성물에서, 광중합성 모노머는 양자점(QD)이 분산되는 제형, 즉 고분자 매트릭스의 전체 가교밀도를 컨트롤하여 매트릭스의 구조 및 제반 물성을 발현하는 역할을 수행한다. 또한 유연성(flexibility) 및 다른 소재와의 접착성 및 부착성을 개선할 수 있다. In the quantum dot composition according to the present invention, the photopolymerizable monomer serves to express the structure and physical properties of the matrix by controlling the total crosslinking density of the formulation in which the quantum dots (QDs) are dispersed, that is, the polymer matrix. In addition, it is possible to improve flexibility and adhesion and adhesion to other materials.
상기 광중합성 모노머는 (메타)아크릴레이트계 모노머를 포함할 수 있다. 사용 가능한 모노머는 당 분야에서 통상적으로 사용하는 모노머라면 특별한 제한없이 사용할 수 있다.The photopolymerizable monomer may include a (meth)acrylate-based monomer. Any monomer that can be used can be used without particular limitation as long as it is a monomer commonly used in the art.
일례로, (메타)아크릴레이트계 모노머는 (메타)아크릴기, 비닐기 및 알릴기 중 적어도 하나를 포함할 수 있다. 구체적으로, 1,6-헥산다이올 다이아크릴레이트(1,6-hexanediol diacrylate), 1,6-사이클로헥산다이올 다이아크릴레이트(1,6-cyclohexanediol diacrylate), 2,2-다이메틸-1,3-프로판다이올 다이아크릴레이트(2,2-dimethyl-1,3-propanediol diacylate), 다이에틸렌 글리콜 다이아크릴레이트(diethylene glycol diacrylate), 다이프로필렌 글리콜 다이아크릴레이트(Dipropylene glycol diacrylate), 1,3-부틸렌 글리콜 다이메타크릴레이트(1,3-butylene glycol dimethacrylate), 트리메틸올프로판 트리메타크릴레이 트(trimethylolpropane trimethacrylate), 이소보닐 아크릴레이트(isobornyl acrylate), 이소보닐 메타크릴레이트(isobornyl methacrylate), 테트라하이드로퓨릴 아크릴레이트(tetrahydrofuryl acrylate), 아크릴로일 모르폴린(Acryloyl morpholine), 2-페녹시에틸 아크릴레이트(2-phenoxyethyl acrylate), 트리프로필렌글리콜 다이아크릴레이트(tripropylene glycol diacrylate), 트리메틸올프로판 트리아크릴레이트(trimethylolpropane triacrylate), 펜타에리쓰리톨 모노(메트)아크릴레이트, 펜타에리쓰리톨 다이(메트)아크릴레이트, 펜타에리쓰리톨 트리아크릴레이트(pentaerythritol triacrylate), 펜타에리쓰리톨 트리메타크릴레이트, 다이펜타에리쓰리톨 헥사아크릴레이트(dipentaerythritol hexaacrylate) 및 다이펜타에리쓰리톨 헥사메타크릴레이트 등이 있다. 이들은 단독으로 사용되거나 또는 2종 이상이 혼합되어 사용될 수 있다. 본 발명에서 광중합성 모노머로서 1,6-헥산다이올 다이아크릴레이트(1,6-hexanediol diacrylate)는 무용매형 양자점 조성물의 점도 특성을 달성하는 데에 바람직하다.For example, the (meth)acrylate-based monomer may include at least one of a (meth)acrylic group, a vinyl group, and an allyl group. Specifically, 1,6-hexanediol diacrylate, 1,6-cyclohexanediol diacrylate, 2,2-dimethyl-1 ,3-propanediol diacrylate (2,2-dimethyl-1,3-propanediol diacylate), diethylene glycol diacrylate, dipropylene glycol diacrylate, 1, 3-butylene glycol dimethacrylate, trimethylolpropane trimethacrylate, isobornyl acrylate, isobornyl methacrylate , tetrahydrofuryl acrylate, acryloyl morpholine, 2-phenoxyethyl acrylate, tripropylene glycol diacrylate, trimethylolpropane Trimethylolpropane triacrylate, pentaerythritol mono(meth)acrylate, pentaerythritol di(meth)acrylate, pentaerythritol triacrylate, pentaerythritol trimethacrylate , dipentaerythritol hexaacrylate and dipentaerythritol hexamethacrylate. These may be used alone or in combination of two or more. In the present invention, 1,6-hexanediol diacrylate as a photopolymerizable monomer is preferable to achieve the viscosity characteristics of the solvent-free quantum dot composition.
본 발명에서 (메타)아크릴아미드계 모노머의 함량은 상기 무용매형 양자점 조성물의 총 중량을 기준으로 35 내지 80 중량%, 바람직하게는 45 내지 70 중량%일 수 있다. In the present invention, the content of the (meth)acrylamide-based monomer may be 35 to 80% by weight, preferably 45 to 70% by weight based on the total weight of the solvent-free quantum dot composition.
광개시제photoinitiator
본 발명에 따른 무용매형 양자점 조성물에서, 광개시제는 자외선(UV) 등의 광원에 의해 여기되어 광중합을 개시하는 역할을 하는 성분으로서, 당 분야의 통상적인 광중합 광개시제를 제한 없이 사용할 수 있다. 일례로, 아세토페논계 화합물, 벤조페논계 화합물, 티오크산톤계 화합물, 벤조인계 화합물, 트리아진계 화합물, 옥심계 화합물 등을 사용할 수 있다.In the solvent-free quantum dot composition according to the present invention, the photoinitiator is a component that is excited by a light source such as ultraviolet (UV) and serves to initiate photopolymerization, and a conventional photopolymerization photoinitiator in the art may be used without limitation. For example, an acetophenone-based compound, a benzophenone-based compound, a thioxanthone-based compound, a benzoin-based compound, a triazine-based compound, an oxime-based compound, and the like may be used.
사용 가능한 광개시제의 비제한적인 예를 들면, Ethyl(2,4,6-trimethylbenzoyl)phenylphosphinate, Irgacure 184, Irgacure 369, Irgacure 651, Irgacure 819, Irgacure 907, 벤지온알킬에테르(Benzionalkylether), 벤조페논(Benzophenone), 벤질디메틸카탈(Benzyl dimethyl katal), 하이드록시사이클로헥실 페닐 아세톤(Hydroxycyclohexyl phenyl acetone), 클로로아세토페논(Chloroacetophenone), 1,1-디클로로아세토페논(1,1-Dichloro acetophenone), 디에톡시아세토페논(Diethoxy acetophenone), 하이드록시아세토페논(Hydroxy Acetophenone), 2-클로로티옥산톤(2-Chloro thioxanthone), 2-ETAQ(2-EthylAnthraquinone), 1-하이드록시-사이클로헥실-페닐-케톤(1-Hydroxy- cyclohexyl-phenyl-ketone), 2-하이드록시-2-메틸-1-페닐-1-프로파논(2-Hydroxy-2- methyl-1-phenyl-1-propanone), 2-하이드록시-1-[4-(2-하이드록시에톡시)페닐]-2- 메틸-1-프로파논(2-Hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone), 메틸벤조일포메이트(methylbenzoylformate) 등이 있다. 이들을 단독으로 사용하거나 또는 2종 이상 혼용할 수 있다.Non-limiting examples of usable photoinitiators include Ethyl (2,4,6-trimethylbenzoyl) phenylphosphinate, Irgacure 184, Irgacure 369, Irgacure 651, Irgacure 819, Irgacure 907, Benzionalkylether, Benzophenone ), Benzyl dimethyl katal, Hydroxycyclohexyl phenyl acetone, Chloroacetophenone, 1,1-Dichloro acetophenone, Diethoxyacetophenone (Diethoxy acetophenone), Hydroxy Acetophenone, 2-Chloro thioxanthone, 2-ETAQ (2-EthylAnthraquinone), 1-hydroxy-cyclohexyl-phenyl-ketone (1- Hydroxy- cyclohexyl-phenyl-ketone), 2-hydroxy-2-methyl-1-phenyl-1-propanone (2-Hydroxy-2- methyl-1-phenyl-1-propanone), 2-hydroxy-1 -[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone (2-Hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone), and methylbenzoylformate. These may be used alone or in combination of two or more.
상기 광개시제의 함량은 당 분야에 공지된 범위 내에서 적절히 조절할 수 있다. 일례로, 당해 무용매형 양자점 조성물의 총 중량을 기준으로 하여 0.01 내지 10 중량%일 수 있고, 바람직하게는 0.1 내지 5 중량%일 수 있다. 상기 광개시제의 함량이 전술한 범위에 해당될 경우, 매트릭스의 물성 저하 없이 광중합 반응이 충분히 이루어질 수 있다. The amount of the photoinitiator may be appropriately adjusted within a range known in the art. For example, it may be 0.01 to 10% by weight, preferably 0.1 to 5% by weight based on the total weight of the solvent-free quantum dot composition. When the content of the photoinitiator falls within the aforementioned range, photopolymerization may be sufficiently performed without deterioration of physical properties of the matrix.
확산제diffuser
본 발명에 따른 무용매형 양자점 조성물에서, 확산제는 광변환 물질에 흡수되지 않은 광을 반사시키고, 상기 반사된 광을 광변환 물질이 다시 흡수할 수 있도록 한다. 즉, 확산제는 광변환 물질에 흡수되는 광의 양을 증가시켜, 광변환 효율을 증가시킬 수 있다.In the solvent-free quantum dot composition according to the present invention, the diffusion agent reflects light not absorbed by the light conversion material, and allows the light conversion material to absorb the reflected light again. That is, the diffusion agent may increase light conversion efficiency by increasing the amount of light absorbed by the light conversion material.
상기 확산제는 당 분야에 공지된 확산제 성분을 제한 없이 사용할 수 있다. 이러한 확산제는 분말과 같은 고형분 형태이거나 또는 확산제가 분산된 분산액일 수도 있다. As the diffusion agent, any diffusion agent component known in the art may be used without limitation. The dispersing agent may be in a solid form such as a powder or may be a dispersion in which the dispersing agent is dispersed.
사용 가능한 확산제의 비제한적인 예로는, 황산바륨(BaSO4), 탄산칼슘(CaCO3), 이산화티타늄(TiO2), 지르코니아(ZrO2) 또는 이들의 조합을 포함할 수 있다. 또한 확산제의 평균입경이나 형상은 특별히 제한되지 않으며, 당 분야에 공지된 구성 내에서 적절히 취사선택할 수 있다. 일례로, 평균 입경(D50)은 150nm 내지 250nm 일 수 있으며, 구체적으로는 180nm 내지 230nm일 수 있다. 상기 확산제의 평균 입경이 전술한 범위 내일 경우, 보다 우수한 광확산 효과를 가질 수 있으며, 광 변환 효율을 증가시킬 수 있다.Non-limiting examples of usable diffusing agents include barium sulfate (BaSO 4 ), calcium carbonate (CaCO 3 ), titanium dioxide (TiO 2 ), zirconia (ZrO 2 ), or a combination thereof. In addition, the average particle diameter or shape of the diffusing agent is not particularly limited, and may be appropriately selected from configurations known in the art. For example, the average particle diameter (D50) may be 150 nm to 250 nm, specifically 180 nm to 230 nm. When the average particle diameter of the diffusing agent is within the above range, a superior light diffusing effect may be obtained and light conversion efficiency may be increased.
상기 확산제의 함량은 당 분야에 공지된 범위 내에서 적절히 조절할 수 있다. 일례로, 당해 무용매형 양자점 조성물의 총 중량을 기준으로 하여 0.01 내지 10 중량% 일 수 있고, 바람직하게는 0.1 내지 5 중량%일 수 있다. 확산제의 함량이 전술한 범위에 해당될 경우, 매트릭스의 물성 저하 없이 광변환 효율 향상 효과를 나타낼 수 있다.The content of the diffusing agent may be appropriately adjusted within a range known in the art. For example, it may be 0.01 to 10% by weight, preferably 0.1 to 5% by weight based on the total weight of the solvent-free quantum dot composition. When the content of the diffusion agent falls within the above-mentioned range, the effect of improving light conversion efficiency may be exhibited without deterioration of physical properties of the matrix.
중합금지제polymerization inhibitor
본 발명에 따른 무용매형 양자점 조성물에서, 중합금지제는 라디칼과 반응하여 중합 반응을 일으킬 수 없는 낮은 반응성의 라디칼 또는 화합물을 형성하는 물질로서, 광 중합 반응의 속도를 조절할 수 있다.In the solventless quantum dot composition according to the present invention, the polymerization inhibitor reacts with radicals to form radicals or compounds of low reactivity that cannot cause polymerization, and can control the rate of photopolymerization.
상기 중합금지제는 당 분야에 공지된 물질을 제한 없이 사용할 수 있다. 예를 들어, 중합금지제로는 퀴논계 화합물, 페놀 혹은 아닐린계 화합물, 방향족 니트로 및 니트로소 화합물을 사용할 수 있다. 구체적으로, 하이드로퀴논(HQ), 메틸하이드로퀴논(THQ), 하이드로퀴논 모노메틸 에테르(MEHQ) 및 하이드로퀴논 모노 에틸에테르(EEHQ) 1,4-벤조퀴논(BQ), 2,5-디페닐벤조퀴논(DPBQ), 메틸-1,4-벤조퀴논(MBQ), 페닐-1,4-벤조퀴논(PBQ); 2,6-디-tert-부틸-4-메틸페놀(BHT), 2,6-디페닐-4-옥타데실옥시페놀, 카테콜; 페노시아진, 비스 (α-메틸벤질)페노시아진, 3,7-디옥틸페노시아진, 비스(α,α-디메틸벤질)페노시아진; 디메틸디티오카밤산, 디에틸디티오카밤산, 디프로필디티오카밤산, 디부틸디티오카밤산, 디페닐디티오카밤산 등이 있다. 이들을 단독으로 사용하거나 또는 2종 이상 혼용할 수 있다.As the polymerization inhibitor, materials known in the art may be used without limitation. For example, as the polymerization inhibitor, quinone-based compounds, phenol or aniline-based compounds, and aromatic nitro and nitroso compounds may be used. Specifically, hydroquinone (HQ), methylhydroquinone (THQ), hydroquinone monomethyl ether (MEHQ) and hydroquinone monoethyl ether (EEHQ), 1,4-benzoquinone (BQ), 2,5-diphenylbenzo quinone (DPBQ), methyl-1,4-benzoquinone (MBQ), phenyl-1,4-benzoquinone (PBQ); 2,6-di-tert-butyl-4-methylphenol (BHT), 2,6-diphenyl-4-octadecyloxyphenol, catechol; phenocyazine, bis(α-methylbenzyl)phenocyazine, 3,7-dioctylphenocyazine, bis(α,α-dimethylbenzyl)phenocyazine; Dimethyldithiocarbamic acid, diethyldithiocarbamic acid, dipropyldithiocarbamic acid, dibutyldithiocarbamic acid, and diphenyldithiocarbamic acid. These may be used alone or in combination of two or more.
상기 중합금지제의 함량은 당 분야에 공지된 범위 내에서 적절히 조절할 수 있다. 일례로, 당해 무용매형 양자점 조성물의 총 중량을 기준으로 하여 0.01 내지 2 중량% 일 수 있고, 바람직하게는 0.05 내지 1 중량%일 수 있다. The content of the polymerization inhibitor may be appropriately adjusted within a range known in the art. For example, it may be 0.01 to 2% by weight, preferably 0.05 to 1% by weight based on the total weight of the solvent-free quantum dot composition.
안정제stabilizator
본 발명에 따른 무용매형 양자점 조성물에서, 안정제는 양자점의 안정성 및 분산성 향상을 위해 첨가될 수 있다. 안정제는 양자점의 쉘 표면에 치환되어 용제에 대한 양자점의 분산 안정성을 향상시켜 양자점을 안정화시킬 수 있다. In the solvent-free quantum dot composition according to the present invention, a stabilizer may be added to improve stability and dispersibility of the quantum dots. The stabilizer may stabilize the quantum dots by substituting the shell surface of the quantum dots to improve dispersion stability of the quantum dots in a solvent.
사용 가능한 안정제는 당 분야에서 양자점의 안정성 및 분산성을 향상시킬 수 있는 물질이라면 제한없이 사용할 수 있고, 예컨대 티올계 안정제를 사용할 수 있다. 상기 티올계 안정제는 광중합성 모노머에 대한 양자점의 분산성을 향상시킬 수 있다. 또한, 티올계 안정제가 가지는 티올기는 광중합성 모노머의 아크릴기와 반응하여 공유결합을 형성함으로써 양자점 조성물의 내열성을 향상시킬 수 있다. Any stabilizer that can be used in the art can be used without limitation as long as it can improve the stability and dispersibility of quantum dots, and for example, a thiol-based stabilizer can be used. The thiol-based stabilizer may improve the dispersibility of the quantum dots with respect to the photopolymerizable monomer. In addition, the thiol group of the thiol-based stabilizer reacts with the acryl group of the photopolymerizable monomer to form a covalent bond, thereby improving heat resistance of the quantum dot composition.
상기 티올계 안정제는 7개 이상의 탄소 원자 가질 수 있고, 그 구조에 따라 말단에 2개 내지 10개, 예컨대 2개 내지 6개의 티올기(-SH)를 가질 수 있으나, 이에 특별히 제한되지 않는다. 사용 가능한 티올계 안정제의 비제한적인 예로는, 펜타에리트리톨테트라키스(3-머캅토프로피오네이트)(pentaerythritol tetrakis(3- mercaptopropionate)), 트리메틸올프로판 트리스(3-머캅토프로피오네이트)(trimethylolpropane tris(3-mercaptopropionate)), 펜타에리트리톨 테트라키스(머캅토아세테이트)(Pentaerythritol tetrakis(mercaptoacetate)), 트리메틸올프로판 트리스(2-머캅토아세테이트)(trimethylolpropane tris(2-mercaptoacetate)), 글리콜 디-3-머캅토프로피오네이트(Glycol di-3-mercaptopropionate), 또는 이들의 혼합물 등이 있다.The thiol-based stabilizer may have 7 or more carbon atoms, and may have 2 to 10, for example, 2 to 6 thiol groups (-SH) at the terminal depending on its structure, but is not particularly limited thereto. Non-limiting examples of usable thiol-based stabilizers include pentaerythritol tetrakis (3-mercaptopropionate), trimethylolpropane tris (3-mercaptopropionate) ( trimethylolpropane tris(3-mercaptopropionate), pentaerythritol tetrakis(mercaptoacetate), trimethylolpropane tris(2-mercaptoacetate), glycol di -3-mercaptopropionate (Glycol di-3-mercaptopropionate), or mixtures thereof.
기타 첨가제Other Additives
전술한 성분들 이외에, 본 발명의 양자점 조성물은, 발명의 효과를 저해하지 않는 범위에서 당 분야에 공지된 첨가제를 제한 없이 사용할 수 있다. 이때 첨가제의 함량은 당 분야에 공지된 범위 내에서 적절히 조절할 수 있다. In addition to the components described above, the quantum dot composition of the present invention may use additives known in the art without limitation within a range that does not impair the effects of the present invention. At this time, the content of the additive may be appropriately adjusted within a range known in the art.
사용 가능한 첨가제의 일례를 들면, 실란계 화합물, 실록산계 화합물, 산화 방지제, 중합 억제제, 윤활제, 표면 조정제, 계면 활성제, 부착증진제, 소포제, 슬립제, 용제, 습윤제, 광안정제, 얼룩 방지제, 유연제, 증점제, 폴리머 등이 있다. 이들은 단독으로 사용하거나 또는 2종 이상 혼용할 수 있다. Examples of usable additives include silane-based compounds, siloxane-based compounds, antioxidants, polymerization inhibitors, lubricants, surface conditioners, surfactants, adhesion promoters, antifoaming agents, slip agents, solvents, wetting agents, light stabilizers, stain inhibitors, softeners, There are thickeners, polymers, and the like. These may be used alone or in combination of two or more.
실란계 화합물은 매트릭스에 접착성을 부여하는 역할을 하며, 실록산계 화합물은 젖음성(wetting성)을 부여하는 역할을 한다. 이러한 실란계 화합물과 실록산계 화합물은 당 분야에 공지된 성분을 제한 없이 사용할 수 있다. The silane-based compound serves to impart adhesiveness to the matrix, and the siloxane-based compound serves to impart wettability. Components known in the art may be used as the silane-based compound and the siloxane-based compound without limitation.
산화 방지제는 열이나 광 조사에 의한 퇴색 및 오존, 활성 산소, NOx, SOx (X는 정수) 등의 각종 산화성 가스에 의한 퇴색을 억제하는 것으로서, 본 발명에서는, 산화 방지제를 첨가함으로써 매트릭스의 착색 방지나 분해에 의한 막두께 감소를 저감할 수 있다. 사용 가능한 산화 방지제의 예로는, 히드라지드류, 힌더드아민계 산화 방지제, 함질소 복소고리 메르캅토계 화합물, 티오에테르계 산화 방지제, 힌더드페놀계 산화 방지제, 아스코르브산류, 황산아연, 티오시안산염류, 티오우레아 유도체, 당류, 아질산염, 아황산염, 티오황산염, 히드록실아민 유도체 등이 있다.Antioxidants suppress discoloration due to heat or light irradiation and discoloration due to various oxidizing gases such as ozone, active oxygen, NOx, and SOx (X is an integer), and in the present invention, by adding antioxidants, matrix coloration is prevented. It is possible to reduce the decrease in film thickness due to decomposition. Examples of usable antioxidants include hydrazides, hindered amine-based antioxidants, nitrogen-containing heterocyclic mercapto-based compounds, thioether-based antioxidants, hindered phenol-based antioxidants, ascorbic acids, zinc sulfate, and thiocyanic acid. Salts, thiourea derivatives, sugars, nitrites, sulfites, thiosulfates, hydroxylamine derivatives, and the like.
레벨링제는 상기 양자점 조성물을 피복할 때 평탄하고 매끄럽게 코팅될 수 있도록 레벨링함으로써, 조성물 내의 접착력을 보다 상승시킬 목적으로 포함될 수 있다. 상기 레벨링제로는 아크릴계, 실리콘계 등을 단독 또는 2종 이상 혼합하여 포함할 수 있다. 일례로, 폴리에테르 변성 폴리디메틸실록산을 포함할 수 있고, 상기 폴리에테르 사슬 안에 (메타)아크릴로일기를 부가하여 포함할 수 있다.A leveling agent may be included for the purpose of further increasing the adhesive strength in the composition by leveling the quantum dot composition so that the quantum dot composition can be coated flatly and smoothly. The leveling agent may include acrylic, silicone, or the like alone or in combination of two or more. For example, polyether-modified polydimethylsiloxane may be included, and a (meth)acryloyl group may be added to the polyether chain.
계면활성제는 상기 양자점 조성물의 혼화 및 도포 균일성을 위해 포함될 수 있다. 상기 계면활성제로는 당 분야에 알려진 통상적인 양이온성, 음이온성, 비이온성 계면활성제를 사용할 수 있으며, 일례로 불소계 계면 활성제, 실리콘계 계면 활성제 및 불소실리콘계 계면 활성제 중 1종 이상을 사용할 수 있다. A surfactant may be included for mixing and coating uniformity of the quantum dot composition. As the surfactant, conventional cationic, anionic, and nonionic surfactants known in the art may be used, and for example, one or more of fluorine-based surfactants, silicone-based surfactants, and fluorosilicone-based surfactants may be used.
광안정제는 자외선 흡수제로서 매트릭스의 내후성을 높이는 효과를 지닌다. 유연제는 건조된 고분자 매트릭스 내의 크랙 발생을 완화하기 위한 것으로서, 경화된 매트릭스 내 크랙 발생을 완화하여 내충격성 및 내굴곡성을 개선할 수 있다.The light stabilizer is an ultraviolet absorber and has an effect of increasing the weatherability of the matrix. The softening agent is for relieving cracks in the dried polymer matrix, and can improve impact resistance and bending resistance by mitigating cracks in the cured matrix.
본 발명에 따른 무용매형 양자점 조성물은 2종 이상의 리간드로 표면 개질된 양자점 및 상기 리간드 치환된 양자점과 혼화성이 우수한 광중합성 모노머를 포함한다.The solvent-free quantum dot composition according to the present invention includes quantum dots surface-modified with two or more ligands and a photopolymerizable monomer having excellent compatibility with the ligand-substituted quantum dots.
전술한 본 발명에 따른 무용매형 양자점 조성물은 광흡수율, 광 변화율 등의 광특성이 우수하고 저점도의 구현이 가능하다. 구체적으로 상온(25℃)에서의 점도는 30 cps 이하, 바람직하게는 28 cps 이하, 보다 바람직하게는 25 cps 이하일 수 있다. 점도를 적절한 범위로 조절함으로써 상기 무용매형 양자점 조성물은 우수한 작업성과 공정성을 가질 뿐만 아니라, 고온에서의 저장 안정성이 우수하다. 또한, 본 발명에 따른 무용매형 양자점 조성물은 저점도의 구현이 가능하므로 잉크젯 프린팅용으로 사용될 수 있다. The above-described solvent-free quantum dot composition according to the present invention has excellent optical properties such as light absorption rate and light change rate, and can realize low viscosity. Specifically, the viscosity at room temperature (25° C.) may be 30 cps or less, preferably 28 cps or less, and more preferably 25 cps or less. By adjusting the viscosity to an appropriate range, the solvent-free quantum dot composition not only has excellent workability and processability, but also has excellent storage stability at high temperatures. In addition, since the solvent-free quantum dot composition according to the present invention can be implemented with low viscosity, it can be used for inkjet printing.
<무용매형 양자점 조성물의 제조방법><Method for producing solvent-free quantum dot composition>
본 발명의 일 실시예를 들면, 무용매형 양자점 조성물의 제조방법은 (a) 양자점을 합성하는 단계, (b) 상기 양자점의 합성이 일어난 용액에서 상기 양자점을 분리하지 않고, ethylene glycol 구조를 포함하는 1차 리간드로 상기 양자점을 1차 표면 개질하는 단계, (c) 1차 표면 개질된 양자점을 하기 화학식 1로 나타나는 2차 리간드로 2차 표면 개질하는 단계, (d) 상기 (c)단계의 결과물을 분리하여 표면 개질된 양자점을 수득하는 단계 및 (e) 상기 수득된 표면 개질된 양자점을 광중합성 모노머에 분산시키는 단계를 포함할 수 있다.In one embodiment of the present invention, a method for producing a solvent-free quantum dot composition includes the steps of (a) synthesizing quantum dots, (b) without separating the quantum dots from the solution in which the quantum dots are synthesized, and containing an ethylene glycol structure Primary surface modification of the quantum dots with a primary ligand, (c) secondary surface modification of the primary surface-modified quantum dots with a secondary ligand represented by Formula 1 below, (d) result of step (c) It may include separating and obtaining surface-modified quantum dots, and (e) dispersing the obtained surface-modified quantum dots in a photopolymerizable monomer.
[화학식 1][Formula 1]
(상기 화학식 1에서, (In Formula 1 above,
M은 2 내지 4가의 금속이고,M is a divalent to tetravalent metal;
R1 내지 R3은 독립적으로 수소 또는 탄소수 3 내지 70의 유기기이고, R 1 to R 3 are independently hydrogen or an organic group having 3 to 70 carbon atoms;
n은 2 내지 4의 정수이다.) n is an integer from 2 to 4.)
또한, 상기 (c)단계 이후에, In addition, after step (c),
(f) 카르복실기를 포함하는 탄소수 3 내지 40의 3차 리간드를 첨가하여 상기 개질된 양자점을 3차 표면 개질하는 단계를 포함할 수 있다.(f) tertiary surface modification of the modified quantum dots by adding a tertiary ligand having 3 to 40 carbon atoms including a carboxyl group.
상기 (c)단계에서 2차 리간드에 의한 양자점의 개질은 1차 리간드로 양자점을 개질한 이후에 수행되는 것이 바람직하다.In step (c), the modification of the quantum dots with the secondary ligand is preferably performed after the modification of the quantum dots with the primary ligand.
여기서, 양자점, 1차 리간드, 2차 리간드, 3차 리간드 및 광중합성 모노머에 관한 것은 전술한 바와 같다. 또한, 양자점의 제조방법은 종래에 다수의 문헌에 알려진 방법(예를 들면, 고온주입법, 미세유체 반응기 방법, microwave irradiation을 이용한 방법 등)을 사용할 수 있다. 본 발명에서는 양자점의 제조방법이 아니라 양자점의 제조 용액 상태에서 리간드의 조성 및 그 개질방법에 특징이 있으므로 이에 대하여 구체적으로 설명한다.Here, the quantum dots, the primary ligand, the secondary ligand, the tertiary ligand, and the photopolymerizable monomer are as described above. In addition, as a method for manufacturing quantum dots, conventionally known methods (eg, a high-temperature injection method, a microfluidic reactor method, a method using microwave irradiation, etc.) may be used. In the present invention, since the composition of the ligand and its modification method in the state of the quantum dot production solution are characteristic, not the manufacturing method of the quantum dot, this will be described in detail.
구체적으로, 상기 (b)단계는 상기 양자점이 합성된 용액의 온도를 낮춰 약 80℃로 유지한 상태에서 1차 리간드를 cyclohexylacetate에 20wt%로 희석시킨 용액을 넣고 약 5시간 동안 교반하여 1차 개질하는 단계일 수 있다. 그리고 상기 (c)단계는 온도를 약 30℃로 낮춘 상태에서 상기 2차 리간드를 cyclohexylacetate에 20wt%로 희석시킨 용액을 투입하고 약 90분 동안 교반하여 양자점의 표면을 2차 개질하는 단계일 수 있다. 또한 (c)단계 이후, 냉각하여 다시 온도를 약 30℃로 낮춘 상태에서 3차 리간드를 투입하여 30분 내지 3시간 동안 반응시켜 양자점의 표면을 개질하는 단계를 포함할 수 있다.Specifically, in the step (b), while the temperature of the solution in which the quantum dots were synthesized was lowered and maintained at about 80 ° C, a solution in which a primary ligand was diluted in cyclohexylacetate at 20 wt% was added and stirred for about 5 hours to perform primary modification. It may be a step to In the step (c), a solution in which the secondary ligand is diluted to 20wt% in cyclohexylacetate is added and stirred for about 90 minutes in a state where the temperature is lowered to about 30 ° C., thereby secondaryly modifying the surface of the quantum dots. . In addition, after step (c), a step of modifying the surface of the quantum dots by adding a tertiary ligand and reacting for 30 minutes to 3 hours in a state where the temperature is lowered to about 30° C. by cooling again may be included.
상기 양자점의 표면 개질 단계는 2 단계 또는 3 단계로 나누어 양자점의 표면 개질을 진행하여 1차 리간드, 2차 리간드 및 3차 리간드간의 반응으로 인한 부가 생성물의 형성을 방지할 수 있으며, 1차 리간드가 소수성인 양자점과 먼저 반응하여 소수성을 약화시킴으로써 전체적으로 소수성인 양자점 합성 용액내에서도 2차 리간드 및 3차 리간드와의 반응이 진행되어 양자점의 표면이 개질되면서도, 이후 광중합성 모노머에서의 분산성이 향상되는 것이다. The surface modification step of the quantum dots can be divided into two or three steps to modify the surface of the quantum dots to prevent the formation of an adduct due to a reaction between a primary ligand, a secondary ligand, and a tertiary ligand. By first reacting with the hydrophobic quantum dots to weaken the hydrophobicity, the reaction with the secondary ligand and the tertiary ligand proceeds even in the overall hydrophobic quantum dot synthesis solution, so that the surface of the quantum dots is modified, and then the dispersibility in the photopolymerizable monomer is improved. .
반면, 상기 양자점에 상기 2차 리간드와 3차 리간드를 동시에 투입하는 경우 2차 리간드의 티올기와 3차 리간드의 아크릴레이트간의 싸이올-엔(thiol-ene) 반응으로 인해 부가 생성물이 형성될 수 있다. 이러한 부가 생성물은 표면 개질된 양자점을 광중합성 모노머에 분산시킬 때 양자점 조성물의 점도를 향상시킬 수 있다.On the other hand, when the secondary ligand and the tertiary ligand are simultaneously added to the quantum dot, an adduct may be formed due to a thiol-ene reaction between the thiol group of the secondary ligand and the acrylate of the tertiary ligand. . These adducts can improve the viscosity of the quantum dot composition when the surface-modified quantum dots are dispersed in the photopolymerizable monomer.
또한, 상기 양자점의 표면 개질 단계는 상기 1차 표면 개질된 양자점에 상기 2차 리간드 및 3차 리간드를 동시에 투입하고 25℃ 내지 100℃에서 30분 내지 3시간 동안 반응하여 양자점의 표면을 개질하는 단계일 수 있다. In addition, the step of modifying the surface of the quantum dots is the step of simultaneously adding the secondary ligand and the tertiary ligand to the primary surface-modified quantum dots and reacting at 25 ° C to 100 ° C for 30 minutes to 3 hours to modify the surface of the quantum dots. can be
전술한 방법으로 양자점의 표면을 개질시킨 후, 표면 개질된 양자점은 원심 분리를 통해 수득될 수 있다. 또한, 무용매형 양자점 조성물은 수득된 표면 개질된 양자점을 중합성 모노머에 분산시켜 제조될 수 있다. After modifying the surface of the quantum dots by the above-described method, the surface-modified quantum dots may be obtained through centrifugation. In addition, the solvent-free quantum dot composition may be prepared by dispersing the obtained surface-modified quantum dots in a polymerizable monomer.
<경화막, 컬러필터 및 디스플레이 장치> <Cured film, color filter and display device>
본 발명은 전술한 무용매형 양자점 조성물을 포함하는 경화막을 제공할 수 있다. 본 발명에 따른 경화막은 광특성이 우수하며 구체적으로 광흡수율이 75% 이상, 바람직하게는 78% 이상일 수 있다. 또한, 상기 경화막은 광 변환율이 25% 이상, 구체적으로 29% 이상일 수 있다. 또한, 10±0.5㎛ 두께로 코팅하였을 때 절대양자효율이 30% 이상일 수 있다.The present invention may provide a cured film comprising the above-described solvent-free quantum dot composition. The cured film according to the present invention has excellent light properties, and specifically, the light absorption rate may be 75% or more, preferably 78% or more. In addition, the cured film may have a light conversion rate of 25% or more, specifically 29% or more. In addition, when coated with a thickness of 10 ± 0.5 μm, the absolute quantum efficiency may be 30% or more.
상기 경화막은 전술한 무용매형 양자점 조성물을 기판 상에 잉크젯 분사방법으로 도포하여 패턴을 형성하는 단계; 및 상기 패턴을 경화하는 단계를 포함하여 제조될 수 있다. Forming a pattern of the cured film by applying the above-described solvent-free quantum dot composition on a substrate by an inkjet spraying method; and curing the pattern.
본 발명은 전술한 무용매형 양자점 조성물을 포함하는 컬러필터를 제공한다. 컬러필터는 배면광원에서 나오는 백색광에서 화소 단위로 빨강, 초록, 파랑 3가지 색을 추출하여 액정 디스플레이에서 컬러를 구현할 수 있도록 하는 박막 필름 형태의 광학부품이다.The present invention provides a color filter comprising the above-described solvent-free quantum dot composition. A color filter is an optical component in the form of a thin film that extracts three colors of red, green, and blue in pixel units from white light emitted from a rear light source to realize color in a liquid crystal display.
이러한 컬러필터는 염색법, 안료분산법, 인쇄법 및 전착법 등의 방법에 의해 제조될 수 있다. 또한, 양자점 조성물을 포함하는 컬러필터는 잉크젯(ink jet)법에 의해 제조될 수 있다. 잉크젯법은 원하는 화소에만 재료를 사용하기 때문에 불필요하게 재료가 낭비되는 것을 방지할 수 있다. Such a color filter may be manufactured by methods such as a dyeing method, a pigment dispersion method, a printing method, and an electrodeposition method. In addition, a color filter including a quantum dot composition may be prepared by an ink jet method. Since the inkjet method uses materials only for desired pixels, unnecessary waste of materials can be prevented.
또한, 본 발명은 전술한 양자점 조성물을 포함하는 디스플레이 장치를 제공한다. 여기서 디스플레이 장치는 액정표시장치(LCD), 전계발광표시장치(EL), 플라스마표시장치(PDP), 전계방출표시장치(FED), 유기발광소자(OLED) 등이 있는데, 이에 한정되지 않는다. In addition, the present invention provides a display device comprising the quantum dot composition described above. Here, the display device includes a liquid crystal display (LCD), an electroluminescence display (EL), a plasma display (PDP), a field emission display (FED), an organic light emitting diode (OLED), and the like, but is not limited thereto.
이하에서, 실시예를 통하여 본 발명을 보다 상세히 설명한다. 그러나, 이하의 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위가 실시예로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through examples. However, the following examples are only for exemplifying the present invention, and the scope of the present invention is not limited to the examples.
[양자점(QD)의 합성예][Synthesis Example of Quantum Dot (QD)]
1) 200ml 플라스크에서 아연 아세테이트 및 올레산을 1-옥타데센(octadecene)에 용해시키고 진공 하에 약 120℃로 가열한 다음 상온으로 식혀 아연 올리에이트 용액을 얻는다. 1) Dissolve zinc acetate and oleic acid in 1-octadecene in a 200 ml flask, heat to about 120° C. under vacuum, and then cool to room temperature to obtain a zinc oleate solution.
2) 반응 플라스크에서 상기 아연 올리에이트와 함께 인듐 아세테이트 및 라우릴산을 진공 하에 약 120℃로 가열한다. 인듐과 라우릴산의 몰 비는 약 1:3으로 한다. 약 1시간 후 반응기 내 분위기를 질소로 전환한다. 반응 플라스크 내 온도를 약 250℃로 올리면서 트리스(트리메틸실릴)포스핀(tris(trimethylsilyl)phosphine: TMS3P)과 트리옥틸포스핀(이하, TOP)의 혼합용액 및 선택에 따라 상기 아연 올리에이트 용액을 상기 반응기 내에 신속히 주입한다. 반응 진행 중 상기 반응 플라스크에 인듐 올리에이트 용액, TMS3P 혼합용액 및 아연 올리에이트를 순차적으로 주입한다. 총 반응시간은 약 30분으로 한다.2) Heat indium acetate and lauryl acid together with the above zinc oleate to about 120° C. under vacuum in a reaction flask. The molar ratio of indium to laurylic acid is about 1:3. After about 1 hour, the atmosphere in the reactor is changed to nitrogen. While raising the temperature in the reaction flask to about 250 ° C., a mixed solution of tris (trimethylsilyl) phosphine (TMS 3 P) and trioctylphosphine (hereinafter referred to as TOP) and optionally the zinc oleate The solution is rapidly injected into the reactor. During the reaction, an indium oleate solution, a TMS 3 P mixed solution, and zinc oleate are sequentially injected into the reaction flask. The total reaction time is about 30 minutes.
3) Se를 약 120℃에서 TOP에 분산시켜 Se/TOP 용액을 준비한다. 또한, S를 TOP에 분산시켜 S/TOP 용액을 준비한다. 3) Prepare a Se/TOP solution by dispersing Se in TOP at about 120°C. In addition, S is dispersed in TOP to prepare an S/TOP solution.
4) 아연 아세테이트와 올레산을 300 mL의 반응기에서 트리옥틸아민(TOA)에 용해시키고 약 120℃에서 약 10분간 진공 처리하여 아연 전구체를 얻는다. 질소(N2)로 상기 플라스크 내를 치환한 후 약 280℃로 승온하고, 소정의 시간 동안 온도를 유지한다.4) Zinc acetate and oleic acid are dissolved in trioctylamine (TOA) in a 300 mL reactor and subjected to vacuum treatment at about 120° C. for about 10 minutes to obtain a zinc precursor. After replacing the inside of the flask with nitrogen (N 2 ), the temperature is raised to about 280° C., and the temperature is maintained for a predetermined time.
5) 제조된 InZnP 코어 및 제조한 Se/TOP를 소정의 비율로 부가한 다음 약 300 ℃이상의 고온으로 가열하여 반응시켜 ZnSe 함유 층을 형성한다.5) The prepared InZnP core and the prepared Se/TOP are added at a predetermined ratio and heated to a high temperature of about 300° C. or more to react to form a ZnSe-containing layer.
6) Se 전구체가 소진된 시점에서, S/TOP와 약 0.07 mmol의 ZnCl2를 동시에 주입한다. 총 1시간 반응하여 ZnS 함유 층을 형성한다.6) When the Se precursor is consumed, S/TOP and about 0.07 mmol of ZnCl 2 are simultaneously injected. It reacts for a total of 1 hour to form a ZnS-containing layer.
7) InZnP/ZnSe/ZnS (core/shell/shell) 양자점이 만들어진다. 최종 산물로서 소수성의 TOA 용매에 분산된 상기 양자점과 반응 잔류물(올레산, TOP 등) 등 불순물을 포함하는 용액이 수득된다.7) InZnP/ZnSe/ZnS (core/shell/shell) quantum dots are made. As a final product, a solution containing the quantum dots dispersed in a hydrophobic TOA solvent and impurities such as reaction residues (oleic acid, TOP, etc.) is obtained.
[제조예 1] 1차 리간드의 제조[Preparation Example 1] Preparation of primary ligand
1) Thioglycolic acid 0.271mol, Triethylene glycol monomethyl ether 0.276mol, p-toluene sulfonic acid monohydrate(촉매) 0.027mol을 cyclohexane 350ml에 혼합하고, 질소 환경에서 약 18시간 동안 약 80℃에서 반응시킨다. 1) Thioglycolic acid 0.271mol, triethylene glycol monomethyl ether 0.276mol, and p-toluene sulfonic acid monohydrate (catalyst) 0.027mol are mixed with 350ml cyclohexane and reacted at about 80℃ for about 18 hours in a nitrogen environment.
2) 반응이 종료되면 cyclohexane을 제거한 후 chloroform에 용해시킨다. 2) When the reaction is complete, remove cyclohexane and dissolve in chloroform.
3) NaHCO3 수용액으로 중화 후 MgSO4로 불순물을 제거한다. 3) Neutralize with NaHCO 3 aqueous solution and remove impurities with MgSO 4 .
4) 잔여 용제를 제거하여 Methoxy triethylene glycol thioglycolate(이하 MTEGT 또는 1차 리간드라고 함)를 얻는다.4) Residual solvent is removed to obtain methoxy triethylene glycol thioglycolate (hereinafter referred to as MTEGT or primary ligand).
[제조예 2-1] 2차 리간드 2-1의 제조[Preparation Example 2-1] Preparation of secondary ligand 2-1
1) Mercaptosuccinic acid 0.271mol, Triethylene glycol butyl ether 0.276mol, p-toluene sulfonic acid monohydrate(촉매) 0.027mol을 cyclohexane 350ml에 혼합하여 질소 환경에서 약 18시간 동안 약 80℃에서 반응시킨다. 1) Mercaptosuccinic acid 0.271mol, triethylene glycol butyl ether 0.276mol, p-toluene sulfonic acid monohydrate (catalyst) 0.027mol mixed with cyclohexane 350ml and reacted at about 80℃ for about 18 hours in a nitrogen environment.
2) 반응이 종료되면 cyclohexane을 제거한 후 chloroform에 용해시킨다.2) When the reaction is complete, remove cyclohexane and dissolve in chloroform.
3) NaHCO3 수용액으로 중화 후 MgSO4로 불순물을 제거한다. 3) Neutralize with NaHCO 3 aqueous solution and remove impurities with MgSO 4 .
4)잔여 용제를 제거하여 Bis-(butoxy triethylene glycol)mercaptosuccinate (이하 BTEGMS라고 함)를 수득한다.4) Remove the residual solvent to obtain Bis-(butoxy triethylene glycol)mercaptosuccinate (hereinafter referred to as BTEGMS).
5) ZnCl2와 BTEGMS를 약 1:3의 몰비로 반응시켜 2차 리간드 2-1로서 Zn-(BTEGMS)2를 얻는다.5) Zn-(BTEGMS) 2 is obtained as the secondary ligand 2-1 by reacting ZnCl 2 and BTEGMS at a molar ratio of about 1:3.
[제조예 2-2] 2차 리간드 2-2의 제조[Preparation Example 2-2] Preparation of secondary ligand 2-2
1) Thioglycolic acid 0.271mol, poly(ethylene glycol)methyl ether 550(수평균 분자량 550 g/mol) 0.276mol, p-toluene sulfonic acid monohydrate 0.027mol을 cyclohexane 350ml에 혼합하여 질소 환경에서 약 18시간 동안 약 80℃에서 반응시킨다. 1) Thioglycolic acid 0.271 mol, poly(ethylene glycol)methyl ether 550 (number average molecular weight 550 g/mol) 0.276 mol, and p-toluene sulfonic acid monohydrate 0.027 mol were mixed in 350 ml of cyclohexane and stirred in a nitrogen environment for about 18 hours at about 80 g/mol. reacted at °C.
2) 반응이 종료되면 cyclohexane을 제거한 후 chloroform에 용해시킨다.2) When the reaction is complete, remove cyclohexane and dissolve in chloroform.
3) NaHCO3 수용액으로 중화후 MgSO4로 불순물을 제거한다. 3) Neutralize with NaHCO 3 aqueous solution and remove impurities with MgSO 4 .
4) 잔여 용제는 제거하여 PEG 550-thioglycolate(이하 PEG550-T라고 함)를 수득한다.4) Residual solvent is removed to obtain PEG 550-thioglycolate (hereinafter referred to as PEG550-T).
5) ZnCl2와 PEG550-T를 약 1:3의 몰비로 반응시켜 2차 리간드 2-2로서 Zn-(PEG550-T)2를 얻는다.5) Zn-(PEG550-T) 2 is obtained as a secondary ligand 2-2 by reacting ZnCl 2 and PEG550-T at a molar ratio of about 1:3.
[제조예 2-3] 2차 리간드 2-3의 제조[Preparation Example 2-3] Preparation of secondary ligand 2-3
둥근 플라스크에 염화아연(ZnCl2)과 하기 화학식 A-1로 표시되는 화합물을 약 1:3 몰비로 사이클로헥실 아세테이트(Cyclohexyl acetate)에 넣은 뒤 약 60℃에서 열 교반을 통해 용해시킨다. 그 후 진공상태에서 약 2시간 동안 HCl을 제거하여 2차 리간드 2-3을 제조하였다.In a round flask, zinc chloride (ZnCl 2 ) and a compound represented by Formula A-1 are put into cyclohexyl acetate at a molar ratio of about 1:3 and then dissolved by thermal stirring at about 60°C. Thereafter, HCl was removed in a vacuum for about 2 hours to prepare a secondary ligand 2-3.
[A-1][A-1]
[제조예 2-4] 2차 리간드 2-4의 제조[Preparation Example 2-4] Preparation of secondary ligand 2-4
제조예 2-3에서 화학식 A-1로 표시되는 화합물 대신 하기 화학식 A-2로 표시되는 화합물을 사용하는 것을 제외하고는 제조예 2-3과 동일하게 수행하여 2차 리간드 2-4를 제조하였다.Secondary ligand 2-4 was prepared in the same manner as in Preparation Example 2-3, except that the compound represented by Formula A-2 was used instead of the compound represented by Formula A-1 in Preparation Example 2-3. .
[A-2][A-2]
[제조예 2-5] 2차 리간드 2-5의 제조[Preparation Example 2-5] Preparation of secondary ligand 2-5
제조예 2-3에서 화학식 A-1로 표시되는 화합물 대신 하기 화학식 A-3으로 표시되는 화합물을 사용하는 것을 제외하고는 제조예 2-3과 동일하게 수행하여 2차 리간드 2-5를 제조하였다.Secondary ligand 2-5 was prepared in the same manner as in Preparation Example 2-3, except that the compound represented by Formula A-3 was used instead of the compound represented by Formula A-1 in Preparation Example 2-3. .
[A-3][A-3]
[제조예 2-6] 2차 리간드 2-6의 제조[Preparation Example 2-6] Preparation of secondary ligand 2-6
제조예 2-3에서 화학식 A-1로 표시되는 화합물 대신 하기 화학식 A-4로 표시되는 화합물을 사용하는 것을 제외하고는 제조예 2-3과 동일하게 수행하여 2차 리간드 2-6을 제조하였다.Secondary ligand 2-6 was prepared in the same manner as in Preparation Example 2-3, except that the compound represented by Formula A-4 was used instead of the compound represented by Formula A-1 in Preparation Example 2-3. .
[A-4][A-4]
[제조예 2-7] 2차 리간드 2-7의 제조[Preparation Example 2-7] Preparation of secondary ligand 2-7
제조예 2-3에서 화학식 A-1로 표시되는 화합물 대신 하기 화학식 A-5로 표시되는 화합물을 사용하는 것을 제외하고는 제조예 2-3과 동일하게 수행하여 2차 리간드 2-7을 제조하였다.Secondary ligand 2-7 was prepared in the same manner as in Preparation Example 2-3, except that the compound represented by Formula A-5 was used instead of the compound represented by Formula A-1 in Preparation Example 2-3. .
[A-5][A-5]
[제조예 3-1] 3차 리간드 3-1의 제조[Preparation Example 3-1] Preparation of tertiary ligand 3-1
둥근 플라스크에 하기 화학식 B-1로 표시되는 화합물을 사이클로헥실 아세테이트(Cyclohexyl acetate)에 20wt%로 넣은 뒤, 상온에서 약 1시간 교반하여 3차 리간드 3-1을 제조하였다.After putting the compound represented by the following formula B-1 in cyclohexyl acetate at 20wt% in a round flask, the mixture was stirred at room temperature for about 1 hour to prepare a tertiary ligand 3-1.
[B-1][B-1]
[제조예 3-2] 3차 리간드 3-2의 제조[Preparation Example 3-2] Preparation of tertiary ligand 3-2
제조예 3-1에서 화학식 B-1로 표시되는 화합물 대신 하기 화학식 B-2로 표시되는 화합물을 사용하는 것을 제외하고는 제조예 3-1과 동일하게 수행하여 3차 리간드 3-2를 제조하였다.A tertiary ligand 3-2 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-2 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
[B-2][B-2]
[제조예 3-3] 3차 리간드 3-3의 제조[Preparation Example 3-3] Preparation of tertiary ligand 3-3
제조예 3-1에서 화학식 B-1로 표시되는 화합물 대신 하기 화학식 B-3으로 표시되는 화합물을 사용하는 것을 제외하고는 제조예 3-1과 동일하게 수행하여 3차 리간드 3-3을 제조하였다.Tertiary ligand 3-3 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-3 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
[B-3][B-3]
[제조예 3-4] 3차 리간드 3-4의 제조[Preparation Example 3-4] Preparation of tertiary ligand 3-4
제조예 3-1에서 화학식 B-1로 표시되는 화합물 대신 하기 화학식 B-4로 표시되는 화합물을 사용하는 것을 제외하고는 제조예 3-1과 동일하게 수행하여 3차 리간드 3-4를 제조하였다.A tertiary ligand 3-4 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-4 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
[B-4][B-4]
[제조예 3-5] 3차 리간드 3-5의 제조[Preparation Example 3-5] Preparation of tertiary ligand 3-5
제조예 3-1에서 화학식 B-1로 표시되는 화합물 대신 하기 화학식 B-5로 표시되는 화합물을 사용하는 것을 제외하고는 제조예 3-1과 동일하게 수행하여 3차 리간드 3-5를 제조하였다.A tertiary ligand 3-5 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-5 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
[B-5][B-5]
[제조예 3-6] 3차 리간드 3-6의 제조[Preparation Example 3-6] Preparation of tertiary ligand 3-6
제조예 3-1에서 화학식 B-1로 표시되는 화합물 대신 하기 화학식 B-6으로 표시되는 화합물을 사용하는 것을 제외하고는 제조예 3-1과 동일하게 수행하여 3차 리간드 3-6을 제조하였다.A tertiary ligand 3-6 was prepared in the same manner as in Preparation Example 3-1, except that the compound represented by Formula B-6 was used instead of the compound represented by Formula B-1 in Preparation Example 3-1. .
[B-6][B-6]
<실시예 1> 양자점 조성물의 제조<Example 1> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
상기 앙자점(QD)의 합성예에 따라 InZnP/ZnSe/ZnS 양자점을 합성한다. 양자점이 합성된 용액에서 양자점을 분리정제하는 과정을 거치지 않는다.InZnP/ZnSe/ZnS quantum dots are synthesized according to the synthesis example of the QD. It does not go through the process of separating and purifying the quantum dots from the solution in which the quantum dots are synthesized.
1-2. 양자점의 표면 개질1-2. Surface modification of quantum dots
1) 상기 양자점이 합성된 용액(약 300g)의 온도를 낮춰 약 80℃로 유지한 상태에서 상기 제조예 1에 따른 MTEGT(1차 리간드)를 cyclohexylacetate에 20wt%로 희석시킨 용액 6.2g을 넣고 약 5시간 교반하여, 상기 양자점을 1차 표면 개질하였다.1) While the temperature of the solution (about 300 g) in which the quantum dots were synthesized was lowered and maintained at about 80 ° C, 6.2 g of a solution diluted with 20 wt% of MTEGT (primary ligand) according to Preparation Example 1 in cyclohexylacetate was added to about After stirring for 5 hours, the quantum dots were subjected to primary surface modification.
2) 상기 1차 표면 개질된 양자점을 포함한 용액의 온도를 약 30℃로 낮추고, 상기 제조예 2-1에 따른 2차 리간드 2-1(Zn-(BTEGMS)2)를 cyclohexylacetate에 20wt%로 희석시킨 용액 0.8g을 넣고 약 90분 교반하여, 2차 표면 개질하였다.2) The temperature of the solution containing the primary surface-modified quantum dots was lowered to about 30 ° C, and the secondary ligand 2-1 (Zn- (BTEGMS) 2 ) according to Preparation Example 2-1 was diluted to 20 wt% in cyclohexylacetate 0.8 g of the prepared solution was added and stirred for about 90 minutes to perform secondary surface modification.
3) 상온으로 냉각시켜 반응을 종료한다.3) Cool to room temperature to complete the reaction.
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
1) 상기 표면 개질이 완료된 양자점을 포함한 용액을 헥산과 아세톤으로 원심분리하여 양자점 파우더를 얻는다.1) Quantum dot powder is obtained by centrifuging the surface-modified quantum dot-containing solution with hexane and acetone.
2) 상기 양자점 파우더를 1,6-hexandiol diacrylate에 50wt%로 분산시켜 QD분산액 1을 제조하였다.2) QD dispersion 1 was prepared by dispersing the quantum dot powder in 1,6-hexandiol diacrylate at 50wt%.
1-4. 1-4. QD ink 조성물의 제조Preparation of QD ink composition
1) 확산제로 TiO2 파우더를 1,6-hexandiol diacrylate에 약 50wt% 로 분산시키고, 입도 분포에 있어서의 90% 입자경(D90) 크기가 300nm를 넘지 않도록 하여 TiO2 분산액을 준비하였다.1) A TiO 2 dispersion was prepared by dispersing about 50wt% of TiO 2 powder in 1,6-hexandiol diacrylate as a dispersing agent and ensuring that the 90% particle diameter (D90) in the particle size distribution did not exceed 300 nm.
2) QD 분산액 1 80g, TiO2 분산액 8g, TPO-L 1g, 1,6-hexandiol diacrylate 11g을 혼합하여 QD Ink(조성물 1)를 제조하였다. 2) QD Ink (Composition 1) was prepared by mixing 80 g of QD dispersion 1, 8 g of TiO 2 dispersion, 1 g of TPO-L, and 11 g of 1,6-hexandiol diacrylate.
<실시예 2> 양자점 조성물의 제조<Example 2> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
실시예 1과 동일하다.Same as Example 1.
1-2. 양자점의 표면 개질1-2. Surface modification of quantum dots
1) 제조예 3-2에 따른 3차 리간드 3-2(mono(2-acryloyloxyethyl) succinate, MEAS)를 준비한다.1) Prepare tertiary ligand 3-2 (mono (2-acryloyloxyethyl) succinate, MEAS) according to Preparation Example 3-2.
2) 실시예 1과 동일하게 양자점을 두 차례 표면 개질한다.2) As in Example 1, the surface of the quantum dots is modified twice.
3) 2차 개질된 양자점을 포함하는 용액의 온도를 다시 약 30℃로 낮추고, 상기 용액에 약 1.19g의 MEAS을 넣고 약 90분 동안 교반하여, 양자점을 3차 표면 개질하였다.3) The temperature of the solution containing the secondary modified quantum dots was lowered again to about 30° C., and about 1.19 g of MEAS was added to the solution and stirred for about 90 minutes to perform tertiary surface modification of the quantum dots.
4) 상온으로 냉각시켜 반응을 종료한다.4) Cool to room temperature to complete the reaction.
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
실시예 1과 동일한 방법으로 QD 분산액 2를 제조하였다.QD dispersion 2 was prepared in the same manner as in Example 1.
1-4. 1-4. QD ink 조성물의 제조Preparation of QD ink composition
실시예 1과 동일한 방법으로 제조하되, QD 분산액 1 대신 QD 분산액 2를 혼합하여 QD Ink(조성물 2)를 제조하였다. QD Ink (Composition 2) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 2 instead of QD Dispersion 1.
<실시예 3> 양자점 조성물의 제조<Example 3> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
실시예 1과 동일하다. Same as Example 1.
1-2. 양자점의 표면 개질1-2. Surface modification of quantum dots
Zn-(BTEGMS)2 대신에 Zn-(PEG550-T)2(2차 리간드 2-2)를 사용한 것을 제외하고 실시예 1과 동일하게 진행한다.Example 1 was performed except that Zn-(PEG550-T) 2 (secondary ligand 2-2) was used instead of Zn-(BTEGMS) 2 .
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
실시예 1과 동일한 방법으로 QD 분산액 3을 제조하였다.QD dispersion 3 was prepared in the same manner as in Example 1.
1-4. QD ink 조성물의 제조1-4. Preparation of QD ink composition
실시예 1과 동일한 방법으로 제조하되, QD 분산액 1 대신 QD 분산액 3을 혼합하여 QD Ink(조성물 3)를 제조하였다. QD Ink (Composition 3) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 3 instead of QD Dispersion 1.
<실시예 4> 양자점 조성물의 제조<Example 4> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
실시예 1과 동일하다. Same as Example 1.
1-2. 양자점의 표면 개질1-2. Surface modification of quantum dots
Zn-(BTEGMS)2 대신에 Zn-(PEG550-T)2(2차 리간드 2-2)를 사용한 것을 제외하고 실시예 2와 동일하게 진행한다.Example 2 was performed except that Zn-(PEG550-T) 2 (secondary ligand 2-2) was used instead of Zn-(BTEGMS) 2 .
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
실시예 1과 동일한 방법으로 QD 분산액 4를 제조하였다.QD dispersion 4 was prepared in the same manner as in Example 1.
1-4. QD ink 조성물의 제조1-4. Preparation of QD ink composition
실시예 1과 동일한 방법으로 제조하되, QD 분산액 1 대신 QD 분산액 4를 혼합하여 QD Ink(조성물 4)를 제조하였다.QD Ink (Composition 4) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 4 instead of QD Dispersion 1.
<실시예 5> 양자점 조성물의 제조<Example 5> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
실시예 1과 동일하다. Same as Example 1.
1-2. 양자점의 표면 개질1-2. Surface modification of quantum dots
Zn-(PEG550-T)2(2차 리간드 2-2)를 cyclohexylacetate에 20wt%로 희석시킨 용액을 1.56g 사용한 것을 제외하고 실시예 3과 동일하게 진행한다.The same procedure as in Example 3 was performed except that 1.56 g of a solution in which Zn-(PEG550-T) 2 (secondary ligand 2-2) was diluted to 20wt% in cyclohexylacetate was used.
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
실시예 1과 동일한 방법으로 QD 분산액 5를 제조하였다.QD dispersion 5 was prepared in the same manner as in Example 1.
1-4. QD ink 조성물의 제조1-4. Preparation of QD ink composition
실시예 1과 동일한 방법으로 제조하되, QD 분산액 1 대신 QD 분산액 5를 혼합하여 QD Ink(조성물 5)를 제조하였다. QD Ink (Composition 5) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 5 instead of QD Dispersion 1.
<실시예 6> 양자점 조성물의 제조<Example 6> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
실시예 1과 동일하다. Same as Example 1.
1-2. 양자점의 표면 개질1-2. Surface modification of quantum dots
Zn-(PEG550-T)2(2차 리간드 2-2)를 cyclohexylacetate에 20wt%로 희석시킨 용액을 1.56g 사용한 것을 제외하고 실시예 4와 동일하게 진행한다.The same procedure as in Example 4 was performed except that 1.56 g of a solution in which Zn-(PEG550-T) 2 (secondary ligand 2-2) was diluted to 20wt% in cyclohexylacetate was used.
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
실시예 1과 동일한 방법으로 QD 분산액 6를 제조하였다.QD dispersion 6 was prepared in the same manner as in Example 1.
1-4. QD ink 조성물의 제조1-4. Preparation of QD ink composition
실시예 1과 동일한 방법으로 제조하되, QD 분산액 1 대신 QD 분산액 6를 혼합하여 QD Ink(조성물 6)를 제조하였다.QD Ink (Composition 6) was prepared in the same manner as in Example 1, but by mixing QD Dispersion 6 instead of QD Dispersion 1.
<비교예 1> 양자점 조성물의 제조<Comparative Example 1> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
실시예 1과 동일하다.Same as Example 1.
1-2. 양자점의 표면 개질1-2. Surface modification of quantum dots
상기 양자점이 합성된 용액(약 300g)의 온도를 낮춰 약 50℃로 유지한 상태에서 2-(2-Methoxyethoxy)acetic acid(이하 MEAA라고 함)를 cyclohexylacetate에 20wt%로 희석시킨 용액 6.4g을 넣고 약 5시간 교반하여 상기 양자점을 표면 개질하였다. 상온으로 냉각시켜 반응을 종료하였다.While the temperature of the solution (about 300 g) in which the quantum dots were synthesized was lowered and maintained at about 50 ° C, 6.4 g of a solution diluted with 20 wt% of 2- (2-Methoxyethoxy) acetic acid (hereinafter referred to as MEAA) in cyclohexylacetate was added. The surface of the quantum dots was modified by stirring for about 5 hours. The reaction was terminated by cooling to room temperature.
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
실시예 1과 동일한 방법으로 QD 비교분산액 1을 제조하였다.QD comparative dispersion 1 was prepared in the same manner as in Example 1.
<비교예 2> 양자점 조성물의 제조<Comparative Example 2> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
실시예 1과 동일하다.Same as Example 1.
1-2. 양자점 표면 계질 단계1-2. Quantum dot surface layering step
MEAA 대신 MTEGT를 사용한 것을 제외하고는 비교예 1과 동일하게 양자점을 개질하였다.Quantum dots were modified in the same manner as in Comparative Example 1, except that MTEGT was used instead of MEAA.
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
실시예 1과 동일한 방법으로 QD 비교분산액 2를 제조하였다.In the same way as in Example 1 QD comparative dispersion 2 was prepared.
1-4. QD ink 조성물의 제조1-4. Preparation of QD ink composition
실시예 1과 동일한 방법으로 제조하되, QD 분산액 1 대신 QD 비교분산액 2를 혼합하여 QD Ink(비교조성물 2)를 제조하였다. QD Ink (Comparative Composition 2) was prepared in the same manner as in Example 1, but by mixing QD Comparative Dispersion 2 instead of QD Dispersion 1.
<비교예 3> 양자점 조성물의 제조<Comparative Example 3> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
실시예 1과 동일하게 양자점을 제조하되, 합성된 양자점을 포함하는 용액을 상온으로 냉각하여 에탄올 및 아세톤으로 원심분리하여 양자점 파우더를 얻는다.Quantum dots are prepared in the same manner as in Example 1, but the solution containing the synthesized quantum dots is cooled to room temperature and centrifuged with ethanol and acetone to obtain quantum dot powder.
1-2. 양자점의 표면 개질1-2. Surface modification of quantum dots
1) 상기 양자점 파우더를 cyclohexylacetate에 약 20wt%로 분산시킨다.1) Disperse the quantum dot powder in cyclohexylacetate at about 20wt%.
2) 분산된 상기 양자점 용액(약 100g)의 온도를 약 60℃로 승온시켜서 유지하고 Zn-(BTEGMS)2(2차 리간드 2-1)을 약 15g을 주입하여 약 3시간동안 교반하여 1차 표면 개질하였다. 2) The temperature of the dispersed quantum dot solution (about 100 g) was raised to about 60 ° C and maintained, and about 15 g of Zn- (BTEGMS) 2 (secondary ligand 2-1) was injected and stirred for about 3 hours to obtain the first surface modified.
3) 이어서 MEAS(3차 리간드 3-2)가 cyclohexylacetate에 약 20wt%로 희석되어 있는 용액 100g을 넣고 약 3시간 교반하여 2차 표면 개질하였다.3) Subsequently, 100 g of a solution in which MEAS (tertiary ligand 3-2) was diluted to about 20 wt% in cyclohexylacetate was added and stirred for about 3 hours to perform secondary surface modification.
4) 상온으로 냉각하여 반응을 종료한다. 4) The reaction is terminated by cooling to room temperature.
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
실시예 1과 동일한 방법으로 QD 비교분산액 3을 제조하였다.QD comparative dispersion 3 was prepared in the same manner as in Example 1.
1-4. 1-4. QD ink 조성물의 제조Preparation of QD ink composition
실시예 1과 동일한 방법으로 제조하되, QD 분산액 1 대신 QD 비교분산액 3을 혼합하여 QD Ink(비교조성물 3)를 제조하였다. QD Ink (Comparative Composition 3) was prepared in the same manner as in Example 1, but by mixing QD Comparative Dispersion 3 instead of QD Dispersion 1.
<비교예 4> 양자점 조성물의 제조<Comparative Example 4> Preparation of quantum dot composition
1-1. 양자점의 제조1-1. Fabrication of quantum dots
비교예 3과 동일하다.Same as Comparative Example 3.
1-2. 양자점의 표면 개질1-2. Surface modification of quantum dots
1차 표면 개질단계에서 Zn-(BTEGMS)2 (2차 리간드 2-1) 대신 Zn-(PEG550-T)2(2차 리간드 2-2) 약 30g을 사용한 것을 제외하고는 비교예 3과 동일하다. Same as Comparative Example 3 except that about 30 g of Zn-(PEG550-T) 2 (secondary ligand 2-2) was used instead of Zn-(BTEGMS) 2 (secondary ligand 2-1) in the first surface modification step. do.
1-3. 양자점-모노머 분산액의 제조1-3. Preparation of quantum dot-monomer dispersion
실시예 1과 동일한 방법으로 QD 비교분산액 4를 제조하였다.QD comparative dispersion 4 was prepared in the same manner as in Example 1.
1-4. 1-4. QD ink 조성물의 제조Preparation of QD ink composition
실시예 1과 동일한 방법으로 제조하되, QD 분산액 1 대신 QD 비교분산액 4를 혼합하여 QD Ink(비교조성물 4)를 제조하였다. QD Ink (Comparative Composition 4) was prepared in the same manner as in Example 1, but by mixing QD Comparative Dispersion 4 instead of QD Dispersion 1.
실시예 1 내지 6 및 비교예 1 내지 4를 정리하면 아래의 표 1과 같다.Examples 1 to 6 and Comparative Examples 1 to 4 are summarized in Table 1 below.
<시험예 1> QD 분산액의 분산성, 절대양자효율(QE), 발광 파장 및 반치폭 측정<Test Example 1> Measurement of dispersibility, absolute quantum efficiency (QE), emission wavelength and full width at half maximum of QD dispersion
실시예 1 내지 6 및 비교예 1 내지 4에서 얻은 QD 분산액 1 내지 6 및 QD 비교분산액 1 내지 4의 QD 침전여부를 살펴 분산성을 확인하고, QD 분산액의 절대양자효율 QE(오츠카, QE-2000), 파장 및 반치폭를 측정하였다. 그 결과를 하기의 표 2에 나타내었다.QD dispersions 1 to 6 and QD comparative dispersions 1 to 4 obtained in Examples 1 to 6 and Comparative Examples 1 to 4 were examined for QD precipitation to confirm dispersibility, and the absolute quantum efficiency of the QD dispersions QE (Otsuka, QE-2000 ), wavelength and full width at half maximum were measured. The results are shown in Table 2 below.
상기 표 2에 나타나는 바와 같이, 양자점이 합성된 용액에 MEAA 1종만 사용했을 때(QD 비교분산액 1), 리간드 치환 후 모노머와의 극성이 맞지 않아 QD의 분산성이 저하되어 침전이 발생한 것이 확인되었다. 그 외에는 침전물 없이(Clear) 분산성이 양호하였다. As shown in Table 2, when only one type of MEAA was used in the solution in which the quantum dots were synthesized (QD comparative dispersion 1), it was confirmed that the dispersibility of QDs decreased due to the polarity of the monomers after ligand substitution and precipitation occurred. . Other than that, the dispersibility was good without precipitate (Clear).
리간드를 1종만 사용한 QD 비교분산액 1과 2를 비교할 때, QD 비교분산액 2만이 분산 가능하였는데, 이는 MEAA(QD 비교분산액 1)보다 MTEGT(QD 비교분산액 2)에서 반복되는 ethylene glycol 구조가 더 많아, QD 표면이 더 친수성으로 개질되었고 그로 인해 분산성이 향상된 것으로 판단된다.When comparing QD comparative dispersions 1 and 2 using only one ligand, only QD comparative dispersion 2 was dispersible, which means that MTEGT (QD comparative dispersion 2) has more repeated ethylene glycol structures than MEAA (QD comparative dispersion 1). It is believed that the QD surface was modified to be more hydrophilic, thereby improving the dispersibility.
1차 리간드(MTEGT)를 1종만 사용한 QD 비교분산액 2와 비교하여, QD 분산액 1 내지 6과 같이 리간드를 2종 이상 사용한 경우 QE 값이 모두 99.4% 이상이므로, 리간드를 2종 이상 사용한 경우 절대양자효율이 좀 더 우수한 것이 확인되었다. Compared to QD comparative dispersion 2 using only one primary ligand (MTEGT), when two or more ligands were used, such as QD dispersions 1 to 6, the QE values were all over 99.4%, so when two or more ligands were used, the absolute quantum It was confirmed that the efficiency was slightly better.
양자점의 합성 후 바로 리간드 치환을 진행한 경우(QD 분산액 1 내지 6)와 합성 후 분리정제된 QD에 리간드 치환을 진행한 경우(QD 비교분산액 3 및 4)를 비교할 때, QE 값의 유의한 차이가 없거나 보다 우수한 것이 확인되었다. 마찬가지로 QD 분산액/비교분산액은 모두 발광 파장이 약 523~524nm이고, 반치폭은 39~40nm로 거의 비슷한 값을 가지는 것을 확인하였다. Significant difference in QE value when comparing the case where ligand substitution was performed immediately after synthesis of quantum dots (QD dispersions 1 to 6) and the case where ligand substitution was performed on separated and purified QDs after synthesis (QD comparative dispersions 3 and 4) It was confirmed that there is no or better. Likewise, it was confirmed that both the QD dispersion/comparative dispersion had an emission wavelength of about 523 to 524 nm and a half width of 39 to 40 nm, which were almost similar values.
따라서, 본 발명에 따르면 QD 합성 이후에 곧바로 리간드 치환이 가능하고 그에 따른 QD 분산성 및 QE의 저하가 일어나지 않으며, 파장 및 반치폭 값이 유사하여 분리정제된 QD에 리간드 치환을 진행한 경우와 비교하여 성능상 유의한 차이가 없거나 보다 우수한 면이 있었다.Therefore, according to the present invention, ligand substitution is possible immediately after QD synthesis, and QD dispersibility and QE do not decrease accordingly. There was no significant difference in performance or there was a better aspect.
<시험예 2> 제조된 조성물의 점도, 광흡수율 및 QE 확인<Test Example 2> Confirmation of viscosity, light absorption and QE of the prepared composition
실시예 1 내지 6 및 비교예 2 내지 4에서 제조된 QD Ink 조성물/비교조성물의 점도를 점도계(RheoStress MARS-40, HAAKE 사)를 이용하여 상온(25℃)에서 100rpm으로 2분간 측정하고, 그 결과를 하기의 표 3에 나타내었다. The viscosity of the QD Ink compositions/comparative compositions prepared in Examples 1 to 6 and Comparative Examples 2 to 4 was measured for 2 minutes at 100 rpm at room temperature (25° C.) using a viscometer (RheoStress MARS-40, manufactured by HAAKE), and the The results are shown in Table 3 below.
실시예 1 내지 6 및 비교예 2 내지 4에서 제조된 QD Ink 조성물/비교조성물을 스핀코팅 방법(스핀코팅기, Mikasa 사, Opticoat MS-A150)으로 유리 기판위에 10㎛ 두께로 도포하여 395nm UV를 조사하여 4000mJ(83℃, 4초)로 노광하여 경화막을 제조하였다. 적분구 장비(QE-2100, otsuka electronics)에 2cm x 2cm 단막 시편을 로딩하여, 초기 광흡수율을 측정하고 QE를 측정(오츠카, QE-2000)하였다. 이후 질소 분위기 하 180℃에서 30분 동안 열처리(Post-Bake)한 후 QE를 측정하였다. 그 결과를 하기의 표 3에 나타내었다.The QD Ink composition/comparative composition prepared in Examples 1 to 6 and Comparative Examples 2 to 4 was applied on a glass substrate to a thickness of 10 μm by a spin coating method (spin coater, Mikasa, Opticoat MS-A150) and irradiated with 395 nm UV. and exposed to light at 4000 mJ (83° C., 4 seconds) to prepare a cured film. A 2 cm x 2 cm single-film specimen was loaded into an integrating sphere equipment (QE-2100, otsuka electronics), the initial light absorption was measured and the QE was measured (Otsuka, QE-2000). Thereafter, QE was measured after heat treatment (Post-Bake) at 180 ° C. for 30 minutes under a nitrogen atmosphere. The results are shown in Table 3 below.
상기 표 3에 기재하지 않았으나, MTEGT(1차 리간드)로 1차 표면 개질하지 않고, 양자점이 합성된 용액에 곧바로 Zn-(BTEGMS)2(2차 리간드 2-1)로 표면 개질한 경우에는 양자점 표면 개질이 이루어지지 않았다. 따라서, MTEGT로 1차 표면 개질해주어야 2차 또는 3차의 표면 개질이 가능한 것으로 보인다.Although not shown in Table 3, in the case of surface modification with Zn-(BTEGMS) 2 (secondary ligand 2-1) directly in the solution synthesized with quantum dots without primary surface modification with MTEGT (primary ligand), quantum dots No surface modification was made. Therefore, it seems that the first surface modification with MTEGT is necessary for the second or third surface modification.
상기 표 3에 나타나는 바와 같이, 2종 이상의 리간드를 사용한 조성물 1 내지 6이 리간드 1종만 사용한 비교조성물 2보다 열처리 전후 QE 값의 차이가 적어, 외부 열원에 대한 안정성(신뢰성)이 우수하고, QD 조성물을 이용한 제품생산에 필요한 후속 열처리 공정에서 QD 성능이 잘 유지될 수 있다는 것을 확인하였다. As shown in Table 3, compositions 1 to 6 using two or more ligands have a smaller difference in QE values before and after heat treatment than Comparative Composition 2 using only one ligand, and thus have excellent stability (reliability) against an external heat source, and QD composition It was confirmed that the QD performance can be well maintained in the subsequent heat treatment process required for product production using .
이러한 특성은, 금속이 결합되지 않은 1차 리간드(MTEGT)보다 금속이 결합된 2차 리간드(Zn-(BTEGMS)2, Zn-(PEG550-T)2)가 QD와의 결합력이 더 커서 QD 표면에 더 안정적으로 결합하여 리간드의 탈리가 줄어들기 때문인 것으로 판단된다.This characteristic is due to the fact that metal-bonded secondary ligands (Zn-(BTEGMS) 2 , Zn-(PEG550-T) 2 ) have a higher binding force with QDs than non-metal-bonded primary ligands (MTEGT), which makes it easier to adhere to the QD surface. It is believed that this is because the ligand is bound more stably and the detachment of the ligand is reduced.
리간드 2종을 사용한 조성물 1, 3, 5와 리간드 3종을 사용한 조성물 2, 4, 6을 각각 대응하여 비교할 때 조성물 2, 4, 6이 더 낮은 점도를 가지며, 열처리 전후 QE 값의 차이가 더 적다는 것을 확인하였다. 이러한 특성은, 3차 리간드를 추가하게 되면, QD표면에 결합하지 않고 단순히 물리적으로 붙어있는 1차 또는 2차 리간드의 탈리를 유도하여, 리간드끼리 또는 리간드와 1,6-hexandiol diacrylate간의 응집(aggregation)을 방지해주기 때문인 것으로 보인다.When comparing compositions 1, 3, and 5 using two ligands and compositions 2, 4, and 6 using three ligands, respectively, compositions 2, 4, and 6 have lower viscosities, and the difference in QE values before and after heat treatment is higher. It was confirmed that less When a tertiary ligand is added, this property induces detachment of the primary or secondary ligand that is simply physically attached without binding to the QD surface, resulting in aggregation between ligands or between ligands and 1,6-hexandiol diacrylate. ) appears to be prevented.
2차 리간드 2-2를 사용한 조성물 3 및 4는 조성물 1, 2에 비하여 점도가 25cps 이상으로 다소 높고, 열처리 전후 QD 값이 차이도 더 크다. 이는 2차 리간드 2-2로서 Zn-(PEG550-T)2의 분자량이 다소 높아 상대적으로 QD 표면에 결합된 2차 리간드 2-2의 몰당량이 조성물 1, 2에 비하여 적어지기 때문인 것으로 보인다. Compositions 3 and 4 using the secondary ligand 2-2 have slightly higher viscosities than those of Compositions 1 and 2, at 25 cps or more, and a larger difference in QD values before and after heat treatment. This seems to be because the molecular weight of Zn-(PEG550-T) 2 as the secondary ligand 2-2 is relatively high, and the molar equivalent of the secondary ligand 2-2 bound to the QD surface is relatively small compared to Compositions 1 and 2.
이러한 문제를 해소하기 위하여 조성물 5 및 6은 조성물 3, 4와 리간드 구성은 동일하되, 2차 리간드 2-2를 2배로 첨가하여 QD를 개질하였다. 조성물 5 및 6은 조성물 3 및 4와 각각 대응하여 비교할 때, 점도가 더 낮아지고 광흡수율이 향상되었으며, 열처리 전후 QE 값의 유지정도는 매우 향상됨을 확인하였다. 또한, 조성물 5와 6을 비교할 때는 3차 리간드로 3차 개질까지 진행한 조성물 6이 보다 우수한 점도 및 광특성을 나타내었다. 따라서, 본 분야의 통상의 기술자는 필요한 점도, QE 값의 신뢰성 등을 고려하여 2차 리간드의 첨가량 및 3차 리간드의 첨가여부 등을 조절할 수 있을 것이다.In order to solve this problem, compositions 5 and 6 had the same ligand composition as compositions 3 and 4, but the secondary ligand 2-2 was added twice to modify the QD. Compositions 5 and 6 were confirmed to have lower viscosity and improved light absorption when compared to compositions 3 and 4, respectively, and the degree of retention of the QE value before and after heat treatment was greatly improved. In addition, when comparing Compositions 5 and 6, Composition 6, which was subjected to tertiary modification with a tertiary ligand, exhibited better viscosity and optical properties. Therefore, those skilled in the art will be able to adjust the addition amount of the secondary ligand and whether or not to add the tertiary ligand in consideration of the necessary viscosity and the reliability of the QE value.
QD 합성 후 해당 용액에서 바로 리간드 치환을 진행한 조성물 1, 2, 5 및 6의 점도, 광흡수율 및 QE 값들(UV경화, 경화 및 열처리)은 분리정제된 QD를 사용한 비교조성물 3, 4와 비슷하거나 더 우수한 것이 확인되었다. 따라서 QD 합성 후 해당 용액에서 곧바로 리간드 치환이 가능하며 그에 따라 조성물의 점도를 추가적으로 더 낮출 수 있고, 광흡수율과 QE의 저하가 일어나지 않음이 확인되었다.The viscosity, light absorption rate, and QE values (UV curing, curing, and heat treatment) of Compositions 1, 2, 5, and 6, in which ligand substitution was performed immediately after QD synthesis, were similar to those of Comparative Compositions 3 and 4 using separated and purified QDs. or was found to be superior. Therefore, it was confirmed that ligand substitution is possible in the solution immediately after QD synthesis, and accordingly, the viscosity of the composition can be further lowered, and the light absorption rate and QE do not decrease.
본 발명은 상기 실시예에 한정되지 않고, 본 발명의 기술적 요지를 벗어나지 아니하는 범위 내에서 다양하게 수정 또는 변형되어 실시될 수 있음은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 자명한 것이다.It is obvious to those skilled in the art that the present invention is not limited to the above embodiments and can be variously modified or modified without departing from the technical gist of the present invention. it did
Claims (35)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024516968A JP7728966B2 (en) | 2021-09-28 | 2022-09-19 | Solvent-free quantum dot composition and method for producing the same, cured film containing the same, color filter and display device |
| CN202280062970.7A CN117980437A (en) | 2021-09-28 | 2022-09-19 | Solvent-free quantum dot composition, method of preparing the same, cured film, color filter and display device including the same |
| US18/692,656 US12173210B2 (en) | 2021-09-28 | 2022-09-19 | Solventless quantum dot composition, method for producing same, and cured film, color filter, and display device comprising same |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210128262A KR102684636B1 (en) | 2021-09-28 | 2021-09-28 | Solvent-free quantumdot composition, manufacturing method thereof and cured film, color filter and display device using the same |
| KR10-2021-0128262 | 2021-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023054952A1 true WO2023054952A1 (en) | 2023-04-06 |
Family
ID=85783066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2022/013950 Ceased WO2023054952A1 (en) | 2021-09-28 | 2022-09-19 | Solventless quantum dot composition, method for producing same, and cured film, color filter, and display device comprising same |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12173210B2 (en) |
| JP (1) | JP7728966B2 (en) |
| KR (1) | KR102684636B1 (en) |
| CN (1) | CN117980437A (en) |
| WO (1) | WO2023054952A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024164835A (en) * | 2023-05-15 | 2024-11-27 | 三星電子株式会社 | Hydrophilic quantum dots, hydrophilic solvent-based quantum dot ink composition containing the same, and light-emitting device and display containing the same |
| US12195635B1 (en) | 2024-01-19 | 2025-01-14 | Applied Materials, Inc. | Liquid dispersion of quantum dot particles |
| JP2025063864A (en) * | 2023-10-04 | 2025-04-16 | 三星電子株式会社 | Quantum dot composition, method for producing same, cured product thereof, and display device including same |
| WO2025155296A1 (en) * | 2024-01-19 | 2025-07-24 | Applied Materials, Inc. | Liquid dispersion of quantum dot particles |
| WO2025220996A1 (en) * | 2024-04-16 | 2025-10-23 | 삼성에스디아이 주식회사 | Quantum dot composition, cured film and display device |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250022949A (en) * | 2023-08-08 | 2025-02-18 | 삼성디스플레이 주식회사 | Quantum dot complex, manufacturing method thereof and display device comprising the same |
| KR20250114190A (en) * | 2024-01-19 | 2025-07-29 | 삼성디스플레이 주식회사 | Quantum dot-containing complex, quantum dot composition including same and electronic device including same |
| WO2025192886A1 (en) * | 2024-03-14 | 2025-09-18 | 삼성에스디아이 주식회사 | Curable composition, cured layer manufactured using composition, color filter comprising cured layer, and display device comprising color filter |
| KR102878190B1 (en) * | 2024-03-28 | 2025-11-03 | 주식회사 한솔케미칼 | Manufacturing method for regenerated quantum dot ink composition, regenerated quantum dot ink composition manufactured thereby, color filter and display device comprising the same |
| KR20250145956A (en) * | 2024-03-29 | 2025-10-13 | 주식회사 한솔케미칼 | Solvent free quantum dot ink and manufacturing method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101350257B1 (en) * | 2012-08-28 | 2014-01-16 | 연세대학교 산학협력단 | Preparing method for fluorescence film, fluorescence film thereby, and display device containing the film |
| KR20190050726A (en) * | 2017-11-03 | 2019-05-13 | 삼성전자주식회사 | Quantum dot composition. quantum dot polymer composite, and layered structures and electronic devices including the same |
| KR20200090493A (en) * | 2019-01-21 | 2020-07-29 | 삼성에스디아이 주식회사 | Quantum dot, curable composition comprising the same, curing layer using the composition, color filter including the curing layer, display device and manufacturing method of the curing layer |
| CN111518543A (en) * | 2019-02-01 | 2020-08-11 | 苏州星烁纳米科技有限公司 | Quantum dot dispersion system, color film and display device |
| KR20210109112A (en) * | 2020-02-26 | 2021-09-06 | 삼성디스플레이 주식회사 | Quantum dot ink composition, apparatus using the same, and light emitting device using the same |
| WO2022163950A1 (en) * | 2021-01-27 | 2022-08-04 | 주식회사 한솔케미칼 | Solventless quantum dot composition, preparation method therefor, and cured film, color filter and display device which comprise same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11737301B2 (en) * | 2018-03-19 | 2023-08-22 | Samsung Electronics Co., Ltd. | Electroluminescent device, and display device comprising thereof |
-
2021
- 2021-09-28 KR KR1020210128262A patent/KR102684636B1/en active Active
-
2022
- 2022-09-19 US US18/692,656 patent/US12173210B2/en active Active
- 2022-09-19 CN CN202280062970.7A patent/CN117980437A/en active Pending
- 2022-09-19 WO PCT/KR2022/013950 patent/WO2023054952A1/en not_active Ceased
- 2022-09-19 JP JP2024516968A patent/JP7728966B2/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101350257B1 (en) * | 2012-08-28 | 2014-01-16 | 연세대학교 산학협력단 | Preparing method for fluorescence film, fluorescence film thereby, and display device containing the film |
| KR20190050726A (en) * | 2017-11-03 | 2019-05-13 | 삼성전자주식회사 | Quantum dot composition. quantum dot polymer composite, and layered structures and electronic devices including the same |
| KR20200090493A (en) * | 2019-01-21 | 2020-07-29 | 삼성에스디아이 주식회사 | Quantum dot, curable composition comprising the same, curing layer using the composition, color filter including the curing layer, display device and manufacturing method of the curing layer |
| CN111518543A (en) * | 2019-02-01 | 2020-08-11 | 苏州星烁纳米科技有限公司 | Quantum dot dispersion system, color film and display device |
| KR20210109112A (en) * | 2020-02-26 | 2021-09-06 | 삼성디스플레이 주식회사 | Quantum dot ink composition, apparatus using the same, and light emitting device using the same |
| WO2022163950A1 (en) * | 2021-01-27 | 2022-08-04 | 주식회사 한솔케미칼 | Solventless quantum dot composition, preparation method therefor, and cured film, color filter and display device which comprise same |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024164835A (en) * | 2023-05-15 | 2024-11-27 | 三星電子株式会社 | Hydrophilic quantum dots, hydrophilic solvent-based quantum dot ink composition containing the same, and light-emitting device and display containing the same |
| JP7765148B2 (en) | 2023-05-15 | 2025-11-06 | 三星電子株式会社 | Hydrophilic quantum dots, hydrophilic solvent-based quantum dot ink composition containing the same, and light-emitting device and display containing the same |
| JP2025063864A (en) * | 2023-10-04 | 2025-04-16 | 三星電子株式会社 | Quantum dot composition, method for producing same, cured product thereof, and display device including same |
| US12195635B1 (en) | 2024-01-19 | 2025-01-14 | Applied Materials, Inc. | Liquid dispersion of quantum dot particles |
| WO2025155296A1 (en) * | 2024-01-19 | 2025-07-24 | Applied Materials, Inc. | Liquid dispersion of quantum dot particles |
| WO2025220996A1 (en) * | 2024-04-16 | 2025-10-23 | 삼성에스디아이 주식회사 | Quantum dot composition, cured film and display device |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024538522A (en) | 2024-10-23 |
| JP7728966B2 (en) | 2025-08-25 |
| CN117980437A (en) | 2024-05-03 |
| KR20230045423A (en) | 2023-04-04 |
| KR102684636B1 (en) | 2024-07-16 |
| US12173210B2 (en) | 2024-12-24 |
| US20240287382A1 (en) | 2024-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2023054952A1 (en) | Solventless quantum dot composition, method for producing same, and cured film, color filter, and display device comprising same | |
| WO2022163950A1 (en) | Solventless quantum dot composition, preparation method therefor, and cured film, color filter and display device which comprise same | |
| WO2018080008A1 (en) | Spontaneous-emission type photosensitive resin composition, color filter manufactured using same, and image display apparatus | |
| WO2012002780A2 (en) | Composition for light-emitting particle-polymer composite, light-emitting particle-polymer composite, and device including the light-emitting particle-polymer composite | |
| WO2021034104A1 (en) | Quantum dot film comprising quantum dot composite, and wavelength conversion sheet for display | |
| WO2019098601A1 (en) | Method for manufacturing quantum dot film, quantum dot film manufactured thereby and wavelength conversion sheet and display comprising same | |
| WO2018151457A1 (en) | Color filter and image display device | |
| WO2020004927A1 (en) | Method for preparing quantum dot film, quantum dot film prepared thereby, and wavelength conversion sheet and display comprising same | |
| WO2015064864A1 (en) | Compensation film and organic dot for compensation film | |
| WO2018143628A1 (en) | Quantum dot dispersion, self-emission type photosensitive resin composition, color filter, and image display device | |
| WO2015060615A1 (en) | Light-emitting complex, hardened material comprising same, optical sheet, backlight unit, and display device | |
| WO2022059942A1 (en) | Curable composition, cured film produced using same, and color filter comprising same | |
| WO2018074726A1 (en) | Quantum dot dispersion, spontaneous emission photosensitive resin composition containing same, color filter manufactured using same, and image display device | |
| WO2018110808A1 (en) | Yellow curable resin composition, color filter manufactured using same and image display device | |
| WO2018093090A1 (en) | Photosensitive resin composition, color filter, and image display device | |
| WO2025206550A1 (en) | Method for preparing recycled quantum dot ink composition, recycled quantum dot ink composition prepared thereby, and color filter and display device comprising same | |
| WO2022124768A1 (en) | Optical sheet having wavelength selectivity and reliability and display device comprising same | |
| WO2014073893A1 (en) | Nanocomposite, and optical member and backlight unit comprising same | |
| KR102367705B1 (en) | Solvent-free quantumdot composition, manufacturing method thereof and cured film, color filter and display device using the same | |
| WO2018093021A1 (en) | Yellow curable resin composition, and color filter and image display device comprising same | |
| WO2022239992A1 (en) | Ink composition, layer using same, and electrophoresis device and display device comprising same | |
| WO2024035042A1 (en) | Ink composition, and electronic device comprising film formed using same | |
| WO2021221304A1 (en) | Compound, anti-reflective film including same, and display device | |
| WO2025100936A1 (en) | Quantum dot, method for producing quantum dot, composition comprising quantum dot, and electronic device | |
| WO2024232536A1 (en) | Quantum dot, method for manufacturing quantum dot, photosensitive resin composition thereof, and electronic device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22876727 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2024516968 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202280062970.7 Country of ref document: CN |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 22876727 Country of ref document: EP Kind code of ref document: A1 |